Cancers are probably pound for pound the least documented side effect of the genetic covid vaccines in the case report literature.

Firstly, the nexus between covid vaccines and cancer is inherently far murkier and harder to spot on an individual basis, for two reasons:

1. On the whole, there’s going to be a substantial time gap between vaccination and clinical manifestation of the cancer

2. Partly because of #1, and also because of the uncharted pathological territory for the novel mRNA platform, doctors are less likely to think there may be a connection between their patient’s cancer and vaccination.

Secondly, even if a doctor thinks that there might be a connection between some aspect of a cancer’s pathology and the patient’s covid vaccines, it is not the sort of thing that lends itself to being written up as a case report:

1. Because of the time gap and lack of direct pathological evidence, it is intrinsically more speculative and less grounded in discrete evidence that you can identify, and so less likely to be written up as a case study

2. The censorship regime, and the culture of golden calving the covid vaccines more generally, regards criticism of the covid vaccines with a very wary eye, something that is especially intense when it comes to the potential genotoxicity of the covid vaccines which is a very big deal.

Thus doctors and clinicians are less likely to even entertain a possible relationship between a cancer and the vaccination status of a covid patient, and much less submit a study with their name attached claiming the possibility of a covid vaccine-induced cancer.

Conversely, there is substantial evidence both anecdotally and in population and economic data that there is ongoing widespread excess cancer incidence, morbidity and mortality especially in highly vaccinated countries.

https://twitter.com/EthicalSkeptic/status/1786115396870746541

There are also multiple well-grounded hypotheses for the mechanistic plausibility that the covid vaccines possess substantial oncogenicity, including the likelihood of reverse transcription of mRNA or contaminant DNA into cellular DNA, the interference of the spike protein with the P53 tumor suppression gene, and the dysregulation of critical TLR’s critical for cancer surveillance, among others.

(Both of these points I presume anyone reading this are already quite familiar with so we needn’t belabor the point further here.)

So I decided to check how many case reports were there that I could identify as documenting a cancer case possibly related to vaccination, which resulted in the list below:

• 29 case reports that documented a cancer whose genesis and/or metastasis was potentially attributable at least in part to vaccination.

• Seven additional case reports documented a cancer, but framed it as an incidental or background phenomenon. I included these because while it may be that these cancers were truly “with” vaccination and not “because” of vaccination (like the with/because of covid dichotomy that created hundreds of thousands of phantom covid deaths and millions of phantom cases), it may also very well be the case that these cancers were impacted by vaccination. The fact that the case report authors did not think so is immaterial, because of the widespread ignorance about the carcinogenic potential of the covid vaccines and that doctors are heavily biased to avoid drawing such a connection.

• Three case reports I found documented benign tumors that were judged possibly attributable to a covid vaccine. These are significant because the ability to cause benign tumors - especially in light of the broader evidence base here - implies the potential to cause malignant tumors, plus benign tumors can sometimes turn malignant.

• Finally, there are two case reports where the covid vaccine led to a spontaneous and unexpected regression of the cancer. Although superficially these case reports might seem to reflect favorably upon the covid vaccines, the fact that the covid vaccines can spur tumor regression points to something far more ominous - that the covid vaccines interfere with or reprogram the immune system in unanticipated ways, including the mechanics of how the immune system deals with cancers. There’s an old medical adage “a cure for one is poison for another”. The fact that the covid vaccines can interfere with the immune system’s cancer-fighting ability in a positive way suggests an ability to do so in a deleterious manner as well in others.

I also included a quote from each case report discussing the potential causal role of the covid vaccine if there was one that was written in clear enough language inside the study.

So without further ado….

1. A Case of Chronic Myelomonocytic Leukemia Unmasked After Receiving J&J COVID-19 Vaccine (Veerballi et al)

https://pubmed.ncbi.nlm.nih.gov/35865440/

"Our case suggests the possibility of developing CMML associated with limited scleroderma after receiving the J&J COVID vaccine."

2. Anaplastic large cell lymphoma at the SARS-CoV2 vaccine injection site (Revenga-Porcel et al)

https://pubmed.ncbi.nlm.nih.gov/36166359/

*paywall*

3. Bell's palsy or an aggressive infiltrating basaloid carcinoma post-mRNA vaccination for COVID-19? A case report and review of the literature (Kyriakopoulos AM et al)

https://pubmed.ncbi.nlm.nih.gov/37927346/

"Overall, the short time frame and extremely invasive characteristics of BCC metastases in our patient suggest that immune system disturbances by the mRNA anti-COVID-19 vaccination may have led to the accelerated progression of the disease."

"A serious limitation in the case we report is the refusal of the hospital that performed the biopsy to provide the histopathological images or perform immunohistochemical staining for the spike protein."

4. COVID-19 Vaccine-Induced Expansion of Pituitary Adenoma: A Case Report (Srimanan W & Panyakorn S)

https://pubmed.ncbi.nlm.nih.gov/38229808/

"Pituitary gland tumors are slowly growing, primarily asymptomatic, with incidental findings. Early detection, reduced aggravating factors, and specific treatment are essential. The COVID-19 vaccine represents a novel potential contributor to the enlargement of the pituitary gland. Individuals with preexisting pituitary adenomas should be particularly vigilant regarding the possible side effects associated with this vaccine."

5. Development of High-Grade Sarcoma After Second Dose of Moderna Vaccine (Bae E et al)

https://pubmed.ncbi.nlm.nih.gov/37197108/

"Based on an extensive search, we describe the first case of rapidly progressive, high-grade undifferentiated sarcoma that seems to have a strong association with the Moderna vaccination."

[Bonus: "It is well-documented in the literature for over 20 years that high-grade sarcomas have been linked to vaccine administration in felines."]

6. Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination (Tachita et al)

https://pubmed.ncbi.nlm.nih.gov/37093551/

"Although the lymphoma lesions of previous reports were not observed at the vaccine injection sites, our case had a lymphoma lesion in the skin and muscle at the BNT162b2 mRNA-vaccine injection site. It is possible that our case is of different pathogenesis from previous reports, in that the disease occurred relatively late after vaccination and at the site of vaccine injection." "There was no evidence of causal relationship between BNT162b2 mRNA vaccination and ENKL in this case, but we speculated that vaccination might lead to the development of ENKL in a manner similar to severe mosquito bite allergy (SMBA)."

7. Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature (Cavanna et al)

https://pubmed.ncbi.nlm.nih.gov/36676781/

8. Ph-Positive B-Cell Acute Lymphoblastic Leukemia Occurring after Receipt of Bivalent SARS-CoV-2 mRNA Vaccine Booster: A Case Report (Ang SY et al)

https://pubmed.ncbi.nlm.nih.gov/36984629/

"Therefore, this case report might present a possible correlation between the development of Ph–positive B-cell acute lymphoblastic leukemia and bivalent mRNA vaccinations."

9. Primary Cutaneous Adenoid Cystic Carcinoma in a Rare Location With an Immune Response to a BNT162b2 Vaccine: A Case Report (Yilmaz A et al)

https://pubmed.ncbi.nlm.nih.gov/38608126/

"The BNT162b2 mRNA vaccine has been associated with a multisystem inflammatory syndrome (MIS-V). A comparable immune reaction could potentially enhance tumor growth rate." [paywall]

10. Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report (Goldman S et al)

https://pubmed.ncbi.nlm.nih.gov/34901098/

"To the best of our knowledge, this is the first observation suggesting that administration of a SARS-CoV-2 vaccine might induce AITL progression. Several arguments support this possibility. First, the dramatic speed and magnitude of the progression manifested on two 18F-FDG PET-CT performed 22 days apart. Such a rapid evolution would be highly unexpected in the natural course in the disease. "

11. Rapid progression of marginal zone B-cell lymphoma after COVID-19 vaccination (BNT162b2): A case report (Sekizawa et al)

https://pubmed.ncbi.nlm.nih.gov/35979213/

"In our case, the same mechanism by which T-cell lymphomas are induced by the COVID-19 vaccine could be considered for the pathogenesis of MZL. mRNA COVID-19 vaccines are reported to induce T follicular helper cells with a Th1 functional profile, which is associated with selective generation of neutralizing antibodies, and stimulate germinal center B-cells, long-lived plasma cells, and memory B-cells. Therefore, these vaccines induce a stronger germinal center reaction than recombinant protein vaccines (11). However, the continuous stimulation of T- and B-cells by mRNA COVID-19 vaccines can trigger aberrant inflammatory responses, leading to lymphoma or accelerating its progression."

12. Recurrence of cutaneous T-cell lymphoma post viral vector COVID-19 vaccination (Panou et al)

https://pubmed.ncbi.nlm.nih.gov/34628691/

"The question which is raised in these cases is whether and via which pathway the vaccine has caused the MF CD30+ LCT and the reappearance of primary cutaneous CD30+ lymphoprolipherative disorder.

According to the literature, the education of CD4+ T, CD8+ T and B cells against SARS‐CoV‐2 S protein appears to be the most feasible way for COVID‐19 vaccine production. Both cancers and coronavirus provide a persistent and chronic antigenic load, amongst which PD‐1, resulting in T‐cell exhaustion. Therefore, it is important to assure the vaccination would not cause a further T‐cell exhaustion state which may have already been induced by tumour cells."

13. Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination (Brumfiel et al)

https://pubmed.ncbi.nlm.nih.gov/33974494/

*paywall*

14. Solitary Eruptive Keratoacanthoma Developing at Site of COVID-19 Vaccine Injection (Yumeen S et al)

https://pubmed.ncbi.nlm.nih.gov/38015786/

"Our case report adds to the literature by describing development of a malignant lesion that may occur following COVID-19 vaccination, and warrants prompt recognition and treatment."

15. Two cases of axillary lymphadenopathy diagnosed as diffuse large B-cell lymphoma developed shortly after BNT162b2 COVID-19 vaccination (Mizutani et al)

https://europepmc.org/article/pmc/pmc9114986

"Thus, it might be conceivable that pre‐existing or subclinical DLBCL may rapidly grow in a specific condition induced by BNT162b2 vaccination." "In conclusion, DLBCL may rapidly grow after BNT162b2 vaccination. Dermatologists should pay attention to enlarging LNs or mass near the injection site of BNT162b2 vaccine."

16. Unilateral conjunctival Classic Kaposi Sarcoma following a COVID 19 booster (White E et al)

https://pubmed.ncbi.nlm.nih.gov/38601193/

"In that the vaccine booster preceded the cancer, it appears etiologic to the appearance of Kaposi's sarcoma. The patient's monocular vision and glaucoma complicated her treatment. This case expands on current concepts of cofactors needed for the development of Kaposi's sarcoma in that vaccine booster administration was relevant to tumor progression and both clinical and mechanistic evidence is presented to support this hypothesis." "In this particular case, it appears that COVID19 vaccination acted as one of the additional co-factors necessary to induce KS in that there was no other clear cause other than the temporal relationship between booster vaccine and development of KS."

17. A Case Report of Posttransplant Lymphoproliferative Disorder After AstraZeneca Coronavirus Disease 2019 Vaccine in a Heart Transplant Recipient (Tang WR et al)

https://pubmed.ncbi.nlm.nih.gov/34702598/

"In summary, we hypothesize that the vaccine may contribute to B lymphocyte tumorigenesis via the reactivation of latent EBV." "We report a case of PTLD after COVID-19 vaccination in a heart transplant recipient, which might show a possible pathogenic link. Although we are not able to exclude the coincidence of COVID-19 vaccination and the development of PTLD in this case, transplant surgeons should be aware of the immunomodulatory effect after COVID-19 vaccination and always think the worst until proven otherwise."

18. Case report: A case of metastatic BRAFV600-mutated melanoma with heart failure treated with immune checkpoint inhibitors and BRAF/MEK inhibitors (Nishizawa A et al)

https://pubmed.ncbi.nlm.nih.gov/38529375/

"In the present case, the vaccine might have elicited a strong immune response, leading to the spontaneous resolution of the primary tumor while simultaneously promoting the axillary lymph node metastasis."

19. Fatal hemophagocytic lymphohistiocytosis with intravascular large B-cell lymphoma following coronavirus disease 2019 vaccination in a patient with systemic lupus erythematosus: an intertwined case (Ueda Y et al)

https://pubmed.ncbi.nlm.nih.gov/38619098/

"We  speculate  that  the  COVID-19  vaccination  and    our    patient’s    autoimmune    condition,    which    predisposes   her   to   develop   lymphoma,   may   have   contributed  to  IVLBCL  development.  The  activation  of  the  B  cell  activating  factor  belonging  to  the  tumor  necrosis  factor  family  (BAFF)  pathway  was  seen  in  aggressive  B  cell  lymphoma"

20. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases (Zamfir et al)

https://www.mdpi.com/1648-9144/58/7/874

"To our knowledge, this is the first report of a severe post-vaccination oral manifestation, immunohistochemically confirmed as T/NK-cell non-Hodgkin lymphoma, emerging within days after mRNA COVID-19 vaccination."

21. Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine (Erdogdu B et al)

https://avesis.hacettepe.edu.tr/yayin/64667112-eb73-4bd3-b8c5-d5df96cc4e09/hematopoietic-adverse-events-associated-with-bnt162b2-mrna-covid-19-vaccine

22. Indolent cutaneous lymphoma with gamma/delta expression after COVID-19 vaccination (Hobayan CG & Chung CG)

https://pubmed.ncbi.nlm.nih.gov/36530557/

"Our patient’s presentation is unusual as it arose at the site of a COVID-19 vaccination several days after vaccination." "Since this presentation and course are not typical of PCGDTCL, it is unclear if his lesions represent an indolent variant of PCGDTCL or other lymphoma with gamma/delta expression. It is unknown if the COVID-19 vaccine directly contributed to his presentation or disease course. One additional case report shows an atypical lymphoproliferative lesion with features mimicking lymphoma following the vaccine booster, monotypic proliferation of B-cells was found histologically."

23. Primary cardiac mesothelioma presenting with fulminant recurrent pericarditis: a case report (Schwartzenberg et al)

https://pubmed.ncbi.nlm.nih.gov/36937239/

"To the best of our knowledge, this is the only second case of pathologically confirmed pericarditis that transformed into mesothelioma,17 in this case within only 4 months. It is unlikely that an earlier correct diagnosis would have made a clinical difference in this case in view of the accelerated disease course."

24. Sporadic Kaposi Sarcoma Following a COVID-19 Vaccine: Mere Coincidence or Something More? (Martínez-Ortega JI et al)

https://pubmed.ncbi.nlm.nih.gov/38465101/

"KSHV is an absolute requirement of oncogenesis and is a direct carcinogen, so when we are looking into the relationship between the AstraZeneca vaccine and Kaposi sarcoma, we may focus on the reactivation of KSHV [1].

Studies have shown that spike proteins of SARS-CoV-2 can reactivate the lytic phase of KSHV. The ChAdOx1 nCoV-19 vaccine contains DNA eDNA-encoding proteins. If these spike proteins encounter HHV8-infected cells, it could potentially trigger the reactivation of the virus, leading to the lytic phase." "While more research is needed to establish a definitive connection, the evidence discussed in this report points to potential mechanisms involving KSHV reactivation, the influence of adenovirus-induced inflammation, and spike protein-related effects."

25. Subcutaneous panniculitis-like T-cell lymphoma after COVID-19 vaccination (Kreher et al)

https://pubmed.ncbi.nlm.nih.gov/35966352/

"In this manuscript, we present a case of SPTCL that developed following the Ad26 viral vector–based COVID-19 vaccine (Janssen Pharmaceuticals). Although causation cannot be established in this single case, this case supports the understanding that certain immunologic triggers, such as a modified adenovirus vaccine, may contribute to the development or exacerbation of SPTCL. Aberrant immune function or lymphocyte hyperstimulation may also be responsible. For example, an association has been established between SPTCL and systemic lupus erythematosus, Sjögren’s syndrome, type 1 diabetes mellitus, and juvenile idiopathic arthritis."

26. Subcutaneous panniculitis-like T-cell lymphoma post-mRNA-1273 COVID-19 vaccination (Ukishima et al)

https://pubmed.ncbi.nlm.nih.gov/37035606/

"Overall, more research is needed to examine possible associations between COVID‐19 vaccination and SPTCL. In this case, COVID‐19 vaccines may cause SPTCL, and skin biopsy at an early stage may help in the diagnosis of erythema nodosum."

27. The case of T-ALL presenting with NK phenotype after COVID-19 vaccination (Yanagida E et al)

https://pubmed.ncbi.nlm.nih.gov/36706586/

"Although the presence of a direct causal relationship between T-ALL and COVID-19 vaccination is unclear, the immunization could be directly related to the immune response of the host." "Although the relationship between vaccination and the onset of this case is unclear, we have reported that careful observation of similar cases is required in order to elucidate the pathophysiology."

28. The first autopsy case of Epstein-Barr virus-positive marginal zone lymphoma that deteriorated after COVID-19 vaccination (Wang Z et al)

https://pubmed.ncbi.nlm.nih.gov/38116849/

*paywall*

29. Unusual Clinical Presentation of Clear Cell Sarcoma in a Young Woman (Asif S et al)

https://pubmed.ncbi.nlm.nih.gov/37877807/

Documented as Incidental/Background in the Case Report

30. Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum (Musaddaq et al)

https://pubmed.ncbi.nlm.nih.gov/35300233/

31. Breast Cancer Screening and Axillary Adenopathy in the Era of COVID-19 Vaccination (Wolfson & Kim)

https://pubmed.ncbi.nlm.nih.gov/36219117/

32. Hypermetabolic lymphadenopathy following the administration of COVID-19 vaccine and immunotherapy in a lung cancer patient: a case report (Tripathy et al)

https://pubmed.ncbi.nlm.nih.gov/36434709/

33. Lymphedema of the Arm after COVID-19 Vaccination in a Patient with Hidden Breast Cancer and Paraneoplastic Dermatomyositis (Aimo et al)

https://pubmed.ncbi.nlm.nih.gov/36016107/

34. Metastatic melanoma in the breast and axilla: A case report (Barnett C et al)

https://pubmed.ncbi.nlm.nih.gov/35255441/

35. Metastatic prostatic adenocarcinoma presenting as generalized lymphadenopathy unmasked by a COVID booster vaccine (Bharathidasan K et al)

https://pubmed.ncbi.nlm.nih.gov/38033690/

36. Progressive multifocal leukoencephalopathy in a patient with B-cell chronic lymphocytic leukemia after COVID-19 vaccination, complicated with COVID-19 and mucormycosis: a case report (Amirifard H et al)

https://pubmed.ncbi.nlm.nih.gov/38704555/

Benign Tumors

37. Pilomatricoma Growing at the SARS-CoV-2 mRNA Vaccination Site (Erkayman MH et al)

https://pubmed.ncbi.nlm.nih.gov/38099131/

38. Reactive Angioendotheliomatosis Following Ad26.COV2.S Vaccination (Faulkner C et al)

https://pubmed.ncbi.nlm.nih.gov/38290076/

39. Development of Pilomatrixoma at the Vaccination Site: A Rare Complication of COVID-19 Vaccination - A Case Report (Yang Z et al)

https://pubmed.ncbi.nlm.nih.gov/38055654/

Vaccine Cured Cancer

40. Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination (Gambicher et al)

https://pubmed.ncbi.nlm.nih.gov/34228815/

41. Spontaneous tumor regression following COVID-19 vaccination (de Sousa LG et al)

https://pubmed.ncbi.nlm.nih.gov/35241495/

Subscribe now

COVID-19 Vaccine Cardiac Complications: A Case Series on Implications of Marijuana in Adolescents With Myopericarditis

https://pubmed.ncbi.nlm.nih.gov/35663665/

Case Presentation:

An 18-year-old previously healthy male with a past medical history of asthma presented to the emergency room for a sudden onset of chest pain. The chest pain started 30 minutes before arrival while he was vaping marijuana. He reported using increasing amounts of cannabis and vaping in the preceding few days.

Urine toxicology reports revealed marijuana was positive, and SARS-CoV-2 polymerase chain reaction (PCR) was negative. He had received his Pfizer COVID-19 vaccination two months prior to the presentation.

(Despite the implication of the title, only one of the two patients was noted for marijuana use.)

There are three significant dimensions of turpitude showcased by this case report:

• Failure of scientists and regulators to “do the science”

• Pathology of vaccine injuries - is drug use a risk factor or actively involved in the pathology of vaccine side effects?

• Epidemiological implications of contaminated data - were deaths or injuries misattributed to drug OD’s?

1. Is drug use a risk factor for vaccine injuries?

This case report suggests a possibility that recreational drugs might adversely interact with the covid vaccines. Though the authors hypothesize that the myocarditis might be exclusively attributable to the marijuana, it is irrelevant. While their suppositions might have been honestly conceived, speculative claims in an evidentiary vacuum, even unchallenged by contraindicating data hardly constitute formidable evidence. Were expert opinion a viable standard to adjudicate safety concerns, the FDA could be retired in the face of the ubiquitous claims of implausibility for unexpected adverse effects to occur prophesized for every novel product introduced to the market. Regrettably, experts seldom recognize the limits of their expertise, and vis-à-vis covid seem unaware that any exist altogether (and in the case of the FDA ought be retired regardless for incorrigible moral corruption).

It must be noted that myocarditis has been associated with marijuana use before, such as the following examples:

The authors report an 11-month-old male who, following cannabis exposure, presented with central nervous system depression after seizure, and progressed to cardiac arrest and died. Myocarditis was diagnosed post-mortem and cannabis exposure was confirmed. Given the temporal relationship of these two rare occurrences - cannabis exposure and sudden death secondary to myocarditis in an 11-month-old - as well as histological consistency with drug-induced myocarditis without confirmed alternate causes, and prior reported cases of cannabis-associated myocarditis, a possible relationship exists between cannabis exposure in this child and myocarditis leading to death.

Myocarditis has also been associated with other recreational drugs besides marijuana, such as cocaine:

In a series of 40 autopsies with cocaine-associated deaths, Virmani et al. (1988) demonstrated that myocarditis with mononuclear infiltrate was nearly 10 times more common than acute thrombotic coronary occlusion. This case illustrates such presentation of acute cocaine-induced myocarditis with aggressive myocardial necrosis and unfavourable cardiac remodelling clearly demonstrated by serial CMR studies. In the absence of coronary artery disease, the CMR study should be considered in symptomatic patients following acute cocaine use and positive biomarkers to assess the extent of myocardial injury that could be prognostically important.

However, even granting that recreational drug use can by itself instigate myocarditis, common sense cautions that exposure to multiple myocarditis antagonists might compound the risk for subsequently developing myocarditis or increase the severity in patients who subsequently develop myocarditis. It is certainly plausible that there might be unique adverse pathological potential posed by the combination of recreational drugs and the mRNA vaccines.

Moreover, the risks are not limited to myocarditis. Various recreational drugs have been associated with other toxicities that might be triggered or aggrandized in the setting of concomitant exposure to a covid vaccine. We also don’t know what we don’t know, and there is probably a vast expanse of vaccine pathogenicity we have yet to explore.

Ultimately, absent more data it is difficult to draw firm conclusions from a solitary case report, but there is undeniably mechanistic plausibility for potential toxic drug interactions between recreational drugs and the genetic covid vaccines.

Which brings us to our next point:

2. Failure of The SCIENCE™️

When releasing a new medical product onto the market for public use, it is insufficient to only test it on physically fit people who live a healthy lifestyle or in sterile laboratory conditions. If you don’t study potential interactions of environmental effects of personal behavior on a novel drug, you won’t know if there are any, unless you boldly charge forth and release it anyways. As the chief editor of the NEJM put it during the Vaccines and Related Biological Products Advisory Committee meeting to approve the covid vaccines for children, “we’re never going to learn about how safe this vaccine is unless we start giving it.” (Points for honesty at least.)

It is common knowledge that a substantial portion of the US population - especially younger people - are drug users, particularly of marijuana which has become a common and easily accessible amenity in society today. According to a Gallup poll in 2022, nearly half of all Americans have tried marijuana, and 16% are “smoke marijuana” - i.e. use marijuana with some degree of regularity:

Frequent marijuana use is notable concentrated in young adults (and presumably to a similar extent in teenagers who are not included in this survey):

Forgoing testing to discover potential toxic interactions of marijuana with the covid vaccines constitutes dereliction sufficiently egregious to disqualify everyone embroiled or responsible from any further involvement in trialing or interrogating medical product.

Some readers are probably thinking - or feeling exasperated - “they are far more evil, and did much worse deliberately, than merely failing to conduct proper science and regulatory oversight, so why are you .” The reason I am highlighting this is twofold:

1. There is still a not-insignificant group of people who are not exactly disposed to our side, but are susceptible to an argument that relies on one of their own self-professed premises, in our case that “they didn’t follow fundamental scientific protocols”.

2. As a moral concept, a murderer does not get a free pass for shoplifting a $20 trinket (legal system nonchalance notwithstanding). The failure to do proper science is a distinct crime apart from the active and deliberate evils inflicted by the establishment et al (and might well prove to be easier as a practical matter to hold them accountable for at some point).

3. Epidemiological implications of recreational drugs predisposing to vaccine injuries

The drug overdose crisis in America is one of the foremost political issues today. The number of deaths attributed to OD’s has skyrocketed over the past few years. But what if some % of the increase in ostensible OD deaths from 2021 onwards actually resulted from the lethal combination of covid vaccines and recreational drugs?

There is already some evidence to suggest that this might well be the case. One of the preeminent data geniuses of the covid era - - has been suggesting for a while that over-attributing deaths to OD’s has helped to conceal the true scope of the increase in ‘unexpected’ or ‘sudden’ deaths (#3):

If recreational drugs could trigger or exacerbate vaccine injuries, then doctors would be expected to organically attribute the death to the drug use in cases where recent drug use was noted - most doctors wouldn't dream to conceive that there might be a universe where there was the faintest possibility of adverse drug - vaccine interaction, and would therefore chalk it up to OD without any malicious intent.

I asked Ethical Skeptic about this hypothesis and he agreed, noting that “doctors are sincerely attributing vaccine deaths to overdose - because they are ill equipped to detect the difference. Until we advocate for the CDC to change the diagnostic protocol - these deaths will be inflated.”

Another observation made by Ethical Skeptic was that the number of US deaths attributed to unspecified or unidentified drug OD - i.e. where the specific drug was not indicated meaning there is a lack of clarity about the role of drug use in the death - has been markedly elevated since around March of 2021 (2020 saw a noticeable spike coinciding with the advent of lockdowns that mostly receded prior to the resurgence in 2021). ES provided an annotated chart to illustrate along with the following explanation:

These excess deaths might represent what essentially amounts to people ‘dying with’ drug usage where the doctor filling out the death certificate figured something like “well it says here that he used recreational drugs, and now he’s dead [possibly killed by a condition that could be caused by drug use], so probably an OD”.

This is not limited to mortality data. It follows that the same misattribution of deaths to drug OD would occur in morbidity data as well - doctors are equally liable to misattribute a vaccine condition to drug OD for live patients as they are for dead patients.

Either way, it must be acknowledged that at minimum there is a potential hazard of contaminated drug OD data (in addition to the other myriad taints in the morbidity and mortality datasets).

Since so little is known about the potential for toxic interaction between recreational drugs like marijuana and the covid vaccines, we are left groping about in the dark until the necessary studies and data accumulate that can resolve this issue. In the meantime, the ramifications for people who are vaccinated, and clinicians treating patients with conditions presumptively attributed to either drug use or vaccines remain quite real.

Subscribe now

• Japanese cardiologist published a study documenting his own experience with vaccinated patients

• Patients ages ranged from 78-89.5 & only 45% were male - these were *not* young men

• 21/55 (38%) of patients with pre-existing subclinical heart failure [defined as BNP ratio 4x normal upper limit] either died (6) or suffered dramatic worsening of heart failure (15) 1-8 months after vaccination

• 0/45 patients with BNP <4x the normal upper limit died or suffered worsening heart failure [defined as an increase in BNP ratio equivalent to at least 10x their baseline BNP ratio post vaccination compared to pre-vaccination] in the 1-8 months following vaccination

• The death rate in his practice over the preceding 4 years was 5-7%

• The death rate in his patients during the first six months of the time period covered by the study was double the historical rate - 13.7%

• Authors proposed that the “most likely explanation is autoimmune myocarditis”

What the study did/found (in English)

A Japanese cardiologist had treated a lot of seniors in Japan, many of whom had been vaccinated, which provided an opportunity to see if there were cardiac adverse events following vaccination.

(They published a follow-up longer term study that will be the subject of a separate substack article.)

He together with a bunch of number-cruncher scientists published a study a while back documenting a bunch of heart failures and deaths in some of his patients:

Subacute Effects of Vaccination with a Messenger RNA-based Vaccine Against Coronavirus Disease 2019 on Elderly Japanese Patients with Cardiac Disorder

https://www.researchsquare.com/article/rs-1391307/v1

(I am not surprised the peer review process seems to be dragging its feet on this one.)

Here’s how he described his experience (in the original study):

Six and 15 patients expired and exhibited significant increment of the BNP ratio, respectively; these patients had a pre-BNP ratio ≥ 4-fold higher than the UNL. Forty-five patients with a pre-BNP ratio < 4-fold higher than the UNL did not expire or show significant increase in the BNP ratio. The pre-BNP ratio was a reliable parameter for predicting cardiac deterioration after vaccination. For the booster or initial vaccination against COVID-19, the BNP ratio may be useful in assessing the cardiac status of elderly patients.

The degree of increase after vaccination (i.e., post-BNP ratio minus pre-BNP ratio) was significantly high (≥ 10-fold higher than their UNL) in five patients who expired and 15 patients who survived. Death and/or remarkable increase in the BNP ratio (i.e., ≥ 10-fold higher than the UNL) were observed only in patients with a pre-BNP ratio ≥ 4-fold higher than the UNL (21/55, 38.2%) (Table 2). In contrast, 45 patients with a pre-BNP ratio < 4-fold higher than the UNL in the pre-vaccination period did not expire or show remarkable increase in the BNP ratio (0/45, 0%) (Table 2). Hence, the pre-BNP ratio was a reliable parameter for predicting cardiac deterioration 1–8 months after vaccination [].

In plain English, 21 of his 55, or 38% (!!) of his patients with a high BNP ratio pre-vaccination (basically a way of quantifying a certain biomarker indicative of heart failure) either died or suffered worsening heart failure in the 8 months following vaccination, whereas none of his 45 patients with a low BNP ratio pre-vaccination died or suffered worsening heart failure post-vaccination.

They concluded as follows:

This study showed that vaccination against COVID-19 was associated with a high risk of death or decompensated heart failure for Japanese elderly patients with severe cardiac dysfunction and a high pre-BNP ratio ≥ 4-fold higher than the UNL (500 ng/mL in NT-pro BNP). However, the risk was negligible in patients with a pre-BNP ratio < 4-fold higher than the UNL (Table 2). The incidence of death and/or remarkable increase in the BNP ratio (i.e., ≥ 10-fold higher than the UNL) in the post-vaccination period was strongly dependent on a pre-BNP ratio ≥ 4-fold higher that the UNL (500 ng/mL in NT-pro BNP in Table 2). Cardiovascular death after the vaccination developed only in patients with a pre-BNP ratio > 12.6-fold higher than the UNL (1,575 in NT-pro BNP). Patients with a pre-BNP ratio < 4-fold higher than the UNL in the pre-vaccination period did not expire or show remarkable increase in the BNP ratio after vaccination. This cardiac deterioration was not accompanied by side effects, such as anaphylactic hemodynamic deterioration or sustained high fever in the acute phase, or myocardial infarction, liver dysfunction, or renal dysfunction (Table 1) both in the acute and subacute phases.

This study offers a very critical insight. People have a tendency to dismiss the covid vaccine as a potential cause of death in patients with pre-existing conditions. Yet, this study highlights that it is precisely in the patients with pre-existing disease that the covid vaccines are particularly dangerous.

Myocarditis?

The authors proposed that the most likely explanation for the observed cardiac side effects was that the covid vaccine triggered an autoimmune myocarditis:

The most likely explanation for this sustained myocardial involvement in the subacute phase would be autoimmune myocarditis; in other words, anti-idiotype antibodies-dependent myocarditis recently proposed by Murphy and Longo.^5,6 The primary antibody induced by vaccination against COVID-19 has antigen-binding domains with a mirror image structure of the spike protein of COVID-19. Hence, it may induce a secondary antibody with a mirror image structure of the antigen-binding domains of the primary antibody. Consequently, the secondary antibodies may be able to bind to the angiotensin-converting enzyme 2 (ACE2) receptor as the spike protein of COVID-19, thereby inducing the release of inflammatory cytokines. This hypothesis may explain our observation that myocardial dysfunction was sustained for several months after vaccination and led to the death of patients with severe damage. Nevertheless, massive myocardial necrosis was not noted. The transition of the BNP ratio suggests that myocardial damage appears to be somewhat reversible (Fig. 1C D) in certain cases, but sustained in others.

It is worth emphasizing that these were not young men - the age range here was 78-89.5, and 55% were women (!!) - but a significant % suffered what the authors suspect was autoimmune myocarditis.

Death rate during the study period was roughly double the death rate during the previous 4 years

An added strength of this study is that this cardiologist had his historical experience to serve as a control group of sorts. Whereas the death rate in his patients over the prior 4 years was about 5-7%, the death rate in his patients during the time period of the study was DOUBLE that, clocking in at *13.5%*:

The BNP and/or NT-pro BNP levels in patients with severe cardiac dysfunction may increase during the natural course of the diseases. Therefore, one may argue that the increase in the BNP ratio after vaccination may be caused by the natural course of the diseases. However, in the previous 4 years, the cardiac death rate every 6 months among patients treated by the corresponding author at home or care facilities was 5.0–7.1% (seven terms). This was accompanied by a maximum BNP ratio ranging 12.6–280-fold higher than the UNL (median: 49.4; interquartile range: 29.7–103.2) and 1,575–35,000 pg/mL in NT-pro BNP (median: 6,180, interquartile range: 3,710–12,900). Nonetheless, the cardiac death rate in the previous 6 months (May 1 to October 31, 2021) was 12 cases (13.5%), including the six patients who expired after vaccination with an mRNA-based vaccine against COVID-19. The cardiac death rate among patients treated at home or care facilities who did not receive the vaccination during the same period was six cases (6.7%).

Note: The 13.5% death rate is NOT stated as the rate for *vaccinated* patients, but for ALL patients during this time span - only 6/12 deaths were vaccinated.

Deaths involving heart failure are way up in the post-vaccine era

I previously wrote about the escalating excess from heart failure in Vermont:

In Minnesota, deaths involving heart failure have also been skyrocketing:

The degree of excess is even more pronounced if we exclude deaths in nursing home or LTC facility residents:

So… welcome to the new guiding principle of health:

Subscribe now

Prolonged infective SARS-CoV-2 omicron variant shedding in a patient with diffuse large B cell lymphoma successfully cleared after three courses of remdesivir

https://pubmed.ncbi.nlm.nih.gov/37182841/

In this case, the brilliant clinical team was able to save their patient by scrupulously adhering to the thoroughly researched NIH guidelines that reflect the best expert opinion in the world. Almost as if they were an oracle through which Science spoke or made clear its Will and Intent. This is an example of the daily miracles performed by faithful practitioners of Science. As the saying goes, Following Fauci Forecloses Fallibility. Indeed it does.

Clinical Narrative

This is gonna be a doozy, so buckle up and get ready for a wild roller coaster ride.

Basically, we have a cancer patient who came to the hospital for his sixth round of chemo (another miracle of Science). Whereupon:

On admission, the patient was tested for SARS-CoV-2 using an in-hospital rapid nicking enzyme amplification reaction (NEAR) assay with a nasopharyngeal swab, which was negative. The patient was afebrile and exhibited no respiratory symptoms.

So far so good.

Three days after admission, another patient in the same room developed respiratory symptoms and was diagnosed with coronavirus disease (COVID-19). Therefore, our patient was tested again for SARS-CoV-2 using an in-hospital loop-mediated isothermal amplification (LAMP) assay, which, too, was negative.

This is obviously attributable to the top-notch standard of care this patient was receiving.

Unfortunately, even with the best care and the most religious adherence to proper covid mitigation, sometimes Science tests us with the scourge of covid to see if we will still remain faithful to its precepts and dictates despite the [misleading] superficial appearance that Science failed (Science forfend!!):

However, six days after admission, the patient developed fever, and a repeated LAMP assay yielded positive results. At that time, the patient's body temperature increased to 38.6 °C. (101.5 °F) […] The patient was diagnosed as having symptomatic COVID-19 Moderate I according to the criteria of the Japanese Ministry of Health and Welfare, which corresponds to a patient who has a shortness of breath or pneumonia without respiratory failure.

In this particular case, Science had chosen to test this man with the most confounding blow that can be dealt to the righteous Follower of Science:

Although the patient had received two doses of the BNT162b2 vaccine approximately six months earlier and the third dose on day 127 after the infection, both serum anti-spike and anti-nuclear protein IgG and IgM tests were negative at day 92, 114, and 149 after the infection.

Just the pain of knowing that you suffered the dreaded excommunication of vaccine inefficacy can be lethal. But as we shall see, despite this monumental Test from Science, this patient and his clinical team did not falter!!

Returning to the story, the clinical team immediately leapt into action, per the proper Science of treating covid:

Remdesivir was administered for five days (200 mg on the first day, then 100 mg/day from days two to five).

This patient is so lucky to be managed by such a team so devoted to the scruples of Science!!

And the impact was felt quickly:

The patient became afebrile two days after symptom onset. As the patient's physical condition seemed to improve, no nucleic acid detection test was performed to confirm the disappearance of viral shedding.

The recovery imparted by the Blessings of Science was so overwhelming that the patient was able to resume his chemo:

Eleven days after the infection, the sixth course of R-CHOP was administered.

Well, as it so happened, Science decided that this patient should be tested again, to see if his devotion to Science was truly genuine:

Eighteen days after the infection, the patient developed fever.

The clinical team did not realize right away that this was another Test from Science, instead attributing the new bout of fever/infection to the chemo:

Initially, since the fever was considered to be due to R-CHOP neutropenia, piperacillin and tazobactam were administered; but the fever persisted, although the neutrophils recovered to normal levels.

However, the clinical team, being such expert Scientific doctors, understood the message from Science and rectified their error

A nasopharyngeal RT-qPCR swab for SARS-CoV-2 on day 47 post-infection yielded a positive cycle threshold value of 28.

Unfortunately, Science had a tougher test for the clinical team and their patient this time around - now, the covid would be more severe with some pulmonary involvement:

As the patient gradually developed cough and sputum production chest CT was performed on day 51, which revealed bilateral ground-glass opacities in both the upper and lower lobes.

Fortunately, the clinical team knew what to do, without question:

A second course of remdesivir was administered for 10 days, from day 72–81 after infection.

If only we could all be as blessed as this patient was to receive such amazing care!!

But Science’s Test of his fealty was not yet complete. Now, in a much more demanding challenge to their faith in Science, Science threw the ultimate curveball: the Remdesivir - the miracle cure bequeathed by Science - failed!!
(*Of course it didn’t truly fail, rather Science merely withheld its full potency.)

However, repeat chest CT showed progression of bilateral infiltration in both lungs. Low-grade fever and cough persisted even after administration of the second dose of remdesivir.

Faced with this unorthodox challenge to Scientific orthodoxy, the clinical team nonetheless rose to the occasion admirably:

As the patient's nasopharyngeal swab specimen taken 100 days after the infection still had infectious virus, remdesivir treatment was administered again for 10 days from days 102–111 after the infection.

At this show of absolute unquestioning acceptance of the Will of Science, while continuing to faithfully execute the instructions of Science, Science Blessed the patient and clinical team with the full abundance of its awesome power:

After the third course of remdesivir treatment, the patient became afebrile, and his cough gradually improved. The nasopharyngeal specimen obtained on day 114 showed no evidence of infection. Chest CT on day 143 after infection showed improvement in bilateral infiltration of SARS-CoV-2 […] After successful viral clearance, the patient was discharged to another long-term care facility 183 days after the infection. A rapid antigen test performed at the facility on day 200 after the infection was negative, and he did not experience recurrence of COVID-19 after the third remdesivir treatment.

This inspirational tale is a lesson to us all, that we should reinvigorate our unerring prostrations to the Great & Powerful Science. And of course, we can see from here how important it is to never deviate even the tiniest insignificant step from the dictates of Science!!

Subscribe now

Case Report #1 - “Terrifying Troponins Triad”

The first case report documents a triad of Australian triplets who all hit the myocarditis jackpot.

Myopericarditis following COVID-19 vaccination in adolescent triplets

https://pubmed.ncbi.nlm.nih.gov/37154289/

Since this study is behind a paywall, I am uploading a PDF copy someone procured for me:

Myopericarditis Following Covid19 Vaccination In Adolescent Triplets

985KB ∙ PDF file

Download

Download

Thirteen-year-old male triplets developed left-sided chest pain after receiving the Pfizer vaccination. For Triplet 1, this occurred on day three following dose one. For Triplets 2 and 3, this occurred following the second dose of Pfizer, on day four and day five post-vaccine respectively. Triplets 1 and 3 reported fever on day one post-vaccination, whereas Triplet 2 had only localised injection site pain.

In all cases, the chest pain was left-sided and radiated down the left arm. Triplet 1 had pain exacerbated by movement, whereas Triplets 2 and 3 had pain exacerbated by lying flat.

All three triplets had a history of prematurity and mild asthma, not requiring preventer therapy. They had no personal history of COVID-19 infection and had no prior, or recurrent, episodes of chest pain, and no other reported adverse events following immunisation. There was no history of congenital cardiac disease, acute pericarditis, or autoimmune disease in immediate family members. Family history of myocarditis was denied at the time of admission; however, during outpatient follow-up, it was revealed that the triplets’ maternal great aunt had an episode of non-vaccine-associated myocarditis, with concerns about a related cardiomyopathy.

Discussion

This case series describes the first case of myopericarditis secondary to Pfizer vaccination occurring in triplets, which may suggest familial risk and a possible genetic association to the underlying pathophysiology.

Case Report #2 - “Matching Myo Mates”

The second case report documents myocarditis suffered by a pair of siblings from New Zealand.

COVID Vaccine-Associated Myocarditis in Adolescent Siblings: Does It Run in the Family?

https://www.mdpi.com/2076-393X/10/4/611

Patient 1 is a 14-year-old male who presented to his general practitioner with acute-onset left-sided chest pain three days after receiving the second dose of the Pfizer–BioNTech COVID-19 vaccine. The patient was previously healthy with no comorbid conditions and no significant family history of cardiac disease.

Patient 2 is a 12-year-old male with no previous medical history or comorbid conditions and is the younger sibling of patient 1 (details in Table 1). Patient 2 presented one week following his brother’s admission with acute left-sided chest pain that developed 48 h after receiving the second dose of the Pfizer–BioNTech COVID-19 vaccine. Patient 2 displayed no symptoms of COVID infection, and a PCR test for COVID-19 was negative. There was no history of previous COVID infection.

This presentation of vaccine-associated myocarditis illustrates the need to better understand the mechanisms of this entity. Our case supports a potential genetic susceptibility; however, statistically this could also be explained by random chance. We considered alternative causes of myocarditis in our cases, including autoimmune conditions and typical viral causes. Investigations for these were negative in both siblings. Genetic background in response to environmental factors may play a role in the immune response seen in patients with myocarditis [22,23,24], such as a dysregulated cytokine response (e.g., IL-1beta, IL-17 and TNF-alpha), leading to infiltration of the myocardium [25]. Other proposed genetic mechanisms include alterations in structural proteins, creating a more vulnerable myocardium [22].

A better understanding of the mechanisms of vaccination-associated myocarditis—particularly the potential for genetic predisposition or the autoimmune response—may help guide future recommendations.

This is the first reported presentation of vaccine-associated myocarditis in siblings. This report supports a possible genetic susceptibility and illustrates the need to understand the mechanisms behind this rare cause of myocarditis.

Case Report #3 - “Kiddie Kidney Kinship”

Sibling cases of gross hematuria and newly diagnosed IgA nephropathy following SARS-CoV-2 vaccination

https://pubmed.ncbi.nlm.nih.gov/35729514/

We report the first sibling cases newly diagnosed as immunoglobulin A (IgA) nephropathy after the second dose of SARS-CoV-2 vaccination. 15- and 18-year-old men presented with gross hematuria following the second dose of SARS-CoV-2 vaccine (Pfizer, BNT162b2) received on the same day. Pathological findings of each kidney biopsy specimen were consistent with IgA nephropathy. Gross hematuria in both cases spontaneously recovered within several days.

Patient 1

A 15-year-old Japanese man with a 6-months history of microscopic hematuria was referred to our hospital due to gross hematuria 1 day after receiving the second dose of SARS-CoV-2 vaccine (Pfizer, BNT162b2). He also had fever and myalgia. He had no prior history of COVID-19 infection, nor gross hematuria after any other infections. He had no family medical history of kidney diseases.

Patient 2

An 18-year-old Japanese man with a 3-years history of microscopic hematuria was referred to our hospital due to gross hematuria 2 days after receiving the second dose of the SARS-CoV-2 vaccine (Pfizer, BNT162b2). In fact, he was the brother of patient 1 and had received the vaccination on the same day. He also had fever and general malaise. He had no prior history of COVID-19 infection, nor gross hematuria after any other infections. He had no family medical history of kidney diseases.

To our best knowledge, this is the first report showing sibling cases that developed gross hematuria and were newly diagnosed as IgA nephropathy following the SARS-CoV-2 vaccination.

One notable point in the present cases is that microscopic hematuria has already existed before the vaccination. In addition, the chronic histopathologic features such as tubulointerstitial damage indicate the possibility that the immune responses to vaccination exacerbated a pre-existing undiagnosed IgA nephropathy in our cases.

In conclusion, we report the first sibling cases of newly diagnosed IgA nephropathy who developed gross hematuria following the second dose of SARS-CoV-2 vaccination. These cases indicate that SARS-CoV-2 vaccination might stimulate the relapse or trigger de novo IgA nephropathy. On the other hand, it remains to be unknown that gross hematuria developed in our patients was caused by chance or due to the genetic related etiology. Further studies are needed to identify how this postvaccination setting can develop and how we should manage these patients with IgA nephropathy.

Observation #1: The Cray-Cray is STRONG in some people

What sort of wackadoodle parent vaccinates kid #2 after kid #1 lands in the hospital with a vaccine injury????

In a rational and sane world, it would be unthinkable for a parent to vaccinate kid #2 AFTER KID #1 ENDED UP IN THE HOSPITAL BECAUSE OF A VACCINE INJURY!!!

Unfortunately, we do not live in a sane world:

(As an aside, instead of literacy tests, we ought to require prospective voters to pass a basic logic test as a condition for voting in elections. This policy would also increase the minority share of the voting electorate because minorities are less likely to. . . ‘fail’ a basic logic test. Win-win!!)

Anyhow, as anyone reading is doubtlessly well aware, when it came to the covid vaccines logic and sanity were quickly cast aside in favor of cultist devotion to the miracle jabs. The CDC infamously advocated that people who suffered myocarditis or pericarditis after dose #1, or who had a prior history of myo/pericarditis, could/should receive [further] covid vaccinations (!!!):

The only remotely ethical and rational answer for ALL of these scenarios was an unequivocal ‘NO!!’. (The CDC uses the language “discuss with your physician” to convey that they support vaccination without explicitly saying so, in order to leave the doctors on the hook should there be subsequent legal or political liability later.)

With such demented guidance from on high, it is hardly surprising that physicians and healthcare workers would aggressively proselytize parents to vaccinate their other children even after one child suffered a severe injury that was obviously presumptively attributable to the vaccine.

In fact, there are a shocking number of case reports where doctors convinced a patient to continue with subsequent vaccinations after they suffered vaccine injuries themselves (!!!):

(*I really liked this picture so I used it as an article thumbnail again)

And there are dozens more such case report studies awaiting further installments in this series.

But we can’t just blame the doctors here (although they get the overwhelming share of the ‘credit’) - some patients were so bought into the religion of the Glorious Vaccine that it was practically a badge of honor to suffer a vaccine injury. So much so in fact that a few even declared on social media they were proud to ‘take one for the team’, had no regrets, or would do it over again even if they knew what the result would be. Kind of like an atheistic equivalent of a suicide-bomber jihadist if you will, where your sacrifice is what endows you with moral virtue and worth.

In our case reports:

• The parents in the Terrifying Troponins Triad case gave triplets 2 & 3 dose #2 after triplet 1 got myocarditis following dose #1

• The parents in the Matching Myo Mates case vaccinated the brother with dose #2 five days after brother #1 landed in the hospital with vaccine myocarditis

Indeed, the cray-cray is strong in some people.

In case #3, they got vaccinated on the same day, so there’s no parental insanity to speak of. (But maybe the parents got them boosted? Can’t rule it out. . .)

I think it is worthwhile to highlight the specific details and the more-than-usual amount of dementedness involved in these cases, even though we all have a well-developed general sense of craziness that has captured a substantial portion of humanity. Details are conducive to better clarity and higher confidence, which are important especially so when proselytizing others.

P.S. We would be remiss to not award bonus points for the mom/dad who took *TWO* more kids to get vaxxed after bro #1 landed in the hospital for a bout of vax-myo. . . who then BOTH (!!) proceeded to develop vaccine myocarditis themselves.

Observation #2: Is there a genetic component to covid vaccine injuries?

Vaccine injuries are not well understood, something hardly surprising considering that the establishment is still unwilling to concede they even exist at all.

All three studies suggest the possibility of a genetic component that affects susceptibility to vaccine injury. The odds that two siblings would not only suffer serious vaccine injury, but identical vaccine injuries is pretty low on an individual case-by-case basis. Even the most adventurous (plausible) estimates of the rates of severe vaccine injuries overall is not more than 1-2% - and that’s for all of the thousands of types of vaccine injuries.

On the other hand, it is reasonable that with a sample size of tens of millions of severe vaccine injuries worldwide, random statistical distribution would result in a few instances of siblings suffering identical SAE’s. And because such a phenomenon stands out as bizarre and also by its nature is inherently more obviously attributable to the vaccines, such instances are probably far morel likely to get published.

However, the odds that *TRIPLETS* would all suffer identical vaccine SAE’s by random chance are at least a full order of magnitude lower if not more. According to the CDC, 80/100,000 live births were triplets, or 0.08% (they have no incentive to doctor this data as far as I’m aware plus it would be pretty hard to do even if they wanted to). Furthermore, not all triplet triads got vaccinated; and despite this case report, it would stand to reason that there exist at least a few triplet triads where #’s 2 and/or 3 declined vaccination after #1 suffered an ostensible vaccine injury. So the odds of that a triplet triad exists where they (1) were all vaccinated (2) despite triplet #1 suffering a vaccine injury and (3) they all suffered severe vaccine injuries (4) that were identical - probably not good betting odds to say the least.

Can these case reports be attributed to “hot lots” instead of genetics?

I doubt it. Putting aside the question of to what degree is variability/inconsistency between different batches of vaccines responsible for fewer or larger numbers of adverse events, it doesn’t really fit the fact pattern here.

In the triplet triad, only 1/3 got myocarditis after dose #1. We confirmed with the corresponding author of the study that triplets 2 & 3 received Dose #2 from a different batch (27 days after all three received dose #1).

In the case report of the ‘myocarditis mates’, the 2nd brother presented 7 days after the first brother & 48 hours post-vaccination; the 1st brother had presented 3 days after his vaccination -- so they were vaccinated ~8 days apart. 8 days seems like a stretch to assume that the same lot was being used in the same state - and that’s assuming they were both vaccinated at the same location, which isn’t stipulated either.

***********

This is something that needs to be exhaustively probed and studied to iron out. At any rate, these case reports are definitely evidence pointing to the possibility that genetics may play a significant role in vaccine injuries and outcomes.

Alternatively, we can just hope for the best (or the best possible scenario given the current degree of existing carnage anyway).

Subscribe now

For each study, I included the title, lead author and selected excerpts that convey the basic story of the vaccine injury.

I bolded the descriptions of the psychiatric or mental conditions in the quotes lifted from the studies.

Case Report Study #1: Focal onset non-motor seizure following COVID-19 vaccination: A mere coincidence?

https://pubmed.ncbi.nlm.nih.gov/34000712/

A 68-year-old man from rural India without comorbidities except well-controlled arterial hypertension (on regular anti-hypertensives, i.e. losartan 50 mg/day and amlodipine 5 md/day) presented with history of sudden onset impaired consciousness for a period of about 2–3 minutes as stated by his wife and son. Family history and history of illicit drug use was non-contributory. This event occurred four days after he received the first dose of Covishield vaccine. On detailed enquiry, his family members said that after receiving it, he had transient muscle aches and feverish sensation that subsided within one day without medications. That morning (day of event), the patient went to bathroom and forgot to lock the door and after some time he came out of toilet completely naked and soiled with feces. Then the person sat on sofa without cleaning himself. His wife was astonished with this bizarre behaviour, but he seemed to be in a “trance state” and without responding to any questions. Soon after, his wife noticed that he became unresponsive lying on the sofa and a “peculiar vocalization” was heard. This state persisted for near about 2–3 minutes after which he regained consciousness but was still disoriented to time, place and person. He went to sleep and slept for long 6–8 hours before waking up normal. For the next two days, he did normal activities, but his family members pointed out that he was inattentive and making frequent trivial mistakes. These problems abated within a week and he was living normal life for the next two weeks. Then he went to a local physician (R.G.) and a consultant neurologist (S.D.) regarding advice whether to take the next dose of vaccination when it is scheduled.

Case Report Study #2: First episode psychosis following receipt of first dose of COVID-19 vaccine: A case report, Grover et al

https://pubmed.ncbi.nlm.nih.gov/35091388/

An 18 years old female student, without any past psychiatric (including the substance use disorders) or medical history, with no family history of mental illness, was brought to the emergency by family members for irrelevant talk and bizarre behavior. There was no past history of physical illness or substance use. Exploration of history revealed that the patient was apparently maintaining well before vaccination and there was no apparent psychosocial stressor prior to vaccination, nor did the patient have any vaccine hesitancy.

As per family members fever subsided the next day, but patient reportedly started to remain anxious. She was not able sleep at night, frequently woke-up, appeared fearful and would appear to be staring in between. She would keep on pacing around and would appear distressed. Over the next 3 to 4 days, she started to remain irritable, talk irrelevantly, try to run away from home, voiced delusions of persecution and reference, and reported visual hallucinations of seeing Gods and demons. As it became difficult to control her at home, she was brought to emergency for further management. There was no history of seizures, altered level of consciousness, use of any other medications, depressive features, and neurological deficits.

Case Report Study #3: Can new onset psychosis occur after mRNA based COVID-19 vaccine administration? A case report, Reinfeld et al

https://pubmed.ncbi.nlm.nih.gov/34388513/

A 31-year-old, single Hispanic male without past medical or psychiatric history, was brought to the emergency room by police because of erratic and bizarre behavior. He was found to be anxious, guarded, superficial and grandiose. He reported becoming ‘clairvoyant’, being able to talk with dead people, hearing ‘people drumming outside his house’ and the constant voice of a co-worker whom he believed to be a paramour- it was later confirmed that there was no romantic relationship. All these symptoms began one month ago, after receiving the first dose of an mRNA-based COVID-19 vaccine, and markedly worsened three weeks later after receiving the second dose. Previously, he was asymptomatic, working full-time as an office manager. Although functional in adolescence and adulthood, he described himself as a loner, with an inclination to overly spiritual ideas, and able to communicate directly with God. He had a few close friends and romantic relationships.

We need to be mindful that this patient had some schizotypal personality traits, strongly associated with the development of schizophrenia, and we could be observing the onset of schizophrenia, with the vaccine being only an epiphenomenon. However, first psychotic breaks occur infrequently at this age and our patient did not exhibit thought disorganization. His-predominant symptoms were auditory hallucinations, grandiose delusions of becoming clairvoyant, and erotomaniac delusions to which he demonstrated poor insight on initial evaluation. His-psychotic symptoms persisted and worsened until one week after the second vaccine dose he required hospitalization and initiation of antipsychotic medication. Hence, the most parsimonious explanation is that the vaccine, innocuous to the millions of people who have already received it, may have triggered psychotic symptoms in an individual with an intrinsic vulnerability, likely via a hyperinflammatory state.

Case Report Study #4: Sequential provocation of Ekbom's syndrome and acute mania following AstraZeneca COVID-19 vaccination, Chang FY et al

https://pubmed.ncbi.nlm.nih.gov/37012199/

A 39-year-old married woman had no history of major mental disorders and revealed good role function previously. During COVID-19 pandemic, she received the first dose of AZ vaccine on July 30, 2021. Two days later, she perceived extreme itching all over the body and became irritable. She was very sure to feel 5–7 cm worms crawling under her skin and used a blade to cut through the dermis layer to find worms. She went to the dermatology department but didn’t find any dermatological abnormality. She was transferred to the psychiatry department for treatment, but poor compliance. She took many kinds of insecticide to get rid of the body worms she perceived. The distressful feeling was diminished 3 months later.

By getting second dose of AZ COVID-19 vaccine on October 23, 2021, she perceived full drive and energy to run her business and became self-inflated. Until February 2022, the patient shown full blown mania including irritable mood, overactivity, spending spree, decrease need of sleep and presented agitated behaviors, and frequent conflicts with her husband. She was brought to our emergency room due to conscious change and low blood pressure after swallowed approximately 40 pills of sleeping pills and beta blockers on March 7, 2022. By acute intervention, she was transferred to acute psychiatric ward. A series of examinations were performed, no neurological deficit or abnormal blood testing. The brain MRI showed gliosis over bilateral frontal lobes. Psychological assessment revealed significant deficit in executive cognitive function. Banda Gestalt test also showed impaired planning ability and delayed memory. She was prescribed aripiprazole 30 mg and valproic acid 1000 mg to control the manic features. She regularly followed up at psychiatric outpatient department after discharge form 3 weeks of hospitalization. Her mood lability and cognitive deficit were gradually subsided after 12- week of treatment.

Case Report Study #5: Psychosis Associated With COVID-19 Vaccination, Aljeshi et al

https://pubmed.ncbi.nlm.nih.gov/35180812/

The patient was a 20-year-old single woman in her final year of technical college, with no significant medical or psychiatric history and no family psychiatric history. She was brought to the emergency department by her family after having a single seizure-like episode at home preceded by a 4-week history of anxiety, sleep disturbance, and behavioral changes that started a few days after receiving the second dose of COVID-19 vaccine.

The patient reported feeling anxious and restless, having a reduced appetite, and hearing terrifying voices and seeing random people staring at her. She also complained of interrupted sleep with frequent nightmares and sleep terror.

While she was in the inpatient unit, she was noted to be aggressive against male hospital staff, which was clearly driven by her paranoid delusional beliefs. The olanzapine dose was gradually titrated to 25 mg/d. She became fully oriented to time, place, and person after a few days, but she continued to complain of auditory and visual hallucinations. Fourteen days later, her paranoia and suspiciousness, aggressiveness, and auditory and visual hallucinations started to improve. She remained in the hospital for a total of 28 days and was discharged home after complete remission of acute psychotic symptoms with some residual symptoms, mainly reduced concentration and motivation.

Case Report Study #6: First Episode Psychosis Following COVID-19 Vaccination: a Case Report, Renemane et al

https://pubmed.ncbi.nlm.nih.gov/36170703/

A 45-year-old single Caucasian male without past medical and psychiatric history visited the outpatient psychiatric clinic accompanied by his parents because of bizarre behaviour and an attempted suicide by hanging in the early morning of the visit day.

A month before the hospitalisation, he received the second dose of the mRNA-based COVID-19 vaccine and immediately developed total insomnia, unreasonable anxiety, and tremor. As a result, he contacted his family doctor who prescribed metoprolol 50 mg a day, phenibut 250 mg a day, zolpidem tartrate 10 mg a day, but this therapy did not help, insomnia and fear remained.

After 2 weeks, he realized that he has been jinxed as he found some white powder under the carpet in his apartment. From that moment, he became cautious, did not leave the apartment, and reported persecution. On the last day before his visit to the psychiatric clinic, the patient saw a man walking past the windows of his apartment and watching him. The patient described the thoughts in his head as not his own, giving him commands to observe the person on the street. He did not sleep that night and had a strong belief that he should commit suicide. He attached a rope, tried to hang himself, but his father stopped him. In the psychiatric department, he was found to be emotionally withdrawn, immersed in his experiences, hypomimic (he sat in one position, spoke very quietly, did not actively participate in the conversation, answered questions in monosyllables or in short sentences after a long pause). Correctly said his name, age, location but was disoriented to time. He reported that he was scared and full of fear. The patient had a decrease in concentration ability, his memory was not altered. The patient demonstrated poor insight but after an explanation agreed to proceed with the investigation and treatment.

Case Report Study #7: Neuroleptic malignant syndrome following COVID-19 vaccination, Alfishawy et al

https://pubmed.ncbi.nlm.nih.gov/33642127/

A 74-year-old female with medical history significant only for dementia and bipolar disorder on maintenance therapy with memantine, Donepezil and quetiapine presented to Emergency Room (ER) after she sustained a fall and facial injury.

Her family members noticed that she had abnormal posture three days prior to admission and was confused so family members increased quetiapine dose and when she remained confused for two more days which ended by a ground level fall and head injury, they brough her to hospital ER, they reported she got COVID-19 vaccine 16 days prior to this event.

In the ER she was vitally stable but febrile at 38.5C with delirium and on and off agitation, she had bilateral periorbital swelling and ecchymosis, she had generalized muscular rigidity including neck rigidity and hyperreflexia.

Case Report Study #8: Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report, Al-Mashdali et al

https://pubmed.ncbi.nlm.nih.gov/34512961/

In this report, we describe a 32-year-old previously healthy man who developed acute confusion, memory disturbances, and auditory hallucination within 24 hours from getting his first dose of the COVID-19 Moderna vaccine.

A 32-year-old Asian male was brought to the emergency department by his neighbors on May 28th, 2021, because he was seen roaming around his apartment with confusion and agitation. Proper history could not be taken as he was disoriented and amnesic. However, he had no significant past medical history based on his electronic medical record and family information. Also, there was no history of psychiatric illnesses, alcohol use disorder, or other substances abuse. Interestingly, he received the first dose of SARS-Cov-2 vaccination (Moderna vaccine) on May 26th, 2021 (two days before the presentation), and that was the last time seen fine. Upon presentation, he was afebrile and vitally stable. The neurological examination was unremarkable, apart from agitation, disorientation to time, place, person, and memory disturbances.

During his hospital stay, he received a five-day course of ceftriaxone and acyclovir for suspected meningoencephalitis, but his disorientation and aggressiveness got worse. Additionally, he developed auditory hallucinations and abnormal behaviours. He received multiple doses of haloperidol and lorazepam and finally required bed restraints. Based on his clinical manifestations, autoimmune encephalitis was suspected, and empirical intravenous methylprednisolone (1 g/day) was started on day six of the hospital stay. After two doses of methylprednisolone, he showed a dramatic improvement and became able to understand and answer our questions. He confirmed that he started to develop forgetfulness and mood disturbance within 24 hours of receiving the covid-19 vaccine dose, but he did not remember what happened after that. CSF extensive workup for autoimmune encephalitis (including anti-aquaporin-4, anti-myelin basic protein, anti-myelin oligodendrocyte glycoprotein, anti-glial fibrillary acidic protein, anti-NMDAR, anti-GAD, and other autoimmune encephalitis antibodies) was negative. He was discharged from the hospital after receiving three days of methylprednisolone. At follow-up in our outpatient clinic (one month after the discharge), he was asymptomatic and fully oriented.

Case Report Study #9: A Single-Health System Case Series of New-Onset CNS Inflammatory Disorders Temporally Associated With mRNA-Based SARS-CoV-2 Vaccines, Ballout et al

https://pubmed.ncbi.nlm.nih.gov/35280277/

Case #1:

An 81-year-old man with no relevant neurological history presented to the emergency department (ED) with rapid-onset acute change in mental status with severe encephalopathy noted about 13 days following the administration of the first dose of the Moderna SARS-CoV-2 vaccine.

Case #5:

A 27-year-old woman presented to the ED with a 2-day history of acute-onset confusion and anxiety of unclear etiology. It started 6 days following the first dose administration of Pfizer-BioNTech SARS-CoV-2 vaccine that resulted in transient headache and fatigue.

Case Report Study #10: Case Report: Acute Necrotizing Encephalopathy Following COVID-19 Vaccine, Bensaidane et al

https://pubmed.ncbi.nlm.nih.gov/35572945/

We case report of a 56-year-old male who was found to have altered mental status upon awakening. The patient had no specific complaints the day prior aside from mild fatigue. He had received his first dose of the ChAdOx1 nCoV-19 vaccine 2 days prior.

Case Report Study #11: Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination, Chaurasia et al

https://pubmed.ncbi.nlm.nih.gov/35496775/

We report a 65-year-old man who developed cognitive deficits and memory impairments following his first dose of Oxford AstraZeneca vaccine (Covishield) against 2019 Coronavirus disease (COVID-19). Patient was admitted to Bhawani Hospital and Research Centre after sudden memory loss lasted for a day. He was not oriented to time, place and person. He was unable to describe both short and long-term memory previously acquired. He received Oxford AstraZeneca vaccine 6 days back with no clinical neurological sign for first 5 days after vaccination. On examination his speech was of a non-fluent type characterized by isolated words. He was completely unaware of his presence in the hospital.

Case Report Study #12: Severe Dyskinesia After Administration of SARS‐CoV2 mRNA Vaccine in Parkinson's Disease, Erro et al

https://pubmed.ncbi.nlm.nih.gov/34368991/

In June 2021, the day after her second vaccine dose, she developed fever (38°C), confusion, delusions, and continuous severe dyskinesia for 3 days. Laboratory tests revealed an increased D‐dimer level (3228 ng/mL). She was treated with paracetamol, and her levodopa was reduced to 350 mg daily. After 2 weeks, she was afebrile, but mild confusion and dyskinesia that are more severe than her baseline persist.

Case Report Study #13: Acute Psychosis Due to Anti-N-Methyl D-Aspartate Receptor Encephalitis Following COVID-19 Vaccination: A Case Report, Flannery et al

https://pubmed.ncbi.nlm.nih.gov/34803896/

We report the first known case of anti-NMDAR encephalitis after SARS-CoV-2 immunization in a young female presenting with acute psychosis, highlighting a rare potential immunological complication of vaccination against SARS-CoV-2 that is currently being distributed worldwide.

A female in her 20's presented to the Emergency Department (ED) with a chief complaint of urinary frequency 1 week after receiving her first dose of the Pfizer-BioNTech COVID-19 vaccine (Figure 1). The patient's family stated she had increasingly frequent bouts of anxiety, decreased mentally acuity, insomnia, and a fixation that she suffered from irritable bowels and kidney disease. She displayed waxing and waning hypochondriacal delusions that she had contracted COVID-19 and that “her body was shutting down.”

Case Report Study #14: ‘Wine Glass’ sign following COVID-19 vaccination in a previously healthy adult, Ghosh et al (1)

https://pubmed.ncbi.nlm.nih.gov/35136277/

A 47-year-old previously healthy man from rural West Bengal (India) was brought to the emergency department with abrupt onset rapidly progressive stiffness of bilateral lower limbs and clumsiness of both upper limbs for the last five days. It was associated with slurring of speech, gait unsteadiness, and behavioral changes in the form of inappropriate laughter, crying spells and inappropriate intermittent anger outbursts. According to his family members, these symptoms started within five days of the second dose of COVID-19 vaccination (COVISHIELD). There was no cognitive impairment, dysphagia, nasal regurgitation, sensory, visual, or sphincter disturbance.

Case Report Study #15: Altered mental status and pronounced febrile response after second mRNA-1273 (Moderna) COVID-19 vaccine administration in a patient with previously documented COVID-19 infection, Hilaire et al

https://pubmed.ncbi.nlm.nih.gov/34580129/

A 54-year-old man who was previously found to be COVID-19 positive received two doses of mRNA-1273 (Moderna) vaccine 4 weeks apart, as recommended by the manufacturer. He was brought to the emergency department 1 day after second dose of the vaccine with altered mental status, headache and high fever. The patient was hospitalised for 2 days and managed with supportive care. He completely recovered with return of mental status to baseline and resolution of fever.

Case Report Study #16: Psychiatric pathology potentially induced by COVID-19 vaccine, Roberts et al

https://wchh.onlinelibrary.wiley.com/doi/full/10.1002/pnp.723

The patient had his first dose of AstraZeneca COVID-19 vaccine in mid March 2021. No other precipitating factors were identified, such as illicit substance use or significant stressors. In the days after administration of this initial dose, he developed flu-like symptoms that included a severe ‘splitting’ headache. Ten days later, his wife observed that he was becoming confused, with a significant change in his behaviour. He was taken to the accident and emergency department of the local general hospital by ambulance after he stopped eating, drinking and communicating. Physical assessment, including a CT head scan and routine blood tests, found no abnormalities. Therefore, two days later he was referred to psychiatric services and was subsequently admitted to the adult mental health inpatient unit under Section 2 of the Mental Health Act 1983.

A number of clinical features were reported by the patient's wife and subsequently observed by the nursing staff during his psychiatric inpatient admission. He was confused and disoriented in time and place. His communication ranged from speaking in short sentences, sometimes whispering or mumbling to being completely mute. He was thought disordered. When he was given some paper to write down his thoughts, he was unable to write anything meaningful and was drawing lines only. He stated that he was hearing voices, both male and female, saying the word ‘Covid’ to him, but he could not elaborate any further. His mood was labile and informed his behaviour, which was bizarre and at times very disinhibited. On one occasion he was incontinent of urine. Physical examination was unremarkable; aside from the aforementioned confusion and disorientation, there were no abnormalities that suggested neurological symptomatology. Physical investigations, including routine bloods, were all normal.

Case Report Study #17: A case report of ChAdOx1 nCoV-19 vaccine-associated encephalitis, Takata et al

https://pubmed.ncbi.nlm.nih.gov/34903200/

A 22-year-old woman of Middle Eastern origin, born in Iran and recently living in Western Europe, presented to a UK hospital with a three-week history of intermittent frontal headache and fatigue a few days after she received her second dose of AstraZeneca ChAdOx1 nCoV-19 vaccine. These symptoms did not respond to paracetamol and progressed on to an acute two-day history of confusion and hallucinations (visual and tactile). She reported seeing “disco balls” and experiencing someone touching her skin. She had non-syndromic retinitis pigmentosa but no other medical co-morbidities, and there was no personal or family history of psychiatric illness. She was a non-smoker and non-drinker, and enjoying undergraduate studies at university.

On admission, she had one recorded fever of 38ºC, but otherwise-normal observations (HR 91, BP 123/81, RR 18, O₂ saturations 100% on air). She was alert but disorientated to time, person and place, and agitated with a labile affect; she complained of auditory and visual hallucinations – for example, that the room was on fire – and delusions that were often hyper-religious in nature. She was also seen to be gesturing to the air as if responding to unseen stimuli.

Case Report Study #18: New-Onset Panic Disorder Following Pfizer-BioNTech COVID-19 Vaccination, Uvais

https://pubmed.ncbi.nlm.nih.gov/35180816/

A 48-year-old married Indian man working in the Middle East for 13 years received a second dose of Pfizer-BioNTech COVID-19 vaccine on July 7, 2021. There were no immediate adverse events after taking the vaccine, and he continued his heavy manual work on that day. The following morning, he developed palpitation, tightness of chest, and restlessness, which lasted for around 10–20 minutes. It was also associated with dryness of mouth, body trembling, sweating, and feeling of impending doom. He had similar episodes in the following days. Gradually, he developed fear of death, fear of being alone, fear of going crazy, and significant loss of sleep. There were no symptoms of fever, body pain, or pain at the injection site or any allergic reactions. There was no history of psychiatric illness. There was family history of generalized anxiety disorder in his mother, who was on regular psychotropic medications. He also denied any vaccine-related fear before taking the second dose.

He was diagnosed with panic disorder, and oral sertraline 50 mg/d was started along with antihypertensive medications, and he was asked to consult a psychiatrist for proper evaluation and optimization of the medication.

He presented to the outpatient department of our hospital within 1 week of reaching India with complaints of palpitation, worries, fear of going crazy, and significant impairment in sleep.

This patient experienced new-onset panic disorder within a day after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine. In the absence of other life stressors or fear of vaccination, we could assume that panic disorder in this patient was caused directly by the vaccine itself.

Case Report Study #19: A novel adverse effect of the BNT162b2 mRNA vaccine: First episode of acute mania with psychotic features, Yesilkaya et al

https://pubmed.ncbi.nlm.nih.gov/34632429/

Case #1:

A 42-year-old male was admitted to the psychiatric emergency department five days after being vaccinated with the first dose of the BNT162b2 mRNA vaccine with complaints of irritability and sleeplessness. Although the patient did not have any symptoms outside of weakness on the day of vaccination, the complaints started one day after receiving the vaccine. The patient had delusions that his family was being followed by the deep state and that they were in danger. This was the patients first psychiatric admission. The medical history of the patient showed absence of any illnesses or regular use of medication. In addition, the patient was vaccinated voluntarily and did not have extreme anxiety about vaccination. At the clinical examination, the patient's cooperation and orientation were intact; however, his speech output, speed as well as psychomotor activity were increased. The patients affect was anxious and the mood was dysphoric. He exhibited a loosening of associations, described persecutory and reference delusions and displayed a lack of insight.

At the routine psychiatric evaluation 15 days after discharge, the patient declared that he was unable to remember the initiation of psychiatric symptoms.

Case #2:

A 57-year-old male was admitted to the psychiatric emergency department with complaints of irritability, sleeplessness, talking to himself and suicidal attempt with thoughts of extinction three days after receiving the second dose of the BNT162b2 mRNA vaccine. While firstly the patient only had local myalgia on the arm on the day of vaccination, psychiatric symptoms started at night on the day he was vaccinated. The patient did not have a history of any diseases that required the use of medication, was vaccinated voluntarily and did have any anxiety about vaccination. Clinical evaluation suggested intact cooperation and orientation while speech output, speed as well as psychomotor activity were increased. The patient was anxious, and his mood was dysphoric. Nihilistic delusions with no insight were recorded.

Case Report Study #20: First Episode of Psychosis Following the COVID-19 Vaccination - A Case Series, Borovina et al

https://pubmed.ncbi.nlm.nih.gov/35772162/

Case #1:

The patient's unusual behaviour began within five days of being vaccinated with Ad26.COV2.S adenoviral vector vaccine. He became anxious, suspicious, paranoid, disorganised and complained of headaches.

Finally, two weeks after the COVID-19 vaccination, persecutory delusions and delusions of reference led the patient to suicide attempt by stabbing himself in the abdomen. After abdominal surgery, the patient was admitted to the Clinic of Psychiatry. In addition to paranoid delusions, the psychiatric evaluation revealed intrapsychic tension and low affect modulation.

After two weeks of treatment, the patient's condition improved enough to allow a psychological evaluation. It revealed mild depressive symptoms with suspected paranoid experiences. After 23 days of treatment in our Clinic, he was discharged without psychotic symptoms.

Case #2:

Five days after the second dose of the BNT162b2 mRNA vaccine, he began to experience frontal headaches, pain in the left intercostal space, paresthesias on the left side of his body, as well as paranoid delusions and severe anxiety. The patient was examined several times by a neurologist. No neurological deficits were found on examination and diagnostic tests (including magnetic resonance imaging (MRI) of the brain). Finally, he was admitted to the Clinic of Psychiatry due to psychotic symptoms and psychomotor agitation. In addition to the above symptoms, the psychiatric examination revealed a depressed, irritable mood and olfactory hallucinations.

Case #3:

Three days after receiving the first dose of the BNT162b2 mRNA vaccine, the patient began to complain of headaches and paraesthesia in his legs. He also had syncope and was examined by a neurologist, who found no deficit. Two weeks later, he visited the psychiatric emergency room twice because of persecutory delusions and delusions of reference.

Due to the ongoing worsening of his psychotic symptoms, the patient was hospitalised in our Clinic a few days later. During the psychiatric evaluation, he was agitated, dysphoric, and paranoid.

After one month of hospitalisation, the patient was discharged with partial remission of his psychotic symptoms.

Case Report Study #21: Delirium triggered by COVID-19 vaccine in an elderly patient, Zavala-Jonguitud & Pérez-García

https://pubmed.ncbi.nlm.nih.gov/33829614/

Herein, we describe the case of an 89‐year‐old patient, who developed delirium after the administration of the aforementioned vaccine.

An 89‐year‐old patient presented to the office the second day after the first dose of BNT162b2 COVID‐19 vaccine was given, with a 24‐h history of confusion, fluctuating attention, anxiety and inversion of the sleep–wake cycle.

Case Report Study #22: Delirium after COVID-19 vaccination in nursing home residents: A case series, Mak et al

https://pubmed.ncbi.nlm.nih.gov/35460269/

In the current study, delirium or subsyndromal delirium of mild to moderate severity was identified in 10% of Nursing Home residents the day after vaccination, with no potential competing explanation. Strengths of this study are the inclusion of older adults with physical and cognitive impairment, underrepresented minorities, baseline assessments to facilitate determination of a change in cognition, and rigorous cognitive testing.

In this study, delirium after COVID‐19 vaccination resolved without complications, which contrasts with complications of COVID‐19 infection itself. Thus, the risk–benefit ratio strongly supports vaccination in this population. Nevertheless, because of the heightened risk of delirium and its potential complications in NH residents, clinicians and staff should monitor for delirium after COVID‐19 vaccination.

Case Report Study #23: Induced Depressive Disorder Following the First Dose of COVID-19 Vaccine, Rammouz et al

https://pubmed.ncbi.nlm.nih.gov/36043719/

The case was a 26-year-old man with a history of Down syndrome with moderately good autonomy for daily routine tasks. The patient, who presented hypothyroidism at 10 years old and schizophrenia at 15 years old, was doing well before the vaccination and received his first dose of the BNT162b2mRNA vaccine. Twenty-four hours later, he presented depressive symptoms that resolved spontaneously after one week. Then, fifteen days later, the symptoms reappeared, and the episode lasted for 5 weeks.

Case Report Study #24: Acute dizziness and mental alteration associated with Moderna COVID-19 vaccine: a case report, Pinzon et al

https://pubmed.ncbi.nlm.nih.gov/36028809/

We describe a 39-year-old female with uncontrolled hypertension who showed behavioral change, communication difficulty, social withdrawal, and a confused state within 7 days from getting her first dose of the Moderna vaccine.

Behavioral changes, communication difficulties, social disengagement, and confusion were reported by the patient’s family 1 day before admission.

The patient had 2 doses of Sinovac vaccine on January 2021 and February 2021 and had 1 dose of Moderna COVID-19 vaccine on August 20th, 2021. On the following day, the patient experienced tenderness and swelling on the Moderna COVID-19 vaccine administration site and subsided after the paracetamol consumption.

Case Report Study #25: Transient Global Amnesia [TGA] Related to the Third Coronavirus Disease-19 (COVID-19) Vaccination, Katsuki M et al

https://pubmed.ncbi.nlm.nih.gov/36004026/

A 65-year-old Japanese woman with no previous medical history presented with confusion and anterograde amnesia 3 hours after her third COVID-19 vaccination [COVID-19 Vaccine Moderna Intramuscular Injection (Lot 000011A, Moderna, Takeda, and Moderna)]. She lived alone and was an elementary school teacher. She had not experienced any side effects of the vaccinations, but she felt undefinable anxiety during the third vaccination.

Her amnestic symptoms improved after 12 hours. She remembered that she had the third vaccination, but other memories during TGA were lost.

Case Report Study #26: First episode psychosis following the anti- COVID vaccination: a case reports, Giné Servén et al

https://www.researchgate.net/publication/360311694_First_episode_psychosis_following_the_anti-_COVID_vaccination_a_case_reports

We reported two patients with first- episode psychosis after anti-COVID vaccination admitted in the psychiatric ward of our hospital.

In relation with clinical presentation, in both cases, the apparition of psychotic symptomatology was acute (12 hours and 7 days) and with an atypical profile (cycloid psychosis-like phenotype and marked cognitive impairment with oro-mandibular movements, respectively).

Case Report Study #27: Severe Panic Disorder After Vaccination With the Pfizer-BioNTech Vaccine: A Case Report, de Souza Melo et al

https://pubmed.ncbi.nlm.nih.gov/36584256/

A 26-year-old woman was admitted to the hospital psychiatric unit with suicidal ideation after episodes of severe and recurrent panic attacks.

Twenty-six days after her full recovery, she received the second dose of the Pfizer vaccine. Approximately 4 hours after getting the second dose, she reported paroxysmal onset of chest pain, palpitations, dyspnea, throbbing holocranial headache, fainting, and an impending sense of doom.

Case Report Study #28: Bipolar I Disorder Exacerbation Following COVID-19 Vaccination, Guina et al

https://pubmed.ncbi.nlm.nih.gov/36204171/

Case #1:

A 60-year-old African American female patient with previously stable BD1 presented to the office after three weeks of depressed mood, anxiety, and decreased need for sleep. She was observed to have increased energy, impulsivity, labile affect, verbose speech with repetitive phrases, tangential thinking and flight of ideas, paranoia, and ideas of reference, consistent with a mixed episode with psychotic features. She reported that her symptoms began within a week of receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine. She denied suicidal and homicidal ideations. Her symptoms were distressing and led her to call off work repeatedly, despite satisfaction with her job.

Case #2:

A 40-year-old White male patient with previously stable BD1 and attention deficit hyperactivity disorder (ADHD) was voluntarily hospitalized due to a mixed episode with psychotic features. He reported depressed mood, suicidal ideation, and auditory hallucinations encouraging him to kill himself, but denied homicidal ideation. Upon admission, he was observed to have hyperactivity, impulsivity, irritability, flight of ideas, labile affect, pressured and hyperverbal speech, tangential thought processes, limited attention, and poor short- and long-term memory, with limited recall of three objects after five minutes and major historical events. He reported that his symptoms began after receiving the second dose of the Moderna COVID-19 vaccine and subsequently worsened after he discontinued his medications five days prior to admission. He lost his job after a verbal altercation with his boss, prompting him to seek inpatient treatment.

Case Report Study #29: Depression following ChAdOx1-S/nCoV-19 vaccine, Uvais

https://pubmed.ncbi.nlm.nih.gov/34608345/

A 73-year-old male who had no past or family history of psychiatric illness, was seen in outpatient psychiatry clinic of our hospital with son in law with psychiatric symptoms of 2 week duration. The symptoms started 2 days after he received first dose of COVID-19 vaccine (ChAdOx1-S/nCoV-19 vaccine) from a primary health centre near his home on 26th April 2021. During the first day after receiving vaccination he complained of pain at the site of injection. From the second day onwards, he started complaining of tiredness, exacerbation in pain in both knee joints, low mood, dryness of mouth, lack of interest in activities which he usually enjoyed like reading news papers or watching TV, marked reduction in appetite, and difficulty in initiating sleep. There was no history of fever, neurological deficits, or seizure following vaccination. According to family, he had no ongoing life stressors and he was very active in family as well as in his job. His mental status examination revealed reduced speech productivity, depressed affect, hopelessness and helplessness. There was no delusions or hallucinations.

Subscribe now

For whatever reason, cancer is one of the least-frequently recorded vaccine injuries in case reports studies. (We can probably all imagine what some of these reasons might be. . .)

Nevertheless, a few case reports documenting post-jab cancers have somehow made it through the fog of censorship to breakthrough onto a pre-print server (or even a peer-reviewed journal!).

HT to @MarketsPuke for the absolutely stunning artwork

1. Anaplastic large cell lymphoma at the SARS-CoV2 vaccine injection site

https://pubmed.ncbi.nlm.nih.gov/36166359/

♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋

2. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases

https://www.mdpi.com/1648-9144/58/7/874

♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋

3. Two cases of axillary lymphadenopathy diagnosed as diffuse large B-cell lymphoma developed shortly after BNT162b2 COVID-19 vaccination.

https://europepmc.org/article/pmc/pmc9114986

♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋

4. Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature

https://pubmed.ncbi.nlm.nih.gov/36676781/

♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋

5. Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report

https://pubmed.ncbi.nlm.nih.gov/34901098/

⏩TURBO CANCER⏩

♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋

6. Recurrence of cutaneous T-cell lymphoma post viral vector COVID-19 vaccination

https://pubmed.ncbi.nlm.nih.gov/34628691/

♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋

7. A Case Report of Posttransplant Lymphoproliferative Disorder After AstraZeneca Coronavirus Disease 2019 Vaccine in a Heart Transplant Recipient

https://pubmed.ncbi.nlm.nih.gov/34702598/

♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋

8. Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir

https://pubmed.ncbi.nlm.nih.gov/35935759/

♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋

9. Rapid progression of marginal zone B-cell lymphoma after COVID-19 vaccination (BNT162b2): A case report

⏩TURBO CANCER⏩

https://pubmed.ncbi.nlm.nih.gov/35979213/

♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋

10. Lymphedema of the Arm after COVID-19 Vaccination in a Patient with Hidden Breast Cancer and Paraneoplastic Dermatomyositis

https://pubmed.ncbi.nlm.nih.gov/36016107/

♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋

11. Subcutaneous panniculitis-like T-cell lymphoma after COVID-19 vaccination

https://pubmed.ncbi.nlm.nih.gov/35966352/

♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋

12. A Case of Chronic Myelomonocytic Leukemia Unmasked After Receiving J&J COVID-19 Vaccine

https://pubmed.ncbi.nlm.nih.gov/35865440/

♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋♋

I put all 12 into the massive running twitter thread (with a bit of commentary) I have going on interesting case reports:

Subscribe now

Master Sheet Case Reports

*As I am constantly adding to this, it will not always be current. Also, there are probably a few errors.

**Please forgive the formatting & messiness, I barely have time for research as it is

***The abbreviations are not necessarily ‘official’, many were chosen for personal convenience

****The categorization of studies is very general, and not intended to be a precise definitive adjudication. Additionally, some case reports involve multiple injuries from multiple categories. Myo includes any cardiac-related issue.

Any other questions, drop a comment & I’ll (hopefully) answer.

Special Request:

I am looking for people, particularly with medical expertise/background, who can help to fill out the information for the individual case reports.

Anyone who can help please email me at ashmedai@substack.com

Thanks so much

Introduction/Background to provide some context for Vaccine Injury Case Reports

It seems prudent to provide an introduction to the compilation of case reports in order to keep things in context and maintain better clarity and precision discussing them. While the widespread avalanche of vaccine carnage is undeniable on a macro level, it is easy to make mistakes or formulate imprecise arguments when dealing with granular details.

I asked one of the most prolific authors involved in case report literature a number of questions about the nature of these case reports, whose answers are the foundation for the rest of this article.

Basically, this a limited FAQ sheet about vaccine injury case reports (even if they are not exactly “frequently asked”).

Are case reports reliable evidence?

One of the advantages of case reports is that they are probably the most reliable type of evidence pound for pound that an individual report of a medical condition following vaccination represents a genuine vaccine injury. A case report is typically written by the doctor/s or even sometimes a multidisciplinary team of specialists who treated and/or consulted on the case of the patient/s whose medical conditions are being documented. This means that the details are generally speaking more likely than any other scenario to be accurately and comprehensively documented. It also means that the judgement of the expert & experienced doctors - typically doctors who treat patients with the types of conditions the patient had - is that the vaccine is at least the likely if not plainly obvious cause of the patient’s condition/s.

Is every case report definitely a condition or injury caused by the vaccine?

No. While there are some that provide definitive evidence that the injury was caused by the vaccine - such as histopathological testing that reveals the presence of spike proteins or immunological infiltrates generated in response to the vaccine in damaged tissues - many case reports for various reasons were unable to affirmatively show a clear pathological chain-of-events from vaccination to injury, instead relying on factors like the timing, the nature of clinical presentation, or the lack of plausible alternate causes for the condition, in addition to the judgement of the medical professionals involved with the patient.

Can authors of case reports make mistakes or fail to consider every option?

Yes. But it is generally uncommon for there to be clear errors significant enough to suggest that the vaccine cannot be the likely cause of the injury or conditions contained in the case report. Remember that medicine is as much an art as it is a science.

Are all case reports more or less the same quality?

No.

• Some contain more details than others for various reasons often based on real-world practicalities (for instance, it is not necessarily feasible to run every available type of background test on a patient who needs treatment now).

• Some case reports are written retrospectively, for example the doctors at a hospital or medical center can go through their records and write up the cases of the patients they treated for a specific condition that started close to vaccination based on the data they recorded after a substantial amount of time has passed.

• Some case reports are written about conditions that were more amenable to being described clinically while others can document conditions or constellations of symptoms that resist an easy or conventional diagnosis.

• Some doctors are simply better at writing than other doctors, something that is more noticeable comparing case reports written by native English speakers to those written by medical professionals for whom English is not their native language.

When someone is reported to be “recovered” from their injury or condition, does that mean they are fully recovered?

Not necessarily, and it’s impossible to really know which ones are without seeing the patient for yourself.

For starters, outcomes are often insufficiently reported. Doctors do not necessarily follow up for enough time to know that the patient truly recovered without any relapses. Patients are also often transferred away from the treating or reporting physician for a variety of reasons such as a hospital policy or the patient requiring more specialized facilities for further treatment.

Additionally, “clinical recovery” often does not account for lingering effects that are not captured by formal diagnostic or laboratory criteria, but can affect quality of life, and can even be permanent. It is also possible for doctors to miss subtle signs or blips that are a manifestation of an underlying ongoing pathology but that are not big enough for them to notice or if they do notice they might not think they indicate anything out of the ordinary.

Do the case reports as a whole mirror the balance of nature, type and severity of the vaccine injuries being reported and experienced worldwide?

No. Overall, the case reports tend to be more predisposed to positive outcomes, and rarely document deaths compared to what is widely reported and indicated in the all-cause type/population level datasets.

Certain vaccine injuries also are more easily documented in case reports than others, for a variety of reasons. Typically the condition will have to be something that is difficult to explain without the vaccine, begins in close proximity to a vaccination event, and is something that a doctor could conceivably associate with the vaccines. Rapid onset or metastasis of cancer for instance is not something that doctors would typically even think to make the connection, and even if they do, it would be very difficult to write a case report about simply because they would be going out on a limb conjecturing without a solid clinical foundation in terms of quantifiable diagnostic markers that are traceable directly to the vaccines.

What is responsible for this disparity?

While it is impossible to definitively answer this question with 100% confidence, here are a few basic points to keep in mind (this list is not exhaustive):

• There is tremendous pressure not to say or do anything that portrays the vaccines in a negative light or can be used to promote “vaccine hesitancy”. Thus doctors will feel more comfortable writing about a case with a positive outcome, so those are more likely to get written up than cases with worse outcomes or prognoses.

• Case reports with worse outcomes will be censored from journals/pre-print servers more often than case reports with better outcomes.

• Doctors are more likely to resist attributing an injury to the vaccine when it’s more severe, because of the cognitive dissonance and because more severe injuries are more forcefully denied to exist generally by the medical community/literature.

• It is psychologically easier to ask a patient for permission to write up their personal medical condition in public literature when the patient recovers than when the patient does not.

• A doctor is more likely to be willing to write up a case report about his success than his failure to diagnose and/or treat a patient. Admitting - publicly - that you might have made a mistake, especially a consequential one, is emotionally difficult to say the least. Furthermore, sometimes a case report would reflect a profound lack of clinical judgement “after the fact” potentially even bordering on malpractice (such as counseling a patient who had a clear reaction from Dose 1 to get Dose 2 after which the patient suffers a severe injury).

Are case report authors always honest when expressing their judgement whether the vaccine caused the injury?

No.

As previously mentioned, and as anyone reading this is well aware, most of the doctors who can see the vaccine carnage are also afraid to say anything or speak up because they are afraid of losing their jobs and social lives or even their license/credentials. So authors are definitely being extra cautious with the language they use.

The culture of censorship has run so amok that in many instances, case reports include soliloquies or editorial opinion commentaries about the virtues and safety of the vaccines, which while often straying so radically that they are quite humorous nevertheless have no place in this type of scientific literature. (I wrote an article highlighting a few comical examples of this.)

The upshot is that case reports often include language that does not represent the genuine views of the authors but rather is intended to appease the censors and maintain their standing among their colleagues and profession.

Therefore, such language, or even claims that “this is unlikely to be related to the vaccine” are far more likely than not insincere representations than reflecting the considered judgement of the authors. And even when the authors do think that the vaccine is not necessarily or even unlikely to be the cause, it is important to remember the overwhelming propaganda campaign unleashed on healthcare professionals that these vaccines cannot possibly cause almost all of the side effects documented in the real world rollouts.

Overall, what % of case reports represent genuine vaccine injuries?

It’s hard to say precisely, but considering the totality of evidence from around the world, it is probably safe to assume that at least 90-95% of the published case reports represent injuries where the vaccine was a causal factor.

Other posts about case reports

Subscribe now

This is the third installment of case reports of vaccine injured patients receiving another dose nonetheless.

Resisting the Intellectual Illiteratti

Vaccine Roulette: Making Outright Human Experimentation Great Again (Part 1)

Welcome to the Post-Nuremberg Ethical Apocalypse: Dose 1 Severe Adverse Event, Dose 2...? You'll have to get jabbed with Dose 2 to find out…

Read more

4 years ago · 45 likes · 34 comments · Ashmedai

Resisting the Intellectual Illiteratti

Vaccine Roulette Part 2

Welcome to the Post-Nuremberg Ethical Apocalypse: Dose 1 Severe Adverse Event, Dose 2...? You'll have to get jabbed with Dose 2 to find out To understand the ethical psychosis we are dealing with here, consider the following study: Patients with post-COVID-19 vaccination facial palsy: To boost or not to boost…

Read more

4 years ago · 29 likes · 11 comments · Ashmedai

Quick primer on the formatting:

• I divided case reports into “Winners” & “Losers” based on whether dose #2 (or 3+) caused new or worsening of the SAE’s following dose #1.

  (Yes, sometimes the patient gets dose #2 without suffering any SAE, at least in the short term, hence the title “Vaccine Roulette”.)

  Obviously, surviving dose #2 without further injury does not suggest that it was a good idea to get dose #2 - this would be akin to claiming that playing real Russian Roulette is harmless because you survived. And there might be long term consequences that don’t show up right away.

• Each report has the case report title, link, timeline of events, and some ‘commentary’; I also am including the excerpts from the case report describing the basic narrative of the case in a footnote placed at the end of the link

• I have identified a few dozen of these case reports so far from the case reports that I have cataloged in detail, However, I have only cataloged about 400-450 or so out of the almost 2,600 that I have compiled to date.

☠☠☠☠☠☠☠☠☠☠☠☠☠☠

Losers 😱

Case Series of Three Neurological Side Effects in Younger-Aged Individuals After Pfizer's mRNA Vaccine

https://pubmed.ncbi.nlm.nih.gov/35382061/

TIMELINE

38yo M:
Day 1: Pfizer Dose #1 😍
Day ?: Tinnitus 😨😵
Day ?: Pfizer Dose #2 😱🤦‍♂️
Day ?: Tinnitus Worsens😵🤮😵
Day ∼180: Presents to doctor, told she is "hopeless"😱😭😵

From the study itself (case #3):

A 42-year-old nulliparous White female with no past medical history of illness or disease presented to the clinic six months after receiving her two doses of Pfizer COVID-19 vaccine. The patient denies having had COVID-19 previously and describes having developed mild to moderate tinnitus after the first dose.

Emphasis on “WAS improving”.

Although she felt it somewhat improving, she was still expected to receive the second shot or compromise her diplomatic status abroad despite her voiced concerns.

That’s one (or more) really twisted bureaucrat who ordered her to get dose #2 despite suffering a serious injury following dose #1.

This is SIX MONTHS after the fact - she was still suffering from persistent tinnitus.

Her physical exam was unremarkable for any auricular or middle ear findings, Dix-Hallpike maneuver, as well as a complete neurological and cardiac exam. The patient was referred by the primary care physician to an otolaryngologist who performed audiometric testing, which was negative, with no subsequent blood work.

This is unfortunately typical of vaccine injuries, they cannot be diagnosed properly with standard tests that the hive-mind formula-follower doctors are trained to perform.

Oh well. Took one for the team.

*🦻*🦻*🦻*🦻*🦻*🦻*🦻*🦻*🦻*🦻*🦻*🦻*🦻*🦻*🦻*🦻*🦻*

Immune-mediated necrotizing myopathy after BNT162b2 vaccination in a patient with antibodies against receptor-binding domain of SARS-CoV-2 and signal recognition particle

 https://pubmed.ncbi.nlm.nih.gov/34970746/

This study provides a timeline complete with all the many, many twists and turns of this clinical saga:

Here’s how hey describe her ordeal:

A previously healthy 55‐year‐old woman received her first dose of BNT162b2 vaccine (Figure 1). The next day she developed myalgia, chills, fatigue, and vague generalized weakness. On day 21, after she received a second dose of BNT162b2 vaccine, the symptoms worsened to progressive weakness, and on day 49 she presented to an emergency department unable to walk. Her serum creatine kinase (CK) level was 7967 IU/L (normal, <190 IU/L). She was treated for rhabdomyolysis with intravenous fluids and discharged home, but she returned on day 56 with persistent symptoms.

So many ‘previously’ healthy people…

To make matters worse, not only did the patient get destroyed by the neurological injuries, she also got not one but *TWO* breakthrough covid infections to boot - within 184 days of the 2nd dose.

The authors’ conclusion?

Our case of IMNM suggests a probable association/interaction between the vaccine‐induced immune response and anti‐SRP–positive IMNM, given the temporal relationship between the disease course and BNT162b2 vaccination, presence of anti–S1‐RBD, and absence of SARS‐CoV‐2 infection in a patient with anti‐SRP autoantibodies.

Maybe they’ll feel more confident in their assessment when she relapses following her booster.

Oh, and she still hadn’t recovered at the time the case report was written up.

*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*

Central serous chorioretinopathy following Pfizer-BioNTech COVID-19 vaccine: A case report

https://pubmed.ncbi.nlm.nih.gov/34949501/

TIMELINE

38yo M:
Day 1: Pfizer Dose #1 😍
Day 7: blurred central vision in the left eye 😨
Day 42: Pfizer Dose #2 😱🤦‍♂️
Day 49: nausea, fever, tiredness and headache, oh my🤢🤮😵
Day ∼68 or 103: visual acuity measured 20/630 😱😱😱

What’s the difference between 20/20 vision and 20/630 vision? Probably something you’d notice. Especially if it’s your ocular ‘new normal’.

*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*

Winners 😍

Yes, some people play the vaccine roulette lottery and win!*

(*‘Win’ might be a bit of an overreach, as you’re not exactly winning something you did not have previously, except perhaps the freedom to not get another covid jab for the next 4 months.)

Marginal keratitis following COVID 19 vaccination

https://pubmed.ncbi.nlm.nih.gov/35756698/

TIMELINE

68yo F:
Day 1: Moderna Dose #1 😍
Day ∼7: Eye pain, tries antibiotics unsuccessfully 😨
Day ∼18: Diagnosed with Keratitis😣😧
Day ∼22: significant improvement in symptoms following treatment😅
Day ∼28: Moderna Dose #2 while still on eyedrops 😱😱😱
Day 28+: No adverse events from dose #2 😰😌

All for the best?

*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*

Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines

https://pubmed.ncbi.nlm.nih.gov/35510657/

This case series is a doozy:

TIMELINE - Case #1

74yo M:
Day 1: Pfizer Dose #1 😍
Day 1 (+ 'few hours'): Tinnitus 🔔😵🤢
Day 4: Symptom resolution 😍😄
Day ∼30: Pfizer Dose #2 😱
Day ∼38: Recurrence of left-side hearing loss 😨🧏‍♂️
Day ∼40: Complete recovery following treatment 😍
Day ?: BOOSTER Dose #3 😱😱😱😱😱😱😱
Day ?+: "Well tolerated" 😍😍

TIMELINE - Case #3

61yo F:
Day 1: Moderna Dose #2 😍
Day 2: Deafness + diplacusis + flu-like symptoms 😨🔔🧏‍♂️🤢
Day ∼3: Vertigo & Vomiting 😵🤮
Day ∼5: 'complete' recovery 😍
Day ∼30: "slight intermittent gait instability" 😵😰🤔
Day ∼38: Recurrence of left-side hearing loss 😨🧏‍♂️
Day ∼245: Pfizer BOOSTER Dose #3 😱😱😱😱😱😱😱
Day 246+: "No recurrence of hearing loss" 😍😍

On the plus side, it’s hard to hear misinformation if you can’t hear anything in the first place.

What about Cases 2 & 4?

The implication here seems to be that patients 2 & 4 declined the benevolent offer to get more of the miraculous wunderkind vaccines. But it was not for the lack of their doctors trying, Heaven forfend!! And their refusals might not be permanent - both have only refused “so far”, leaving the door open to changing their minds [once the memory of their adverse events have sufficiently faded away].

Lesson #1: Don’t admit to your doctor that you’re completely recovered from the injury caused by the previous dose if you want to avoid more jabs. Ever.

Lesson #2: It might be better if you don’t ever fully recover to spare you the temptation to just admit it already if you have indeed recovered just to get your doctor to stop pestering you about it.

Subscribe now

Some apologists are now trying to rewrite the history of the medical community’s stance on this issue, claiming that health officials acknowledged that the covid vaccines were causing myocarditis (however rare and mild) immediately following the emergence of indications of a potential association between the covid vaccines and increased incidence of myocarditis.

When did they first acknowledge the *possibility* that the vaccines *might* be causing myocarditis?

As far as I’m aware, the first official acknowledgement of the possibility of vaccine-associated myocarditis came at the end of May:

The FDA here was trying to downplay the possibility that myocarditis was connected to the vaccines, with FDA vaccine chief Dr. Peter Marks saying he would vaccinate his own kids. Not exactly an honest disclosure that could conceivably be considered to fulfill the basic requirements of “informed consent”.

(Side observation: Someone injected a child on *May 19, 2021*.)

It wasn’t until July 6 that the CDC posted a MMWR report - “Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021” - acknowledging that myocarditis was indeed confirmed in at least a few instances as caused by one of the covid vaccines.1 (Keep in mind that even after this MMWR was released, the medical establishment continued to either deny or downplay vaccine myocarditis for months in the public communications and messaging, so even this ‘admission’ was ‘lacking’, to say the least.)

This MMWR report covered the June 23 ACIP meeting where data concerning myocarditis (among other potentially vaccine-related adverse events) from the various pharmacovigilance systems was presented.

Notably missing however was any mention of the case studies reporting vaccine associated myocarditis, despite the submission of at least 36 case reports documenting *145* cases of vaccine-associated myocarditis before June 23.

Although this might seem like a trivial number compared to the 1,000+ VAERS reports of myocarditis that were submitted during that time, it is not.

Firstly, the medical establishment’s (absurd) claim that VAERS reports are uniformly unreliable because (allegedly) any random person could submit one does not apply to case reports, which are formal academic literature written by trained clinicians documenting expert clinical opinion and experience.

Secondly - and more importantly - there are at least 11 case reports documenting a minimum of 4 separate cases of presumed vaccine myocarditis, that presented to ONE medical facility, typically within at most 4-7 days of vaccination, over a relatively short timespan (anywhere from 4-12 weeks), with robust exclusions (usually they exclude anyone with past history of either covid infection or myocarditis). This includes one case series that documented 8 cases, and one that documented 13 - THIRTEEN (!!) - despite all of the abovementioned limitations. The odds of having so many cases even with such widely ranging and encompassing exclusions if the vaccines were not responsible is so infinitesimally small as to be a joke.

NOTE:

• I chose to use the date a study was submitted and not the date it was first published online because the government agencies and public health officials responsible for vaccine policies and determinations had access to studies that were submitted, and can thus not claim to have been “unaware” that they existed.

• I used the PubMed metadata page if I couldn’t find the date received on the study’s regular page, which looks like this:

  

  I included both the PubMed metadata & the regular study page for the first few studies so you can see they’re the same. Additionally, all PubMed screenshots are linked to the source, so you can check for yourself that they are accurate.

• In the few instances where there is no date provided for the study’s submission, I used the next earliest date available (either the date accepted or the date published online).

• The studies are organized chronologically starting from oldest/earliest.

The following 42 case reports documenting peri/myocarditis or myocardial injury were all submitted before July 1, 2021:

1. Acute myocarditis associated with anti-COVID-19 vaccination (Nevet)

https://pubmed.ncbi.nlm.nih.gov/34222133/

Cases: 3

We report on three young male patients, who developed acute myocarditis 2 days after receiving the second dose of the BNT162b2 vaccine.

2. Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19 (García et al)

https://pubmed.ncbi.nlm.nih.gov/33994339/

Cases: 1

Given the temporal association between vaccination and the onset of symptoms, and having excluded other acute cardiological disorders, we suggest that this acute myocarditis was an adverse reaction to the BNT162b2 vaccine.

3. Myocarditis After SARS-CoV-2 Vaccination: A Vaccine-Induced Reaction? (D’Angelo et al)

https://pubmed.ncbi.nlm.nih.gov/34118375/

Cases: 1

We report a case of a 30-year-old man who presented progressive dyspnea and constrictive retrosternal pain after receiving SARS-CoV-2 vaccine. Cardiac magnetic resonance and laboratory data revealed typical findings of acute myopericarditis.

4. Myocarditis following COVID-19 mRNA vaccination (Abu Mouch et al)

https://pubmed.ncbi.nlm.nih.gov/34092429/

Cases: 6

We report six cases of myocarditis, which occurred shortly after BNT162b2 vaccination.

5. Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection (Ammirati et al)

https://pubmed.ncbi.nlm.nih.gov/33821210/

Cases: 1

An otherwise healthy 56-year-old man presented to the emergency department complaining of acute onset of chest pain 3 days after the second dose of BNT162b2 mRNA COVID-19 vaccine.

6. Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases (Mansour et al)

https://pubmed.ncbi.nlm.nih.gov/34166884/

Cases: 2

We report two cases of myocarditis, in two young and previously healthy individuals, temporally related to the second dose of the mRNA-COVID-19 vaccine.

7. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military (Montgomery et al)

https://pubmed.ncbi.nlm.nih.gov/34185045/

Cases: 23

This retrospective case series studied patients within the US Military Health System who experienced myocarditis after COVID-19 vaccination between January and April 2021. Patients who sought care for chest pain following COVID-19 vaccination and were subsequently diagnosed with clinical myocarditis were included.

8. Acute Myocardial Injury Following COVID-19 Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events Reporting System Database (Deb et al)

https://pubmed.ncbi.nlm.nih.gov/34219532/

Cases: 1

Here we present a case of acute myocardial injury that developed as a result of an acute immune response following the second dose of COVID-19 vaccination (Moderna) in a 67-year-old man who presented in acute congestive heart failure.

9. A case report: symptomatic pericarditis post-COVID-19 vaccination (Ashaari et al)

https://pubmed.ncbi.nlm.nih.gov/34693198/

Cases: 1

We described a case of pericarditis post-first dose of Pfizer-BioNTech vaccine.

10. Myocarditis following COVID-19 vaccination (Albert et al)

https://www.sciencedirect.com/science/article/pii/S1930043321003289

Cases: 1

We report a case of a 24-year-old man who presented to the hospital with acute substernal chest pain, 4 days after his second COVID-19 Moderna vaccination.

11. Myocarditis and pericarditis after vaccination for COVID-19 (Hudson et al)

https://pubmed.ncbi.nlm.nih.gov/34337595/

Cases: 2

Two previously healthy males presented to the emergency symptoms with signs of pericarditis/myocarditis after being vaccinated with an mRNA vaccine for COVID-19.

12. Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine (Ramírez-García et al)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196309/

Cases: 2

Here we report 2 cases of pericarditis after administration of the BNT162b2 vaccine.

13. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination (Kim et al)

https://pubmed.ncbi.nlm.nih.gov/34185046/

Cases: 4

Objective: To describe a group of 7 patients with acute myocarditis over 3 months, 4 of whom had recent messenger RNA (mRNA) COVID-19 vaccination.

14. Acute myocarditis following administration of BNT162b2 vaccine (Habib et al)

https://pubmed.ncbi.nlm.nih.gov/34189042/

Cases: 1

Here, we describe a young male patient, who presented with acute myocarditis, three days after the second dose of BNT162b2 vaccine.

15. Possible Association Between COVID-19 Vaccine and Myocarditis (Shaw et al)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245050/

Cases: 4

We present cardiac magnetic resonance (CMR) imaging findings in 4 cases of acute myocarditis that were temporally related to the receipt of COVID-19 vaccine and could raise the possibility of being associated with the vaccination (Figures 1, ​,2, ​,3, 4, and ​and 5 ).

16. Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report (Hasnie et al)

https://pubmed.ncbi.nlm.nih.gov/34348657/

Cases: 1

17. Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine (Snapiri et al)

https://pubmed.ncbi.nlm.nih.gov/34077949/

Cases: 7

This is a case series of patients diagnosed with perimyocarditis following vaccination.

18. A spectrum of cardiac manifestations post Pfizer-BioNTech COVID-19 vaccination (Lee et al)

https://academic.oup.com/qjmed/article/114/9/661/6311674

Cases: 3

In this case series, we describe three previously asymptomatic patients who presented with cardiac-related manifestations shortly after receiving the Pfizer-BioNTech COVID-19 vaccine.

19. Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine (Tailor et al)

https://pubmed.ncbi.nlm.nih.gov/34514306/

Cases: 1

A 44-year-old man presented with chest pain and ST-segment elevation 4 days after receiving the second dose of mRNA-1273 SARS-CoV-2 Vaccine.

20. A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2 (Dickey et al)

https://www.sciencedirect.com/science/article/pii/S1936878X21004861

Cases: 6

Six previously healthy men (17-37 years of age) with no infectious prodrome developed severe chest pain and elevated troponin I within 2 days-4 days of their second vaccination (Figure 1).

21. Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination (Marshall et al)

https://pubmed.ncbi.nlm.nih.gov/34088762/

Cases: 7

We report 7 cases of acute myocarditis or myopericarditis in healthy male adolescents who presented with chest pain all within 4 days after the second dose of Pfizer-BioNTech COVID-19 vaccination.

22. COVID-19 mRNA Vaccine and Myocarditis (Singh et al)

https://pubmed.ncbi.nlm.nih.gov/34268277/

Cases: 1

We report the case of 24-year-old male patient who developed chest pain after administration of the second dose of the Pfizer-BioNTech mRNA COVID-19 vaccine and who was diagnosed with myocarditis on work-up.

23. Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine (Tano et al)

https://academic.oup.com/jpids/article/10/10/962/6329543

Cases: 8

We describe clinical characteristics of 8 adolescents who presented over the course of 36 days to Nicklaus Children’s Hospital with perimyocarditis within 4 days of receiving a dose of BNT162b2 vaccine.

24. Myocarditis after BNT162b2 vaccination in a healthy male (Watkins et al)

https://pubmed.ncbi.nlm.nih.gov/34229940/

Cases: 1

In this article, we present a case of a 20-year-old male with no prior medical history who presented to the emergency department (ED) with chest pain. He had received the BNT162b2 vaccine two days prior to his presentation to the ED.

25. Myocarditis Associated with mRNA COVID-19 Vaccination (Starekova et al)

https://pubmed.ncbi.nlm.nih.gov/34282971/

Cases: 5

Five patients (4:1 male:female; age range, 17–38 years) were identified who had abnormal MRI findings and were vaccinated against COVID-19 prior to MRI.

26. Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report (McLean & Johnson)

https://pubmed.ncbi.nlm.nih.gov/34133825/

Cases: 1

We report the case of a previously healthy 16‐year‐old male who developed myopericarditis following the second dose of his Pfizer‐BioNTech COVID‐19 vaccine, with no other identified triggers.

27. Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series (Patel et al)

https://pubmed.ncbi.nlm.nih.gov/34496880/

Cases: 5

We report a case series of 5 young male patients with cardiovascular magnetic resonance (CMR)-confirmed acute myocarditis within 72 h after receiving a dose of an mRNA-based COVID-19 vaccine.

28. Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines (Vidula et al)

https://pubmed.ncbi.nlm.nih.gov/34277198/

Cases: 5

In this case series, we describe two patients with clinically suspected myocarditis, one patient with stress cardiomyopathy, and two patients with pericarditis after receiving an mRNA-based COVID-19 vaccine.

29. Myocarditis following COVID-19 vaccination - A case series (Levin et al)

https://pubmed.ncbi.nlm.nih.gov/34535317/

Cases: 8

We identified 7 cases of myocarditis with symptoms starting in the first week after the second dose of COVID-19 Pfizer-BioNTech vaccine.

30. Myocarditis After BNT162b2 and mRNA-1273 Vaccination (Larson et al)

https://pubmed.ncbi.nlm.nih.gov/34133884/

Cases: 8

Here, we describe 8 patients who were hospitalized with chest pain and who were diagnosed with myocarditis by laboratory and cardiac magnetic resonance imaging within 2 to 4 days of receiving either the BNT162b2 or mRNA-1273 vaccine (Table).

31. In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine (Muthukumar et al)

https://pubmed.ncbi.nlm.nih.gov/34133883/

Cases: 1

A 52-year-old man presented to the emergency department ≈90 min after the onset of substernal chest pain. Three days before presentation, he received his second dose of mRNA-1273 (Moderna) vaccine for coronavirus disease 2019 (COVID-19), and the next day had a severe reaction that he described as being the “worst he had ever felt.”

32. Myocarditis Temporally Associated With COVID-19 Vaccination (Rosner et al)

https://pubmed.ncbi.nlm.nih.gov/34133885/

Cases: 7

We present a case series of 7 patients hospitalized for acute myocarditis-like illness after COVID-19 vaccination, from 2 US medical centers in Falls Church, VA, and Dallas, TX.

33. Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients (Abbate et al)

https://pubmed.ncbi.nlm.nih.gov/34416319/

Cases: 2

We herein report two cases of fulminant myocarditis following BNT162b2 mRNA Covid-19 vaccination associated with systemic hyperinflammatory syndrome and refractory shock requiring support with veno-arterial extracorporeal membrane oxygenation.

34. Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination (Williams et al)

https://pubmed.ncbi.nlm.nih.gov/34308326/

Cases: 1

In this report, we present a case of acute perimyocarditis in a young, healthy man after vaccination with the mRNA-1273 severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2; Moderna) vaccine.

35. Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents (Schauer et al)

https://pubmed.ncbi.nlm.nih.gov/34228985/

Cases: 13

We describe 13 patients aged 12-17 years who presented with chest pain within 1 week after their second dose of the Pfizer vaccine and were found to have elevated serum troponin levels and evidence of myopericarditis.

36. Takotsubo syndrome after receiving the COVID-19 vaccine (Fearon et al)

https://pubmed.ncbi.nlm.nih.gov/34539938/

Cases: 1

This case presents a post-menopausal woman with a recent diagnosis of MINOCA who developed TTS shortly after receiving the COVID-19 vaccine.

37. Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis? (Chamling et al)

https://pubmed.ncbi.nlm.nih.gov/34333695/

Cases: 3

We would like to present the findings of three different patients that presented to our hospital until mid of June 2021 and showed unusual serious adverse cardiovascular events of infarct-like myocarditis (in the absence of CAD), possibly linked to preceding COVID-19 vaccination. CMR imaging revealed some interesting patterns of myocardial damage suggestive of “autoimmune” myocarditis that show some minor differences to the well-known CMR pattern of “viral” myocarditis.

38. Acute Myocarditis after COVID-19 vaccination: A case report (Schmitt et al)

https://pubmed.ncbi.nlm.nih.gov/34740463/

Cases: 1

A 19-year-old man, presenting with troponin-positive acute chest pain, was referred to our department. He had received the Pfizer-BioNTech COVID-19 vaccine three days prior to his admission. The diagnosis of acute myocarditis was confirmed by cardiovascular magnetic resonance imaging.

39. Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine (Park et al)

https://pubmed.ncbi.nlm.nih.gov/34180390/

Cases: 2

Two adolescent males presented within 3 days after the first and second dose of the BNT162b2 vaccine with chest pain. Elevated troponin levels, ST segment elevation, and enhancement of the myocardium in cardiac MRI suggested myocarditis.

40. COVID-19 vaccine-induced myocarditis: Case report with literature review (Nassar et al)

https://pubmed.ncbi.nlm.nih.gov/34293552/

Cases: 1

A 70-year-old Caucasian female with a history of multiple sclerosis presented to the hospital after two days of receiving the Janssen COVID-19 vaccine.

41. A Case of Acute Pericarditis After COVID-19 Vaccination (Sonaglioni et al)

https://pubmed.ncbi.nlm.nih.gov/35387019/

Cases: 1

Herein we describe the case of a middle-aged healthy women who developed symptoms and signs of acute pericarditis 7-10 days after the second dose of Pfizer-BioNTech COVID-19 vaccination.

42. MODERNA mRNA-1273 vaccine-associated myopericarditis in a patient with a subclinical autoimmune predisposition (Badshah et al)

https://pubmed.ncbi.nlm.nih.gov/34868402/

Cases: 1

We present a rare case of myopericarditis developing one day after the injection of the second dose of the MODERNA mRNA-1273 vaccine.

Subscribe now

Enjoy!!

Format:

Main article will contain the title, lead author, link, vaccine/dose, and # of patients for each case report study. Excerpts from each describing the basic clinical events are in endnotes.

Note #1: All case reports here pertain to only the “Big 4” quadruplet (Pfizer, Moderna, J&J, AstraZeneca).

Note #2: There are a few case reports here that are a bit ‘shaky’, insofar as attribution of the death to the vaccine. Not every single case report documenting an adverse event following vaccination necessarily represents an adverse event *caused* by the vaccine (see Introduction to Vaccine Injury Case Reports for more details).

Category #1: Autopsies

The following case reports are autopsies performed on patients who died following an adverse event associated with one of the covid vaccines:

Autopsy #1: Post-mortem findings in vaccine-induced thrombotic thombocytopenia1 (Pomara et al)

https://haematologica.org/article/view/haematol.2021.279075

2 patients, both AstraZeneca, dose unspecified (implied both Dose #1)

Autopsy #2: An autopsy case report of fulminant myocarditis: Following mRNA COVID-19 vaccination2 (Hoshino et al)

https://pubmed.ncbi.nlm.nih.gov/35812802/

1 patient, Moderna Dose #1

Autopsy #3: An autopsy case of fulminant myocarditis after severe acute respiratory syndrome coronavirus 2 vaccine inoculation3 (Satomi et al)

https://pubmed.ncbi.nlm.nih.gov/36040128/

1 patient, Pfizer Dose #1

Autopsy #4: Histopathologically TMA-like distribution of multiple organ thromboses following the initial dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech): an autopsy case report4 (Kaimori et al)

https://pubmed.ncbi.nlm.nih.gov/36203145/

1 patient, Pfizer Dose #1

Autopsy #5: A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against Covid-195 (Mörz)

https://www.preprints.org/manuscript/202206.0308/v2

1 patient, Pfizer Dose #3

Autopsy #6: Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings6 (Choi et al)

https://pubmed.ncbi.nlm.nih.gov/34664804/

Autopsy #7: Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose (Gill et al)7

https://meridian.allenpress.com/aplm/article/146/8/925/477788/Autopsy-Histopathologic-Cardiac-Findings-in-2

2 patients, both Pfizer Dose #2

Autopsy #8: Histological and immunohistochemical findings in a fatal case of thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination8 (Pomara et al [#2])

https://pubmed.ncbi.nlm.nih.gov/35144085/

1 patient, AstraZeneca Dose #1

Autopsy #9: First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction (Ameratunga et al)9

https://pubmed.ncbi.nlm.nih.gov/34978002/

1 patient, Pfizer Dose #1

Autopsy #10: Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature (Fanni et al)10

https://pubmed.ncbi.nlm.nih.gov/34355379/

1 patient, AstraZeneca Dose #1

Autopsy #11: Deterioration of vaccine-induced immune thrombotic thrombocytopenia treated by heparin and platelet transfusion: Insight from functional cytometry and serotonin release assay (Bérezné et al)11

https://pubmed.ncbi.nlm.nih.gov/34485807/

1 patient, AstraZeneca Dose #1

Autopsy #12: Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA-1273 vaccine: A case report (Kamura et al)12

https://pubmed.ncbi.nlm.nih.gov/35189339/

1 patient, Moderna Dose #1

Autopsy #13: Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma (Choi GJ et al)13

https://pubmed.ncbi.nlm.nih.gov/34459725/

1 patient, J&J Dose #1

Autopsy #14: Fatal cerebral haemorrhage after COVID-19 vaccine (Bjørnstad-Tuveng et al)14

https://pubmed.ncbi.nlm.nih.gov/33928772/

1 patient, AstraZeneca Dose unspecified

Autopsy #15: Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination (Ujueta et al)15

https://pubmed.ncbi.nlm.nih.gov/34514078/

1 patient, J&J Dose #1

Autopsy #16: Fatal intracranial hemorrhage in patient with thrombocytopenia and positive HIT antibodies after vaccination with ChAdOx1 nCoV-19 - VITT without thrombosis? (Medić et al)16

https://pubmed.ncbi.nlm.nih.gov/35640515/

1 patient, AstraZeneca Dose #1

Autopsy #17: Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination (Grome et al)17

https://pubmed.ncbi.nlm.nih.gov/34586059/

1 patient, Pfizer Dose #2

Category #2: Case Series

The following are case reports documenting at least 3 cases of a fatal vaccine-associated adverse event:

CS #1: Towards the emergence of a new form of the neurodegenerative Creutzfeldt-Jakob disease: Twenty six cases of CJD declared a few days after a COVID-19 vaccine Jab (Perez et al)18

https://www.researchgate.net/publication/363484655

26 patients (20 deaths), Pfizer Dose #1 x4 / Dose #2 x14 / Dose #3 x2; AstraZeneca Dose #2 x2, unknown Dose x1; Moderna Dose #2 x2 / Dose #1 x1

CS #2: Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination (Greinacher et al)19

https://pubmed.ncbi.nlm.nih.gov/33835769/

11 patients, 6/11 died, see chart in footnote for vaccination details

CS #3: Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination (Schultz et al)20

https://pubmed.ncbi.nlm.nih.gov/33835768/

5 patients, all AstraZeneca Dose #1

CS #4: Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination (Scully et al)21

https://pubmed.ncbi.nlm.nih.gov/33861525/

7/23 patients died, all AstraZeneca Dose #1

CS #5: Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series (Wiedmann et al)22

https://pubmed.ncbi.nlm.nih.gov/34393988/

4/5 patients died, all AstraZeneca Dose #1

CS #6: Case Series: Acute Hemorrhagic Encephalomyelitis After SARS-CoV-2 Vaccination (Ancau et al)23

https://pubmed.ncbi.nlm.nih.gov/35185757/

2/3 patients died, all AstraZeneca Dose #1

Category #3: Transplanting Organs from VITT Victims

The following are case reports documenting cases where organ transplants from patients killed by VITT caused by a covid vaccine were either performed or at least considered Patient/s listed refers to donor/s killed by vaccine:

T-VITT #1: Organ Donation From a Brain Dead Donor With Vaccine-induced Immune Thrombotic Thrombocytopenia After Ad26.COV2.S: The Risk of Organ Microthrombi (Uzun et al)24

https://pubmed.ncbi.nlm.nih.gov/34974451/

1 patient, J&J Dose #1

T-VITT #2: Fatal cerebral venous sinus thrombosis after COVID-19 vaccination (Jamme et al)25

https://pubmed.ncbi.nlm.nih.gov/33983464/

1 patient, AstraZeneca Dose #1

T-VITT #3: Vaccine-Induced Thrombotic Thrombocytopenia Due to Coronavirus Disease 2019 Vaccine From a Deceased Donor: A Case Report (Guditi et al)26

https://pubmed.ncbi.nlm.nih.gov/34916063/

1 patient, AstraZeneca Dose #1

T-VITT #4: Outcome After Organ Transplantation From Brain-dead Donors After a Cerebral Insult Following SARS-CoV-2 Vaccination Within the Eurotransplant Region27

https://pubmed.ncbi.nlm.nih.gov/34570086/

6 patients, AstraZeneca, Dose unspecified x5; J&J Dose #1 x1

T-VITT #5: Successful Liver Transplantation From a Deceased Donor With Vaccine-Induced Thrombotic Thrombocytopenia Causing Cerebral Venous Sinus and Hepatic Veins Thrombosis After ChAdOx1 nCov-19 Vaccination (Centonze et al)28

https://pubmed.ncbi.nlm.nih.gov/34172647/

1 patient, AstraZeneca Dose #1

T-VITT #6: Transplantation Outcome in Recipients Engrafted With Organs Recovered From the First French Deceased Donor With a SARS-COV-2 Vaccine-induced Thrombotic Thrombocytopenia (Jamme et al [#2])29

https://pubmed.ncbi.nlm.nih.gov/34115658/

1 patient, AstraZeneca Dose #1

T-VITT #7: New-Onset Antibodies to Platelet Factor 4 Following Liver Transplantation From a Donor With Vaccine-Induced Thrombotic Thrombocytopenia (Valsecchi et al)30

https://pubmed.ncbi.nlm.nih.gov/34416086/

1 patient, vaccine unknown but presumed to be one of the Big 4 because all authors are from Italy (paywall)

T-VITT #8: Organ transplantation from deceased donors with vaccine-induced thrombosis and thrombocytopenia (Greenhall et al)31

https://pubmed.ncbi.nlm.nih.gov/34214257/

13 patients, AstraZeneca Dose #1 x13

T-VITT #9: Solid organ procurement and transplantation from deceased donors with vaccine-induced thrombosis and thrombocytopenia (Loupy et al)32

https://pubmed.ncbi.nlm.nih.gov/34233058/

Category #4: Otherwise Uncategorized Case Reports

The following are case reports documenting a death following a covid vaccine-associated adverse event:

CR #1: Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia (De Michele et al)33

https://pubmed.ncbi.nlm.nih.gov/34341358/

1 patient, AstraZeneca Dose #1

CR #2: Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in Korea (Choi JK et al)34

https://pubmed.ncbi.nlm.nih.gov/34402235/

1 patient, AstraZeneca Dose #1

CR #3: Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US (Rodriguez et al)35

https://pubmed.ncbi.nlm.nih.gov/34626338/

1 patient, J&J Dose #1

CR #4: Brain death in a vaccinated patient with COVID-19 infection (Watchmaker & Belani)36

https://pubmed.ncbi.nlm.nih.gov/34656887/

1 patient, Pfizer Dose #2

CR #5: Fatal myositis, rhabdomyolysis and compartment syndrome after ChAdOx1 nCoV-19 vaccination (Huang ST et al)37

https://pubmed.ncbi.nlm.nih.gov/35504826/

1 patient, AstraZeneca Dose #2

CR #6: Fatal intracerebral haemorrhage associated with thrombosis with thrombocytopenia syndrome after ChAdOx1-S vaccine (Gómez-Roldós et al)38

https://pubmed.ncbi.nlm.nih.gov/36169326/

1 patient, AstraZeneca Dose #1

CR #7: Cerebral Venous Sinus Thrombosis With Severe Thrombocytopenia: A Fatal Adverse Event After Johnson & Johnson COVID-19 Vaccination (Ali M et al)39

https://cp.neurology.org/content/11/6/e971

1 patient, J&J Dose #1

CR #8: Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins - a rational for monitoring immunoglobulin G levels (Douxfils et al)40

https://pubmed.ncbi.nlm.nih.gov/34847660/

1 patient, AstraZeneca Dose #1

CR #9: Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine (Aladdin et al)41

https://pubmed.ncbi.nlm.nih.gov/34171649/

1 patient, AstraZeneca Dose #1

CR #10: First and fatal case of autoimmune acquired factor XIII/13 deficiency after COVID-19/SARS-CoV-2 vaccination (Shimoyama et al)42

https://pubmed.ncbi.nlm.nih.gov/34856014/

1 patient, Pfizer Dose #2

CR #11: Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report (Calò et al)43

https://pubmed.ncbi.nlm.nih.gov/35891185/

1 patient, Pfizer Dose #3

CR #12: Acute transverse myelitis after BNT162b2 vaccination against COVID-19: Report of a fatal case and review of the literature (Nakano et al)44

https://pubmed.ncbi.nlm.nih.gov/34953348/

1 patient, Pfizer Dose #2

CR #13: An Interesting Case of Fatal Myasthenic Crisis Probably Induced by the COVID-19 Vaccine (Sonigra et al)45

https://pubmed.ncbi.nlm.nih.gov/35449619/

1 patient, AstraZeneca Dose #1

CR #14: A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination (Kim SH et al)

https://pubmed.ncbi.nlm.nih.gov/35380028/46

1 patient, AstraZeneca Dose #2

CR #15: Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (Al-Mayhani et al)47

https://pubmed.ncbi.nlm.nih.gov/34035134/

1 patient, AstraZeneca Dose unspecified

CR #16: [Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19] (Wolthers et al)48

https://pubmed.ncbi.nlm.nih.gov/34477089/

1 patient, AstraZeneca Dose unspecified

CR #19: A Single-Health System Case Series of New-Onset CNS Inflammatory Disorders Temporally Associated With mRNA-Based SARS-CoV-2 Vaccines (Ballout et al)49

https://pubmed.ncbi.nlm.nih.gov/35280277/

1 patient, Moderna Dose #1

Subscribe now

19

Results: Of the 11 original patients, 9 were women, with a median age of 36 years (range, 22 to 49). Beginning 5 to 16 days after vaccination, the patients presented with one or more thrombotic events, with the exception of 1 patient, who presented with fatal intracranial hemorrhage. Of the patients with one or more thrombotic events, 9 had cerebral venous thrombosis, 3 had splanchnic-vein thrombosis, 3 had pulmonary embolism, and 4 had other thromboses; of these patients, 6 died. Five patients had disseminated intravascular coagulation. None of the patients had received heparin before symptom onset. All 28 patients who tested positive for antibodies against PF4–heparin tested positive on the platelet-activation assay in the presence of PF4 independent of heparin. Platelet activation was inhibited by high levels of heparin, Fc receptor–blocking monoclonal antibody, and immune globulin (10 mg per milliliter). Additional studies with PF4 or PF4–heparin affinity purified antibodies in 2 patients confirmed PF4-dependent platelet activation.

Conclusions: Vaccination with ChAdOx1 nCov-19 can result in the rare development of immune thrombotic thrombocytopenia mediated by platelet-activating antibodies against PF4, which clinically mimics autoimmune heparin-induced thrombocytopenia. (Funded by the German Research Foundation.)

20

We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus disease 2019 (Covid-19). The patients were health care workers who were 32 to 54 years of age. All the patients had high levels of antibodies to platelet factor 4–polyanion complexes; however, they had had no previous exposure to heparin. Because the five cases occurred in a population of more than 130,000 vaccinated persons, we propose that they represent a rare vaccine-related variant of spontaneous heparin-induced thrombocytopenia that we refer to as vaccine-induced immune thrombotic thrombocytopenia.

21

We report findings in 23 patients who presented with thrombosis and thrombocytopenia 6 to 24 days after receiving the first dose of the ChAdOx1 nCoV-19 vaccine (AstraZeneca). On the basis of their clinical and laboratory features, we identify a novel underlying mechanism and address the therapeutic implications.

27

These 6 donors with a median age of 48 y (37–72 y), 50% female, provided 20 organs to 17 recipients (Table ​(Table1).1). After a median follow-up of 43 d (19–93 d), all recipients were alive and 19 organs (95%) were functioning well. Two recipients (11.8%) developed thrombosis-related complications; 1 kidney developed thrombotic microangiopathy but recovered completely. One split-liver recipient developed thrombotic material in different vessels and necrosis of liver cells, resulting in urgent retransplantation.

Overall, the outcome of our small analysis of transplanted organs from possible VITT-related donors does not seem to differ from “non-VITT donors.” Nevertheless, caution is urged with these donors, and the acceptance of each organ remains to be assessed on an individual basis by the transplant team.

31

We identified 13 consented deceased organ donors, who presented with thrombosis and/or hemorrhage and laboratory features consistent with VITT, 4 between 28 January and 9 April 2021. All had received their first dose of ChAdOx1 nCoV‐19 vaccine before admission (see Table ​Table1).1). Ten donors proceeded to donate 27 allografts to 26 recipients. After a median follow‐up of 19 days, 21 of 27 (78%) allografts have satisfactory function. Three recipients developed early allograft failure requiring explantation (two livers and one kidney); two transplanted kidneys have impaired allograft function, currently requiring hemodialysis; and one recipient died within a day of transplantation from a presumed cardiac event. There were seven major thrombotic or hemorrhagic postoperative complications (three bleeds and four venous or arterial allograft thromboses) in six recipients, resulting in the loss of three transplants as described above; these events occurred within 9 days of transplantation. Of the six recipients with bleeding or thrombotic events, two had received their second dose of ChAdOx1 nCoV‐19 vaccine within 30 days before transplantation; neither patient had features suggestive of VITT at the time of transplantation. Two of the three patients with bleeding had preexisting risk factors for hemorrhage (dual antiplatelet agent therapy, anticoagulation for metallic cardiac valve); none of the patients with thromboses had significant preexisting procoagulant tendencies.

So far, three liver recipients had detectable anti‐PF4 antibodies between 3 and 22 days posttransplant; one of these recipients experienced a thrombotic complication without allograft loss and the other two had uncomplicated postoperative courses. Ten recipients (six kidneys and four livers) tested negative for anti‐PF4 antibodies.

The UK experience to date suggests that the potential risks of transplanting organs from donors with VITT are twofold. First, early major thrombosis or clinically significant bleeding, which may result from preexisting hemostatic and endothelial dysfunction in the allograft. Second, possible transmission of pathogenic lymphocytes producing anti‐PF4. The clinical significance of this is unclear; further follow‐up will determine whether this portends development of VITT in the recipient.

32

From April 9 up to May 7, 2021, we identified five potential deceased donors with VITT, using existing diagnostic criteria 1 with confirmation by hematologist evaluation. All the patients had received the ChAdOx1 n‐CoV‐19 adenoviral vector vaccine at a median of 13 days (range, 8–14 days) prior to intensive care unit admission. Four patients presented with cerebral venous thrombosis. All presented thrombosis in other sites, intracranial hemorrhage and thrombopenia (Table ​(Table1).1). Two organ procurement procedures were canceled (one due to family refusal and the other because of severe disseminated intravascular coagulation). Three organ procurement procedures were achieved. During these ones, two livers were discarded because of extensive portal vein thrombosis and one lung required a thrombectomy for segmental pulmonary embolism. Finally, 10 organs (six kidneys, two hearts, one lung, and one liver) were recovered and transplanted to nine recipients, who were followed until June 21, 2021 (Table ​(Table11).

After a median follow‐up of 52 days (range, 16–77 days), all recipients were alive with adequate functioning transplants. Patients experienced neither severe thrombotic nor hemorrhagic event. Two kidney transplant recipients displayed delayed graft function (including one showing glomerular microthrombi on preimplantation biopsy), that finally gradually recovered. One kidney transplant recipient underwent a biopsy at 10 days posttransplant showing mild interstitial inflammation and tubulitis, unrelated to VITT, which was treated by steroid pulses, with good subsequent function. Only one recipient displayed thrombocytopenia, but was present before transplantation and secondary to hepatic cirrhosis. To date, no recipient had detectable anti‐PF4 antibodies (tests performed at a median of 10 days posttransplant) and eight have been discharged from hospital (Table ​(Table11).

This report summarizes the outcomes of organ procurement and transplantation from deceased donors with VITT in France. The potential risks were to transplant organs with thrombosis (as in the case of disseminated intravascular coagulation 4 ), which could compromise organ function, and/or transmitting the systemic disease to the recipient. 5 To mitigate these risks, the French National Organ Procurement Agency immediately provided guidelines for the screening, procurement, and transplantation from such donors, as well as recipient monitoring (the detailed protocol is provided in the Supplementary Material). These guidelines led to the following: (1) a donation procedure was canceled in the case of severe disseminated intravascular coagulation; (2) organs were extensively assessed for the presence of thrombi (including biopsy if required) and discarded if thrombi were extensive; (3) after transplant, recipients underwent serial monitoring of thrombotic/hemorrhagic events, hemostasis, and anti‐PF4 antibodies. Our analysis shows that the early outcomes of these transplants were favorable. While the presence of thrombi in a few organs suggests the possibility that organ function could be compromised if thrombosis was extensive, we were able to select organs with limited thrombi and did not find any evidence of transmission of VITT to the recipients. In conclusion, our data support that organs from deceased donors with VITT may be suitable for transplantation and should be carefully assessed, but not systematically discarded.

While sifting through the mountains of academic literature & compiling case reports of adverse events following the covid vaccines, I have come across a number of case reports of SAE’s following other vaccines. One of the things that has really jumped out at me is the remarkable consistency in the types of injuries reported following other vaccines and many of those reported following the covid vaccines.

The similarity in reported adverse suggests that some of the underlying pathologies of covid vaccine injuries are shared by other vaccines - in other words, that are generalizable to vaccines as a whole.

The similarities are so startling that it is pretty much impossible to discern which is which from the titles.

I chose to highlight only vaccine reports from the influenza/flu vaccines to better demonstrate that many of the covid vaccine injuries are shared by another single type of vaccine, implying that this is a broad problem with vaccination in general as opposed to being associated with something unique to a specific vaccine - the odds that the covid vaccines and influenza vaccines (or any other individual vaccine) would share so many types of SAE’s by completely different etiologies or mechanisms is probably pretty remote.

Would you be able tell if a case report is covid vaccine or flu vaccine?

Below are 35 pairs of studies documenting SAE’s following either the covid vaccines or Flu vaccines. These do not represent anywhere near the totality of types of injuries from either the covid vaccines or the various influenza vaccines. (There are 33 types of SAE’s in this list of 35 pairs of case reports.)

#1

A. Delayed inflammatory reaction to hyaluronic acid filler following Shingrix and Fluzone vaccines treated with lisinopril

B. Hypersensitivity reaction to hyaluronic acid dermal filler after COVID-19 vaccination: A series of cases in São Paulo, Brazil

#2

A. Subacute thyroiditis following influenza vaccine (Vaxigrip) in a young female

B. Subacute Thyroiditis After Receiving the Adenovirus-Vectored Vaccine for Coronavirus Disease (COVID-19)

#3

A. Acute Demyelinating Encephalomyelitis Post-COVID-19 Vaccination: A Case Report and Literature Review

B. Post-vaccination encephalomyelitis: literature review and illustrative case (Influenza vaccine)

#4

A. Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine

B. MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report

#5

A. Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine

B. Vogt-Koyanagi-Harada Syndrome following influenza vaccination

#6

A. Acute idiopathic blind spot enlargement syndrome following influenza vaccination

B. Unilateral Acute Idiopathic Blind Spot Enlargement following Second Dose of Covid-19 mRNA Vaccine

#7

A. Multiple Evanescent White Dot Syndrome following BioNTech SARS-CoV2 mRNA vaccination

B. Multiple evanescent white dot syndrome following influenza immunization - A multimodal imaging study

#8

A. Adult-onset Still's disease following mRNA COVID-19 vaccination

B. Onset of adult-onset Still's disease following influenza vaccination

#9

A. Lichen planus occurring after influenza vaccination: report of three cases and review of the literature

B. Lichen planus arising after COVID-19 vaccination

#10

A. Hemophagocytic Lymphohistiocytosis After Inactivated Influenza Vaccination in a Young Man Complicated by Severe Rhabdomyolysis

B. A case of hemophagocytic lymphohistiocytosis following second dose of COVID-19 vaccination

#11

A. Minimal change disease following influenza vaccination and acute renal failure: just a coincidence?

B. A Case of Minimal Change Disease after SARS-CoV-2 Vaccination under the Age of 18

#12

A. Vogt-Koyanagi-Harada disease following influenza vaccination

B. De Novo Vogt-Koyanagi-Harada Disease following Covid-19 Vaccine: A Case Report and Literature Overview

#13

A. Presumed oculomotor nerve palsy following COVID-19 vaccination

B. Complete Oculomotor Palsy after Influenza Vaccination in a Young Healthy Adult: A Case Report

#14

A. Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccine

B. Stevens-Johnson Syndrome Due to Influenza Vaccination

#15

A. [A case of autoimmune hemolytic anemia caused by type A influenza infection in a patient with alcoholic liver cirrhosis]

B. A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination

#16

A. Postinfluenza Vaccination Idiopathic Thrombocytopenic Purpura in Three Elderly Patients

B. Idiopathic Thrombocytopenic Purpura and the Moderna Covid-19 Vaccine

#17

A. SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: "Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?" by Manzo et al. Joint Bone Spine 2021;88:105150

B. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review

#18

A. Novel case of takotsubo cardiomyopathy following COVID-19 vaccination

B. Takotsubo cardiomyopathy after anti-influenza vaccination: catecholaminergic effects of immune system

#19

A. A case of Evans' syndrome following influenza vaccine

B. New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination

#20

A. Autoimmune Hemolytic Anemia in a Renal Transplant Patient Following Seasonal Influenza Vaccination

B. A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination

#21

A. Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis

B. Hemodynamic Collapse After Influenza Vaccination: A Vaccine-Induced Fulminant Myocarditis?

#22

A. Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre

B. Psoriasis flare after influenza vaccination in Covid-19 era: A report of four cases from a single center

#23

A. Recurrence of pericarditis after influenza vaccination: a case report and review of the literature

B. COVID-19 mRNA Vaccine Induced Pericarditis With Large Pericardial Effusion Followed by New-Onset Arrhythmia

#24

A. Influenza virus vaccine: Kounis syndrome: case report

B. Kounis syndrome associated with BNT162b2 mRNA COVID-19 vaccine presenting as ST-elevation acute myocardial infarction

#25

A. Pityriasis rosea following influenza (H1N1) vaccination

B. Pityriasis rosea following SARS-CoV-2 vaccination: A case series

#26

A. Acute Unilateral Ptosis and Myositis Following the H1N1 Influenza Vaccine

B. COVID-19 vaccine-induced cellulitis and myositis

#27

A. Erythema multiforme secondary to H1N1 vaccine

B. Erythema Multiforme after BNT162b2 Vaccination

#28

A. Cutaneous Leukocytoclastic Vasculitis Following Influenza Vaccination in Older Adults: Report of Bullous Purpura in an Octogenarian after Influenza Vaccine Administration

B. Cutaneous leukocytoclastic vasculitis following COVID-19 vaccination with Ad26.COV2.S vaccine: a case report and literature review

#29

A. A case of non-episodic angioedema with eosinophilia induced by influenza vaccine

B. Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses

#30

A. A case of acquired haemophilia following H1N1 vaccination

B. Acquired hemophilia A after vaccination against SARS-CoV-2 with the mRNA-1273 (Moderna) vaccine

#31

A. HENOCH-SCHÖNLEIN PURPURA NEPHRITIS FOLLOWING INFLUENZA VACCINATION: A CASE REPORT AND REVIEW OF THE LITERATURE

B. Henoch-Schönlein purpura following COVID-19 vaccine in a child: a case report

#32

A. Ischaemic stroke and influenza A H1N1 vaccination: a case report

B. Acute Thalamic Ischemic Stroke in an Older Patient Newly Vaccinated with COVID-19 Vaccine Based on Adenoviral Vectors

#33

A. Autoimmune hepatitis following influenza virus vaccination: Two case reports

B. COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature

#34

A. Membranous nephropathy and severe acute kidney injury following influenza vaccination

B. A Case of Membranous Nephropathy Hypothesized to be Associated With COVID-19 Vaccine

#35

A. An Unusual Side Effect of the COVID-19 Vaccine: A Possible Trigger of Polymyalgia Rheumatica

B. Polymyalgia rheumatica following influenza vaccination

Subscribe now

Resisting the Intellectual Illiteratti

Vaccine Roulette: Making Outright Human Experimentation Great Again (Part 1)

Welcome to the Post-Nuremberg Ethical Apocalypse: Dose 1 Severe Adverse Event, Dose 2...? You'll have to get jabbed with Dose 2 to find out…

Read more

4 years ago · 44 likes · 29 comments · Ashmedai

To understand the ethical psychosis we are dealing with here, consider the following study:

Patients with post-COVID-19 vaccination facial palsy: To boost or not to boost?

https://pubmed.ncbi.nlm.nih.gov/36061346/

A possible association between Bell's palsy and COVID-19 vaccination has been suggested. While it is likely that COVID-19 vaccine recipients from the general population do have a slightly increased risk of developing Bell's palsy, there are little data regarding this risk in individuals with a history of disease. Gaining a better understanding of this association is particularly important for informing evidence-based recommendations regarding future booster shots in subjects who developed Bell's palsy as a side effect of vaccination, or as a result of SARS-CoV-2 infection. We previously described the first case of COVID-19 vaccine-related Bell's palsy; here we report an 18-month clinical and electromyographic follow-up and discuss the implications of receiving further vaccine doses in patients with positive disease history.

Clearly, there is a mass psychosis amongst medical practitioners. In a sane world, even asking such a question would mark a doctor as morally ‘adventurous’. Not anymore.

Quick primer on the formatting:

• I divided case reports into “Winners” & “Losers” based on whether dose #2 (or 3+) caused new or worsening of the SAE’s following dose #1.

  Yes, sometimes the patient gets dose #2 without suffering any SAE, at least in the short term, hence the title “Vaccine Roulette”.

  Obviously, surviving dose #2 without further injury does not suggest that it was a good idea to get dose #2 - this would be akin to claiming that playing real Russian Roulette is harmless because you survived.

• Each report has the case report title, link, timeline of events, and some ‘commentary’; I also am including the excerpts from the case report describing the basic narrative of the case in a footnote placed at the end of the link

• I have identified a few dozen of these case reports so far from the case reports that I have cataloged in detail, However, I have only cataloged about 350-400 or so out of the 2,470+ (and growing) that I have compiled to date.

☠☠☠☠☠☠☠☠☠☠☠☠☠☠

Losers 😱

A Case of COVID-19 Vaccine Associated New Diagnosis Myasthenia Gravis

 https://pubmed.ncbi.nlm.nih.gov/34709075/1

TIMELINE

82yo M:
Day 1: Pfizer Dose #1 😍
Day ∼7-14: Neuro symptoms begin 😫
Day ∼28: Pfizer Dose #2 😱
Day ∼30: ER 😨
Day ∼70: Worsening symptoms, Myasthenia Gravis diagnosed 😫😕💣
Day ∼100: Treatment with improvement! 😇
Day ∼114: Develops eyelid droop 😱😰
Day ∼156: Hospitalized 😱😡
Day ?: Discharged from hospital to rehab 😰😥

This case report never explicitly acknowledges that “yeah, he was experiencing significant neuro deficits post dose 1 but we judged that dose 2 was vitally necessary”. You have to combine different statements in the case report to extrapolate this - that he presented to ER 2 days after dose 2 and 4 weeks after Dose 1, and that his symptoms began a few weeks prior to presentation - which means that symptoms began prior to dose #2.

Their conclusion: “This case highlights the need for clinicians to be aware of the uncommon presenting symptoms in late-onset myasthenia gravis and the possibility of vaccine provoked diagnoses of immune mediated diseases”

“highlights the need for clinicians to be aware of […] the possibility of vaccine provoked diagnoses of immune mediated diseases”

So the authors are essentially saying that clinicians are not sufficiently knowledgeable about vaccine misinformation, and are literally calling for this knowledge ‘deficiency’ to be remedied.

Maybe vaccinating the censors wasn’t a good idea, cuz boy do they seem to be Brandon-ing around.

Rest assured, we’re definitely in good hands.

*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*

A case of recurrent fixed drug eruption following two different coronavirus disease 2019 vaccination verified through intradermal and patch tests

https://pubmed.ncbi.nlm.nih.gov/36062201/2

TIMELINE

50yo M:
Day 1: AZ Dose #1 😍
Day 2: Lesions 😫
Day ∼62: AZ Dose #2 😱
Day 63: Return of the Lesions 😨😱😫
Day ∼245 Pfizer Dose #3 😱😱😱😱😱😱😱😱😱😱
Day 246: Lesion TRIFECTA!!💣💣💣💣💣💣💣💣💣

And there was also this:

Unfortunately, the intradermal or patch test with AZD1222 or mRNA-1273 was unavailable because of the Korean government’s regulations.

*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*

Vogt-Koyanagi-Harada Disease Exacerbation Associated with COVID-19 Vaccine

https://pubmed.ncbi.nlm.nih.gov/35326462/3

TIMELINE

46yo F:
Day -20: "bilateral visual blurring and mild headache" 🤢
Day 1: Pfizer Dose #1 😕🤔
Day 3: Brutal eye problems 😨😰😫
Day 10: Partial Recovery 🤨😪😰
Day 24: Pfizer Dose #2 😱😱😱😱😱
Day 26: Even worse eye probs  💣😵💣😵💣😵💣
Day 29: Partial symptom/condition resolution 🙄😕😪😥

What happened to this poor woman? Did she ever recover? Did she get a booster?

All good questions.

And while the authors apparently felt that these questions were unimportant, they thought it was pertinent to conclude the following remarkable sentiments:

“Although it is difficult to determine causality, these cases raise the possibility of COVID vaccines being a trigger for VKH disease development, and this should be considered, especially in patients with vitiligo or previous history of the disease. Regardless, in all the reported cases, the patients responded to treatment and the benefit of vaccination probably outweighs the possible but very low risk of this side effect.”

“difficult to determine causality”???

Ummmm, I don’t know, that seems like a bit of a stretch here? We should stay tuned for the updated case report when she gets her booster, maybe then we’ll be better situated to assess causality.

“Regardless,”

They sure do seem to hold the possibility of vaccine injury in overwhelming disregard.

“in all the reported cases, the patients responded to treatment”

Let’s go apply that to, say, waterboarding!!

“in all reported instances of waterboarding prisoners, the prisoners recovered”

Alternatively, instead of waterboarding, we can just shine lasers in their eyes to do a bit of damage that we can treat afterwards, because apparently, that’s all that matters.

“the benefit of vaccination probably outweighs the possible but very low risk of this side effect”

That might depend on who you’re asking. This sounds like the case report that explained cardiogenic shock apparently “does not detract from the overwhelming benefit of vaccination from COVID-19”. Or at least reports of cardiogenic shock don’t detract from the sheer exhilaration of the literally heart-stopping excitement that is the vaccination experience.

*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*

Winners 😍

Third cranial nerve palsy in an 88-year-old man after SARS-CoV-2 mRNA vaccination: change of injection site and type of vaccine resulted in an uneventful second dose with humoral immune response

https://pubmed.ncbi.nlm.nih.gov/35135792/4

TIMELINE

88yo M:
Day 1: Moderna Dose #1 😍
Day 4: Cranial Palsy 😨😱
Day 10: Recovery 😇
Day 18: "no evidence" of antibodies from vaccine 🤔💣😱
Day ?: Pfizer Dose #2 😱😱😱
Day ?+: No adverse events from dose #2 😰😌

(I covered a separate dimension of this study in a different article.)

They certainly seem to be proud of their achievement here:

“We demonstrated the efficacy and safety of a second dose of Pfizer mRNA-BNT162b2 SARS-CoV-2 vaccination performed in a different site in producing a protective humoral response in an elderly person having experienced a severe vaccine complication and no antibody response.”

See, the efficacy was an open question, since the treatment for the palsy involved immune-suppressing steroids. If you suppress the immune system, it won’t make immune cells like antibodies, which in effect neuters the vaccine. So if there was a recurrence after Dose #2, then it would have been for naught.

*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*

Acute corneal endothelial graft rejection following COVID-19 vaccination

https://pubmed.ncbi.nlm.nih.gov/34281760/5

TIMELINE

71yo M:
Day 1: Pfizer Dose #1 😍
Day 8: Graft Failure 😵😵
Day 15: Mostly recovered 😪🧐
Day ?: Pfizer Dose #2 with steroid prophylaxis 🙄😱🙄
Day ?+: No adverse events from dose #2 😰😌🥴

Kudos to his doctors, at least they actually told the patient that he might get socked in his eye all over again with dose #2:

“We discussed with the patient the possibility of an association between the first dose of vaccination and the acute transplant rejection. Given his history of cardiovascular risk factors, it was decided to move forward with the second dose of the vaccine while keeping him on topical steroids q2 h.”

Not everyone who plays Russian Roulette ends up with their brain on the walls. Still a bad idea though.

A new study came out recently on this subject, Characteristics and Clinical Ocular Manifestations in Patients with Acute Corneal Graft Rejection after Receiving the COVID-19 Vaccine: A Systematic Review.

This study essentially analyzed a few of these case reports to “determine the characteristics and clinical ocular manifestations of acute corneal graft rejection after coronavirus disease 2019 (COVID-19) vaccination”. They included a grand total of “13 articles on 21 patients (23 eyes) with acute corneal graft rejection after COVID-19 vaccination, published between April and December 2021”.

Daniel Horowitz wrote a great piece on this study (I encourage you to read it in its entirety):

Horowitz: New study shows rejection of cornea transplants following COVID vaccination

It was one of the worst human rights violations of the COVID regime, and it’s still going on in most hospitals. Hospitals were de-listing people from organ transplant lists who would not get the COVID shots, no matter how much information came out on how the shots were unsafe and ineffective, particularly among the immunocompromised. From day one, the policy should have been the other way around – kidneys shouldn’t have been wasted on those who got the shots – and now we have the proof.

According to a study published by Japanese researchers last month in the Journal of Clinical Medicine, a number of patients receiving cornea transplants experienced rejections of the cornea tissue following the COVID vaccines. Cornea grafts are considered a much lower-risk transplant procedure than solid organ transplants and tend to have a much lower rejection rate. Which is why the researchers were surprised to find a total of 23 eyes from 21 patients who had undergone corneal graft procedures who experienced rejection anywhere from one day to six weeks following COVID vaccination. In some cases, the rejection occurred suddenly after being jabbed despite the cornea graft having held steady for many years.

Like so many other studies indicating concerning safety signals about the shot, don’t expect any follow-up to this analysis. If our government really cared about safety and science, it would immediately identify these cases of rejected corneal tissue and study them for spike protein and other tissue protein expression markers.

What this study demonstrates is that rather than accusing the unvaccinated recipients of potentially wasting a transplant, we should be studying whether vaccinated recipients might be at higher risk of wasting transplants and whether vaccinated donors run the risk of transferring to the recipients the spike protein through the grafted tissue or in solid organs.

Although the paper has not yet identified a likely mechanism of action causing rejections in eye tissue, Dr. Richard Urso, an ocular specialist, told me he is not surprised that the mRNA expressing the spike would be able to find and inflame tissue that is typically protected from the immune system. “We’re seeing inflammatory markers in tissues that usually don’t receive this protein because the lipid nanoparticles can spread it anywhere in the body. These particles are particularly adept at crossing tight junctions and can deliver the mRNA to parts of the body like the brain and eye. One thing about blood vessels around the eye is that they are covered by pericytes that are full of ACE2 receptors, which makes sense that it would trigger all the pathways for inflammation including natural killer cells.”

Of course, the authors of this new study concluded that “Corneal transplant recipients may require further vaccination, necessitating appropriate management and treatment.”

A cult in every sense of the word.

So let’s see for ourselves what exactly these austere authors are suggesting is worth the amazing benefits of vaccination, by reviewing case reports of graft rejection.

Vocabulary:

Keratoplasty = transplant

Descemet membrane endothelial keratoplasty / DMEK = “a method of corneal transplantation. The DMEK technique involves the removal of a very thin sheet of tissue from the posterior side of a person's cornea, replacing it with the two innermost layers of corneal tissue from a donor's eyeball. The two corneal layers which are exchanged are the Descemet's membrane and the corneal endothelium.” (Wikipedia)

1. Acute corneal endothelial graft rejection following COVID-19 vaccination

https://pubmed.ncbi.nlm.nih.gov/34281760/

Vaccine: Pfizer, Dose 1

A 71-year-old male patient with a history of high blood pressure, smoking, coronary artery disease and endothelial decompensation after phacoemulsification underwent DMEK of the right eye.

Five months after surgery, the patient presented to the eye clinic for a sudden painless decrease of vision in the right eye that started on the morning of his presentation to our department.

On further questioning it was revealed that he received his first dose of the BNT162b2 mRNA SARS-CoV-2 (BioNTech/Pfizer) 7 days ago.

This we will discuss further in the series on “Vaccine Roulette”:

We discussed with the patient the possibility of an association between the first dose of vaccination and the acute transplant rejection. Given his history of cardiovascular risk factors, it was decided to move forward with the second dose of the vaccine while keeping him on topical steroids q2 h.

The patient received his second dose. The graft remained clear and the visual acuity remained stable three weeks after the second dose. It was decided at that point to taper the topical steroids progressively over four weeks to reach a maintenance dose of twice a day.

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

2. Acute Corneal Epithelial Rejection of LR-CLAL After SARS-CoV-2 Vaccination

https://pubmed.ncbi.nlm.nih.gov/34743101/

Vaccine: ? (it’s behind a paywall)

A 27-year-old woman developed acute epithelial rejection of LR-CLAL 2 weeks after receiving the SARS-CoV-2 vaccine. She received the LR-CLAL transplant 4 years and 7 months previously and had a stable clinical course with no history of rejection.

The novel SARS-CoV-2 vaccine upregulates the immune system to produce an adaptive immune response. The SARS-CoV-2 vaccine may potentially be associated with increased risk of rejection in those with ocular surface transplants.

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

3. Acute Bilateral Descemet Membrane Endothelial Keratoplasty Graft Rejection After the BNT162b2 mRNA COVID-19 Vaccine

https://pubmed.ncbi.nlm.nih.gov/35444474/

Vaccine: Pfizer, Dose 1

This poor woman lost both her corneal transplants:

We report a case of acute bilateral Descemet membrane endothelial keratoplasty (DMEK) rejection two weeks following BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech), reflecting on possible changes to the management of patients with DMEK scheduled for COVID-19 vaccination.

A 94-year-old woman with Fuchs’ endothelial dystrophy who underwent DMEK 24 months earlier (right eye) and 20 months earlier (left eye) demonstrated bilateral graft rejection two weeks after the first dose of COVID-19 vaccine.

Treatment was with dexamethasone/tobramycin six times daily. Poor response resulted in re-DMEK transplantation, starting in the left eye. At one-month follow-up, BCVA and CT were 0.5 and 538µm right eye and 0.63 and 504µm left eye.

We report the first acute bilateral DMEK graft rejection after a single dose of COVID-19 vaccine. We recommend clinicians exercise vigilance and consider dexamethasone 0.1% during the vaccination period.

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

4. A case of delayed inflammatory filler reaction following vaccination with succesful response to colchicine

https://pubmed.ncbi.nlm.nih.gov/34407723/

Vaccine: ? (it’s behind a paywall)

A 43-year-old female patient treated with HA fillers developed an inflammatory reaction following vaccination in all areas of injection, including temples, lips, and lower eyelids. Systemic steroid and ciprofloxacin were used as a first-line treatment without response. Colchicine 1 mg/day along with hyaluronidase in lower eyelids improved all lesions successfully.

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

5. Five Cases of Corneal Graft Rejection After Recent COVID-19 Vaccinations and a Review of the Literature

https://pubmed.ncbi.nlm.nih.gov/35383622/

Vaccine: 
Pfizer, Dose 1
Pfizer, Dose 1
AZ, Dose 2
AZ, Dose 2
Pfizer, Dose 1

We describe 5 cases—2 patients with Descemet stripping automated endothelial keratoplasty (for Fuchs endothelial dystrophy) who presented with acute corneal graft rejection after their first dose of mRNA (BNT162) vaccine. The other 3 patients who had penetrating keratoplasty performed more than 10 years ago for keratoconus presented with acute graft rejection—2 patients after their second dose of adenovirus vector (AZD1222) vaccine and 1 patient after first dose of mRNA (BNT162) vaccine. Three patients were not using any topical steroid treatment at the time of diagnosis of graft rejection. The mean duration between vaccination and onset of symptoms was 16.86 ± 6.96 days for the mRNA vaccine and 17 ± 11.89 days for the adenovirus vector vaccine.

Corneal graft rejection has recently been reported after COVID-19 vaccination. Patients with keratoplasty need to be advised regarding the risk of corneal graft rejection and warning symptoms of rejection after COVID-19 vaccination. Seeking early referral to the emergency department and increasing topical steroids pre–COVID-19 and post–COVID-19 vaccination may reduce the risk of rejection.

“Patients with keratoplasty need to be advised regarding the risk of corneal graft rejection and warning symptoms of rejection after COVID-19 vaccination”

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

6. A case of acute endothelial corneal transplant rejection following immunization with ChAdOx1 nCoV-19 coronavirus vaccine

https://pubmed.ncbi.nlm.nih.gov/35502082/

Vaccine: AZ, Dose 1

A 28-year-old female who underwent an uneventful femtosecond laser enabled keratoplasty (FLEK) in her left eye presented with pain, redness, and blurring of vision in the operated eye two weeks after getting immunized with COVID-19 vector vaccine (ChAdOx1 nCoV19 Vaccine Recombinant COVISHIELD, AstraZeneca).

The patient was diagnosed with acute corneal graft rejection and advised hourly topical steroids with cycloplegics and oral steroids. The patient responded to treatment and there was progressive reversal of graft rejection with the patient achieving best spectacle-corrected visual acuity (BSCVA) of 20/30 after five weeks of treatment. Our case highlights possible immune corneal graft rejection after COVID19 vaccination and the need to step up topical steroids before vaccination.

The ChAdOx1 nCoV-19 messenger RNA vaccine, however, uses a chimpanzee adenovirus (AZD1222 or ChAdOx1), which carries the SARS-CoV-2 spike protein. Following administration, the genetic material of the part of coronavirus is expressed which stimulates an immune response. Despite the immune privilege of the cornea, immune-mediated corneal allograft rejection can occur, especially after penetrating keratoplasty due to breakdown in the blood aqueous barrier.

Thus, there is a possibility of immune corneal graft rejection after COVID 19 vaccination even 11 years post penetrating keratoplasty. Timing the second dose of vaccination in patients presenting with rejection as well as the need for pre-vaccination immunosuppression regimen in high-risk eyes is equally important. We suggest starting corneal graft recipients on topical corticosteroids or stepping up the topical steroids at least 1 week before taking the vaccine to suppress the immune response and bring down chances of graft rejection. We also advocate informing the patients with corneal transplant to follow-up immediately after the vaccination to look for any signs of graft rejection.

How about informing patients it might be best to forgo vaccination altogether?

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

7. Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical Concerns

https://pubmed.ncbi.nlm.nih.gov/34835205/

Vaccine: Pfizer, Dose 1

A 44-year-old Caucasian woman presented with a 2-day history of blurred vision, redness, and discomfort in her left eye, 13 days after receiving the first shot of the SARS-CoV-2 mRNA vaccine BNT162b2 (Comirnaty, Pfizer-BioNTech, Mainz, Germany).

At a 4-week follow-up, a further episode of rejection in her left eye was observed, in parallel with persistence of vitamin D deficiency (serum [25(OH)D] of 19 ng/mL). The corneal clinical picture was similar to previous episode. Steroid drops were re-started, and higher doses of vitamin D were prescribed (50,000 IU of vitamin D three times weekly). The corneal inflammation regressed in four weeks, and at six-months of follow-up, no further rejection episodes were observed.

Kudos to the patient’s GP, whoever he or she is:

Nonetheless, in agreement with her GP, the patient refused to receive the second dose of the vaccine.

“Nonetheless”

Makes it sound like the authors beg to differ…

Although it is difficult to demonstrate the causality between COVID-19 vaccine and corneal graft rejection, our case shows a temporal association between the two events. Moreover, a series of issues and criteria described in the specific guidelines (Causality Assessment of an Adverse Event Following Immunization—AEFI) suggests that this rare adverse event is likely due to immunization through a number of pathophysiological pathways.

A “number of pathways”, eh? We were told that there wasn’t even *ONE* plausible mechanism for the vaccines to cause severe adverse events, let alone “a number of pathways”.

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

8. Acute graft rejection in a high-risk corneal transplant following COVID-19 vaccination: A case report

https://pubmed.ncbi.nlm.nih.gov/34827040/

Vaccine: Pfizer, Dose 1

A 35-year-old Indian male laborer presented with an acute onset of diminished vision in his left eye (LE) since 2 days. He had history of taking the first dose of COVID-19 vector vaccine (ChAdOx1 nCoV-19 Corona Virus Vaccine Recombinant, COVISHIELD™) 4 days prior. He had undergone a repeat penetrating keratoplasty (re-PK, donor cornea size 7.5 mm) in his LE 6 months back after having a failed large graft (size not known) post therapeutic PK 3 years ago at another center.

Anticipating the second dose of the COVID-19 vaccine, the patient was advised consultation with an immunologist for systemic nonsteroidal immunosuppression for prophylaxis.

To conclude, as the COVID-19 pandemic and the COVID-19 vaccination drive are still on, corneal surgeons need to be aware of the possibility of acute graft rejection following vaccination. Patients awaiting optical CT should schedule a timeline of vaccine ahead of transplant surgery. Simultaneously, patients with CT need to be sensitized about post vaccination rejection episodes as timely diagnosis and prompt topical &/or systemic management of an acute graft rejection as observed in present case is important to prevent graft failure especially in HR category.

What we really need are doctors with a functioning prefrontal cortex.

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

9. Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine

https://pubmed.ncbi.nlm.nih.gov/33910885/

Vaccine: Pfizer Dose 1, Pfizer Dose 2

A 66-year-old woman with Fuchs endothelial corneal dystrophy (FECD) and a unilateral Descemet's membrane endothelial keratoplasty (DMEK) transplant received COVID-19 mRNA vaccine BNT162b2 14 days post-transplant. Seven days later, she presented with symptoms and signs of endothelial graft rejection. An 83-year-old woman with bilateral DMEK transplants for FECD 3 and 6 years earlier developed simultaneous acute endothelial rejection in both eyes, 3 weeks post second dose of COVID-19 mRNA vaccine BNT162b2. Rejection in both cases was treated successfully with topical corticosteroids.

All’s well that ends well?

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

10. Stromal rejection in penetrating keratoplasty following COVID-19 vector vaccine (Covishield) - A case report and review of literature

https://pubmed.ncbi.nlm.nih.gov/34937268/

Vaccine: AZ Dose 2

A 79-year-old single eyed patient presented with diminution of vision of one-week duration in the left eye. He had taken his second shot of COVID-19 vector vaccine (COVISHIELD) 6 weeks ago prior to the onset of symptoms.

The graft had a localized central stromal edema suggestive of a stromal rejection.

Considering his single-eyed status, he was started on hourly topical steroids along with oral steroids, which were tapered gradually. At 2 months review, BCVA maintained at 20/120, edema resolved with a mild residual stromal haze [Fig. 2].

Ours is probably the first case of stromal rejection following COVID-19 vaccination. Like in all previous reports, we can only speculate that this is vaccine related as the patient was systemically stable and there were no ocular risk factors.

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

11. Corneal graft rejection after COVID-19 vaccination

https://pubmed.ncbi.nlm.nih.gov/34146066/

Vaccine: AZ Dose 1

A 62-year-old man presented with corneal graft rejection after COVID-19 vaccination. He had undergone penetrating keratoplasty for a childhood corneal scar in his right eye, 2 years ago.

He presented with congestion and diminution of vision of 5 days duration, having taken his first shot of COVID-19 vector vaccine (ChAdO × 1 nCoV-19 Corona Virus Vaccine Recombinant COVISHIELD™), 3 weeks prior.

There was an advancing horizontal Khodadoust’s rejection line in the center of the endothelium with graft edema at its wake inferiorly [Fig. 1] and grade 2 anterior chamber reaction. The graft superior to the rejection line was clear [Fig. 2]. Treatment for corneal allograft rejection was started. This may be the first report of graft rejection after COVID-19 vector vaccination.

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

12. Acute Corneal Transplant Rejection After COVID-19 Vaccination

https://pubmed.ncbi.nlm.nih.gov/34620770/

Vaccine: Moderna Dose 1, Moderna Dose 2, Moderna Dose 2, Moderna Dose 2

Four patients with prior keratoplasty developed presumed immunologic rejection after the mRNA-1273 vaccination for coronavirus 2 (SARS-CoV-2).

Case 1 had received Descemet membrane endothelial keratoplasty 6 months ago and presented with endothelial graft rejection 3 weeks after the first vaccine dose.

Case 2 had undergone penetrating keratoplasty 3 years previously and presented with acute endothelial rejection 9 days after the second vaccine dose.

Case 3 had prior Descemet stripping automated endothelial keratoplasty (DSAEK) and began experiencing symptoms of endothelial graft rejection 2 weeks after the second vaccine dose.

Case 4 presented with endothelial rejection of the penetrating keratoplasty graft 2 weeks after the second vaccine dose.

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

13. Keratoplasty Rejection After the BNT162b2 messenger RNA Vaccine

https://pubmed.ncbi.nlm.nih.gov/34029238/

Vaccine: Pfizer Dose 1, Pfizer Dose 1

Two men, aged 73 and 56 years, with a history of penetrating keratoplasty due to keratoconus were noted to have acute corneal graft rejection 2 weeks after receiving a first dose of the BNT162b2 mRNA vaccine. Both patients were treated with hourly dexamethasone 0.1% and oral prednisone 60 mg per day with prompt resolution of keratoplasty rejection.

Patient 1

A 73-year-old man presented with discomfort in his left eye 13 days after receiving a first dose of BNT162b2 vaccine. Ocular history included penetrating keratoplasty (PKP) in this eye due to keratoconus (1977) and regraft (2019) due to late endothelial failure. Medical history was unremarkable. The patient was maintained on 1 drop of dexamethasone 0.1% daily. A clear corneal graft was documented 2 months before admission. On presentation, corrected distance visual acuity decreased from 20/80 to 20/200. On biomicroscopy, ciliary injection, corneal edema, Descemet folds, and keratic precipitates (KPs) were noted (Fig. ​(Fig.1A).1A). A diagnosis of corneal graft rejection was made.

Patient 2

A 56-year-old man presented with a 2-day history of blurred vision and redness of the right eye, 14 days after receiving a first dose of the BNT162b2 vaccine. Medical history was unremarkable. Ocular history included keratoconus, with bilateral PKP performed 25 and 7 years before in the right and left eyes, respectively.

Diffuse corneal edema, KPs, and anterior chamber (AC) cells were noted on slit lamp biomicroscopy, indicating corneal graft rejection.

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

14. Acute Corneal Transplant Rejection After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccination

https://pubmed.ncbi.nlm.nih.gov/34690266/

Vaccine: Moderna Dose ? (Paywall)

A 51-year-old man with a history of keratoconus and penetrating keratoplasty underwent repeat penetrating keratoplasty for graft failure. The patient had an uncomplicated intraoperative and postoperative course with improved vision and a healthy graft. The patient received the SARS-CoV-2 Moderna vaccine on postoperative week 3, and within 3 days, the patient began developing eye pain, photophobia, and blurred vision. The patient was found to have graft rejection with corneal edema and endothelial keratic precipitates. The rejection did not improve despite a trial of increased topical steroids and ultimately evolved into graft failure.

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

15. Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19

https://pubmed.ncbi.nlm.nih.gov/35918988/

Vaccine: Pfizer Dose 1

This report shows a case of corneal transplant rejection after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), short after receiving the BNT162b2 vaccine, in a patient who had undergone keratoplasty more than 20 years ago, with no previous episodes of rejection and no other factor that could lead to the findings on his examinations. After treatment with high doses of topic, oral, and sub-conjunctival corticoids, the patient had a favorable therapeutic response. The signs of corneal transplant rejection must be oriented to the patients and the causing factors actively searched by ophthalmologists so that treatment is rapidly initiated and sequels are avoided. This report raises the question if these events are correlated and whether the patient should receive the second dose of the vaccine against SARS-CoV-2 or not.

Yeah, that should be an easy question.

Unfortunately, given the track records of most docs……

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

16. Corneal graft rejection following COVID-19 vaccine

https://pubmed.ncbi.nlm.nih.gov/34426655/

Vaccine: Pfizer Dose 1

In February 2021, a 68-year-old woman attended the eye casualty with a 1-day history of left painful red eye and rapid deterioration of vision. Four days earlier, she received her first dose of mRNA-based BNT162b2 COVID-19 vaccine (Pfizer-BioNtech). On the next day, she developed moderate systemic reactions, including chills, myalgia, and tiredness, followed by unexpected ocular symptoms on the third day.

The patient was immediately treated with hourly topical dexamethasone 0.1% and a week of oral acyclovir 400 mg 5x/day (to cover for any possible underlying herpes simplex keratitis), with no treatment modification in the right eye. Significant improvement was noted by 3-week post-treatment with complete resolution of corneal graft rejection (Fig. 1C, D).

The authors of this study had some eye-opening (pun intended) thoughts on the matter:

Discussion

Corneal graft rejection after vaccination is rare, with most evidence so far being linked to influenza vaccination. To our best knowledge, this is the second report of corneal allograft rejection following COVID-19 vaccine [4].

COVID-19 vaccines have been shown to induce SARS-CoV-2 neutralising antibodies and elicit strong Th1-biased CD4+ responses in human [3]. CD4+ Th1 cells have been shown to be the main mediators of corneal graft rejection [5], which could have contributed to the graft rejection. Intriguingly, corneal graft rejection only occurred in the left eye despite the presence of bilateral grafts. This may be attributed to the more recent history of left eye surgery and a repeat graft, which is known to have a higher risk of rejection. Although a direct cause-and-effect relationship remains to be established, it would be prudent to defer elective corneal transplant by 3–6 months after the second dose of COVID-19 vaccines and to consider institution of intensive topical steroids (6–8 times a day) in grafted eyes at the time of the first dose of vaccine until at least a month after the second dose, as the immune response peaks on 7–28 days post vaccine [3].

👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨👁👁‍🗨

Bonus:

There are a few more case reports of covid infection leading to rejection of eye grafts or transplants. This suggests that the reports of similar rejections occurring shortly after vaccination are indeed attributable to the vaccines, which share the primary features of the covid virus responsible for causing these injuries.

Acute Endothelial Graft Rejection Following COVID-19 *Infection*

https://pubmed.ncbi.nlm.nih.gov/34722015/

Here, we report a case of acute endothelial graft rejection following coronavirus disease 2019 (COVID-19). A 57-year-old woman who underwent therapeutic penetrating keratoplasty for a perforated infectious corneal ulcer in her right eye developed severe acute respiratory syndrome coronavirus 2 infection, which required intensive care and treatment with steroids. Acute endothelial graft rejection was seen at three weeks postoperatively and managed with high-dose corticosteroids. Despite standard therapy, secondary graft failure was observed. Immune dysregulation associated with COVID-19 may be a significant cause of acute endothelial graft rejection among keratoplasty patients with COVID-19.

Four cases of cytokine storm after COVID-19 vaccination: Case report

https://pubmed.ncbi.nlm.nih.gov/36045681/

Selected excerpts followed by a “translation”:

Abstract

The global coronavirus disease 2019 (COVID-19) pandemic has led to the rapid development of vaccines against this disease. Despite the success of the international vaccination program, adverse events following vaccination, and the mechanisms behind them, remain poorly understood. Here we present four cases of death following receipt of a second dose of COVID-19 vaccine, with no obvious cause identified at autopsy. Using RNA sequencing, we identified genes that were differentially expressed between our post-vaccination cases and a control group that died of blood loss and strangulation. Three hundred and ninety genes were found to be upregulated and 115 genes were downregulated in post-vaccination cases compared with controls. Importantly, genes involved in neutrophil degranulation and cytokine signaling were upregulated. Our results suggest that immune dysregulation occurred following vaccination. Careful observation and care may be necessary if an abnormally high fever exceeding 40°C occurs after vaccination, even with antipyretic drugs.

Introduction

Coronavirus disease 2019 (COVID-19) has spread rapidly worldwide, with the number of infected cases exceeding approximately 550 million as of July 2022, defining it as a significant global health concern [WHO coronavirus (COVID-19) dashboard. Geneva: World Health Organization, https://covid19.who.int/table]. While there is growing interest in the use of vaccination for reducing disease severity, there are some reports of vaccination-related side effects, such as immune thrombocytopenia, myocarditis, and death (1–3). Meanwhile several studies have reported systemic immune response syndrome (SIRS) after vaccination (4, 5). We experienced four cases who died 1–10 days after receiving their second COVID-19 vaccination. Their body temperatures were estimated to be abnormally high at the time of death. Autopsies were performed on these patients but revealed no information about the cause of death, with evidence that pathologic analysis showed no changes to the primary organs. Here, we report the cause of death estimated by sequencing RNA.

Case profiles

The profiles of four cases who died at home after receiving the COVID-19 vaccine are summarized in Table 1. Three cases received two doses of the Moderna mRNA COVID-19 vaccine, tozinameran, and one case received two doses of the Pfizer-BioNTech mRNA COVID-19 vaccine, elasomeran. The time from receipt of the second dose to death was 1–10 days. In case 3, side effects following vaccination, such as fever and headache, were not observed on the day before death, whereas in the other cases, they were observed on the day before death. Autopsies revealed no information about the cause of death for any patient, and pathologic analysis showed findings of sudden death, such as congestion of primary organs, and no information about the cause of death, including myocarditis. The postmortem interval inferred from postmortem phenomena and coroner’s rectal temperature measurements estimated high body temperatures for all cases at the time of death (6). Two female cases who experienced sudden death by blood loss (54 years old) and strangulation (86 years old) and had also received two doses of tozinameran [Pfizer] were used as controls for RNA sequencing analysis.

Discussion

While the causes of death of the cases reviewed in this study could not be identified by autopsy, RNA sequencing of blood samples obtained and properly stored shortly after death provided valuable information. RNA sequencing analysis using postmortem specimens has rarely been performed because of the degradation of RNA due to postmortem changes. However, in the present case group, it was possible to collect blood samples within 24 hours after death, which was relatively early, and RNA sequencing analysis may have been successful (13).

Conclusions

We present four cases of death following receipt of a second dose of COVID-19 vaccine, with no obvious cause identified at autopsy. RNA sequencing revealed that genes involved in neutrophil degranulation and cytokine signaling were upregulated in these cases, suggesting that immune dysregulation occurred following vaccination. Careful observation and care may be necessary if an abnormally high fever exceeding 40°C occurs after vaccination, even with antipyretic drugs.

Translation:

The authors are reporting their experience autopsying 4 vaccine deaths.

Basically, there wasn’t an obvious cause of death for these patients immediately visible.

However, luckily for these clinicians, they received the bodies within 24 hours of death, which meant that they could perform tests that were not usually a viable option because the body had degraded or decomposed too much by the time a coroner had the opportunity to perform an autopsy. Specifically, they were able to do RNA sequencing1 of RNA isolated from the deceased patients’ blood.

They also included two sudden deaths in vaccinated people that were not because of the vaccine2.

Back to the RNA, the authors employed what seems to be a rather unorthodox - or at least creative - method to try and ascertain a cause of death. They sequenced the RNA to see if they could observe any differences in the RNA’s between the vaccine deaths and the non-vaccine deaths, hoping to find something that could indicate what pathology ‘happened’ that killed these 4 patients.

Let’s explain how this works (it’s not that hard, just intimidating):

When we refer to a gene as a technical concept, it means a piece of the DNA that is the code for a protein that is made by the organism, in our case humans.

When a cell ‘wants’ to make a protein, the DNA inside the nucleus that holds the code for that specific protein - its gene - has to make a strand of mRNA into a mirror of that gene. When a gene is copied onto an RNA strand to be translated into a protein, that gene is being “expressed” - it’s “on” in the sense that it is activated to create RNA copies of itself to make the protein that it codes for.

The mRNA then exits the nucleus where a ribosome comes along and attaches to the RNA. The ribosome reads the RNA and creates the corresponding protein encoded by that strand of RNA. This is how the mRNA vaccines ‘work’ - the vaccine inserts RNA that encodes the spike protein into cells so that the cells read the RNA blueprint and spit out a bunch of spike proteins.

Since different RNA’s encode for different proteins, the authors could sequence the RNA’s in the dead patients to see what proteins were being created by cells when the patients died. Or in technical sciency jargon, they could determine the pattern of which genes were expressed and how much they were being expressed. (In overly simplistic terms, think “how often did gene ‘X’ make an RNA” / “how many RNA’s of gene ‘X’ did they find”.)

What did they find?

We’ll break this down into a few steps for clarity:

Step #1: They found a total of 505 (yeah, that’s a lot) genes that were “differentially expressed [] between individuals with unknown cause of death (unknown group) and the control group”. 390 genes were ‘higher’/more expressed in the vaccine death patients, and 115 genes were ‘lower’/less expressed in the vaccine death patients, compared to the 2 control patients that died of other causes.

Step #2: They then had to identify these 505 RNA’s/genes - ie, what proteins were these coding for or relevant to.

Step #3: They then had to try and figure out what this combination of genes would do/cause. This is not the most exact science as there is a lot we still don’t understand about the human genome & proteins. They “estimated” that some of the genes expressed more in the vaccine death patients were involved in increasing immune cells and activity, such as cytokines (think of the dreaded covid “cytokine storm”, which is what they titled their study)3.

Step #3b: They extrapolated from the increased expression of these immune-system genes that there was aggressive immunological activity run amok - “these results provide evidence of a hyperactive immune response in the group with unknown cause of death” - that killed these patients - “the RNA sequencing results suggested that an abnormal secretion of cytokines, possibly a cytokine storm, may have occurred after vaccination, resulting in SIRS and death.”

(SIRS = Systemic Inflammatory Response Syndrome)

Limitations:

This is not necessarily an open-and-shut case. The authors stipulate that “However, in the present case group, it was possible to collect blood samples within 24 hours after death, which was relatively early, and RNA sequencing analysis may have been successful (13). Although we have no way of knowing whether the cases we reported met these criteria, the RNA sequencing results suggested that an abnormal secretion of cytokines, possibly a cytokine storm, may have occurred after vaccination, resulting in SIRS and death.”

This study furthermore is on a grand total of 6 subjects, of which only 4 were detectably vaccine injured, which is way too small to definitively extrapolate from here that this effect is occurring in vaccine injured patients on a grand scale, is caused by the vaccine on a grand scale, or that their interpretation of the RNA sequencing is correct.

However, in the broader context of everything else we know about these covid vaccines, this study is decidedly ominous and in a sane world would by itself be sufficient to halt the use of these vaccines at least until this epic danger signal was properly investigated and adjudicated.

Additional point:

A scientist in government employ whom I asked for his/her opinion on this thought that this study’s methodology was fairly poor. Firstly, there is a strong possibility that the RNA had substantially degraded by the time they extracted it from blood samples. Secondly, they did not get enough RNA samples from each patient. Thirdly, the analysis of the RNA itself was deficient (for reasons too technical to go into here). Fourthly, the correlation between detectable RNA in blood samples and protein expression often do not correlate so well.

To be clear, this does not mean that the study’s conclusions are therefore incorrect, just that the direct evidence is pretty weak - which means that follow up studies should be done with larger patient samples and more robust biomarker testing that can more reliably capture with better certainty changes in gene expression in vaccine injured people (or anything else too for that matter).

Implications:

The most immediate takeaway here is that the vaccines seem to have caused runaway immune activation that killed the 4 vaccinated patients where there was no other observable cause of death.

However, there is a broader and far more ominous implication of this study. The discovery of 505 genes with significantly altered gene expression suggests that the vaccines fundamentally screw up - “dysregulate” - the normal pathways and chemistry that controls or regulates the immune system. It also shows that the vaccines do something very “not good” to something/s in the nucleus of cells. In other words, the vaccines precipitate “unanticipated” irregular cellular “stuff” that alters the state of the DNA and the proteins/enzymes that control the DNA (“epigenetic factors”).

DNA stuff going wrong is the paradigmatic precipitating cause for the creation of cancerous cells.

Immune dysregulation is one of the standard causes for cancerous cells to evade immune detection and be able to metastasize instead of being snuffed out right away by roving Killer T-Cells.

Ideally, someone will follow up and sequence RNA from blood samples of live vaccinated people with vaccine injuries and without vaccine injuries, and from unvaccinated people, and compare them.

In other news, we’re past 2,400 case reports of vaccine associated SAE’s (I have to update the grand master list).

2,400!!

• Yikes!! Avalanche of Clots / Injuries - Clots here, clots there, clots everywhere. Oh, and some other goodies too. More than enough spike protein for all parts of the anatomy to help themselves.

• Hard Evidence That Vaccine Killed the Fetus - and then killed the mother too.

• Ignorance Abounds - Take it from their own admissions.

• Sheer Quantity - When your hospital gets deluged by VITT’s

• Long Term - The promised transient-ness of your vaccine injury turns out to have been a transient promise by the medical authorities.

• Consequences of Denialism - A surprisingly explicit take on what happens when ostriches are in charge of public health.

(Note: The number for each study before the study title is from the Compilation of 195 Case Reports Documenting 386 Vaccine Associated Hematological Injuries.)

Previous installation in this series:

Resisting the Intellectual Illiteratti

27 Noteworthy Myocarditis Case Studies

The following are studies that show more than just a “routine” case of vaccine myocarditis, organized into the following categories: Long Term Damage - Contrary to popular mainstream opinion that vaccine myocarditis is a transitory phenomenon. Rare & Scary Forms of Myocarditis…

Read more

4 years ago · 22 likes · 6 comments · Ashmedai

***********************************************************************************

Yikes!! Avalanche of Clots / Injuries

159: Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine: A Case Report

Link: https://pubmed.ncbi.nlm.nih.gov/35173141/

Diagnoses: TCP, Myo, PH, Myositosis, Rhabdomyolysis

Case: “A 37-year-old man presented to the Emergency Department (ED) with a 3-day history of back pain and a 1-day history of left upper limb swelling with paresthesia and shortness of breath, 12-days after receiving the first dose of Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine. He was diagnosed with severe myositis complicated with rhabdomyolysis and non-oliguric acute kidney injury, thrombocytopenia, myocarditis with pulmonary edema, and pulmonary hemorrhage. Screens for potential toxic, infectious, paraneoplastic, and autoimmune disorders were unremarkable. The patient was treated with a 5-day course of intravenous methylprednisolone and intravenous immunoglobulin, with a good response. He was hospitalized for 16 days and discharged home on a tapering dose of oral prednisolone for 6 weeks.”

“The case describes a possible link between Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine and immune-mediated myocarditis, pulmonary vasculitis, myositis, and thrombocytopenia. However, further data are required to confirm such an association.”

50: Case Report of Clot from mRNA Vaccine: Thrombosis With Thrombocytopenia After the Messenger RNA–1273 Vaccine | Annals of Internal Medicine

Link: https://www.acpjournals.org/doi/10.7326/L21-0244

Diagnoses: VITT, TTS, DVT, PE, MT, CVST, TCP, AGH

Case: “He was diagnosed with severe myositis complicated with rhabdomyolysis and non-oliguric acute kidney injury, thrombocytopenia, myocarditis with pulmonary edema, and pulmonary hemorrhage.

A computed tomography angiogram of the chest showed large, bilateral, acute pulmonary emboli with right ventricular strain. Doppler studies of the lower extremities revealed acute deep venous thromboses in both lower extremities. The patient had severe thrombocytopenia (14 × 109 cells/L) (Table and Figure) (171 × 109 cells/L had been documented 18 months earlier).

Three days later, the patient developed an acute gluteal hematoma requiring withdrawal of heparin.

“The case describes a possible link between Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine and immune-mediated myocarditis, pulmonary vasculitis, myositis, and thrombocytopenia. However, further data are required to confirm such an association.”

13: A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration - PubMed

Link: https://pubmed.ncbi.nlm.nih.gov/33917902/

Case: “We report the case of a 54-year-old woman who developed disseminated intravascular coagulation (DIC) with multi-district thrombosis 12 days after the AstraZeneca COVID-19 vaccine administration. A brain computed tomography (CT) scan showed multiple subacute intra-axial hemorrhages in atypical locations, including the right frontal and the temporal lobes. A plain old balloon angioplasty (POBA) of the right coronary artery was performed, without stent implantation, with restoration of distal flow, but with persistence of extensive thrombosis of the vessel. A successive thorax angio-CT added the findings of multiple contrast filling defects with multi-vessel involvement: at the level of the left upper lobe segmental branches, of left interlobar artery, of the right middle lobe segmental branches and of the right interlobar artery. A brain magnetic resonance imaging (MRI) in the same day showed the presence of an acute basilar thrombosis associated with the superior sagittal sinus thrombosis. An abdomen angio-CT showed filling defects at the level of left portal branch and at the level of right suprahepatic vein. Bilaterally, it was adrenal hemorrhage and blood in the pelvis. An evaluation of coagulation factors did not show genetic alterations so as the nasopharyngeal swab ruled out a COVID-19 infection. The patient died after 5 days of hospitalization in intensive care.”

146: Acute ST-Segment Elevation Myocardial Infarction After ChAdOx1 nCoV-19 Vaccination in a 33-Year-Old Man

Link: https://pubmed.ncbi.nlm.nih.gov/35065747/

Diagnoses: vaccine-induced thrombotic thrombocytopenia, thrombotic thrombocytopenia, cerebral venous sinus thrombosis, arterial thrombosis, myocardial injury, ischemic infarcts, Intracerebral Hemorrhage, coronary artery thrombosis, et al

Whole-body imaging studies with CT/MRI/MRA were done and disclosed multiple thrombi at the straight, left transverse cerebral venous sinuses down to the left internal jugular veins, subsegmental pulmonary arteries, descending aorta, and hepatic veins. Tiny ischemic infarcts in the right centrum semiovale and temporal cortex and segmental infarctions in the spleen were also found. His clinical course was very complicated, and his persistent thrombocytopenia, decreased fibrinogen level, and very high D-dimer level were refractory to treatment with intravenous immunoglobulin, methylprednisolone, a direct oral anticoagulant, and cryoprecipitate. A severe headache happened on day 7 of hospitalization. An emergency decompressive craniotomy was undertaken for an intracerebral hemorrhage in his left cerebrum, followed by a retrograde thrombectomy of his intracranial venous sinuses on the next day. His cardiac troponin level was elevated again on day 9. A total occlusion of the left circumflex artery at the ostium and heavy thrombi in the right coronary artery were disclosed and treated. Although his platelet count and fibrinogen and D-dimer levels began to improve with plasma exchanges, his condition deteriorated, he had multiple organ failures, and he succumbed on day 14 of hospitalization.

75: Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature - PubMed

Link: https://pubmed.ncbi.nlm.nih.gov/34355379/

Diagnoses: VITT, MIT, MT, FT, PVT, TCP, CT

At histology, in the lungs, interalveolar septa appeared thickened with microthrombi in the capillaries and veins. Interalveolar septa appeared thickened and showed vascular proliferation. Thrombi were detected in the capillaries of glomerular tufts. In the hearth, thrombi were observed in veins and capillaries. In the liver, voluminous fibrin thrombi were diffusely observed in the branches of the portal vein. Microthrombi were also found in the vasa vasorum of the wall of abdominal aorta. In the brain, microthrombi were observed in the capillaries of the choroid plexuses. Diffuse hemorrhagic necrosis was observed in the intestinal wall with marked congestion of the venous vessels.

Extra Credit:

Platelet Count of *0* (!!)

178: BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura

Link: https://pubmed.ncbi.nlm.nih.gov/35464782/

Herein, we present a patient who presented with severe ITP with a platelet count of 0 after receiving the second dose of the BNT162b2 mRNA COVID-19 vaccine [..].

Covid Lung Destruction

147: Ultrastructural findings of lung injury due to Vaccine-induced Immune Thrombotic Thrombo- cytopenia (VITT) following COVID-19 vaccination: a scanning electron microscopic study

Link: https://pubmed.ncbi.nlm.nih.gov/35049004/

Alveoli were mainly dilated, irregular in shape, and occupied by a reticular network of fibrin, while interalveolar septa appeared thickened. The proliferation of small capillaries gave rise to plexiform structures and pulmonary capillary hemangiomatosis-like features. Near the alveoli occupied by a dense fibrin network, the medium-sized arteries showed a modified wall and an intraluminal thrombus. This scenario looks quite similar to that found during COVID-19, where the lungs suffer from the attack of the antigen-antibodies complexes and the virus respectively. In both diseases, the final outcome is a severe inflammation, activation of the haemostatic system and fibrinolysis.

***********************************************************************************

Hard Evidence That Vaccine Killed the Fetus

The following case report actually straight up admits that the placental vessels got whacked with clots. Obviously, clots in placental vessels is bad news for the clump of cells inside the placenta, which deprived of blood flow will shrivel up into an even smaller clump of cells that will thus never become more than a (really massive) clump of cells:

40: Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following ChAdOx1 nCOVID-19 vaccine in a pregnant woman - PMC

Link: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8561298/

Besides that, thrombosis was observed in placental vessels.

The constellation of signs and symptoms suggests VITT diagnosis complicated by intracranial hemorrhage with a fatal outcome both to fetus and mother.

***********************************************************************************

Ignorance Abounds

121: Case Report: Vaccine-Induced Immune Thrombotic Thrombocytopenia in a Pancreatic Cancer Patient After Vaccination With Messenger RNA-1273 - PubMed

Link: https://pubmed.ncbi.nlm.nih.gov/34790684/

Vaccination plays an important role during the COVID-19 pandemic. Vaccine-induced thrombotic thrombocytopenia (VITT) is a major adverse effect that could be lethal. For cancer patients, cancer-related thromboembolism is another lethal complication. When cancer patients receive their COVID-19 vaccines, the following thromboembolic events will be more complicated.

The titer of anti-platelet factor four and d-dimer level decreased, but the patient ultimately died.

The complicated condition of VITT superimposed cancer-related thromboembolism was considered. To our knowledge, only one case of mRNA-1273 related VITT was reported, and this case study was the first to report a cancer patient who was diagnosed with VITT after mRNA-1273 vaccination. Therefore, when the need for vaccination among cancer patients increased under the current COVID-19 pandemic, the possible risk of VITT for cancer patients should be carefully managed. Further studies of the risk evaluation of the COVID-19 vaccine in cancer patients might be required in the future.

130: VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis

Link: https://pubmed.ncbi.nlm.nih.gov/34587255/

To our knowledge, this is the first reported case of VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis. Our patient highlights the importance of knowing vaccine status and initiating treatment as soon as possible in the right clinical setting, even in the absence of radiographic evidence of thrombus. Early VITT recognition and treatment provide an opportunity to prevent serious thrombotic complications.

141: Abrupt worsening of occult IgA nephropathy after the first dose of SARS-CoV-2 vaccination

Link: https://pubmed.ncbi.nlm.nih.gov/34988883/

We should pay more attention to the development/worsening of clinically significant kidney disease after SARS-CoV-2 vaccination not only in those with known glomerular disease but also in those with only mild urinary abnormality.

108: Immune thrombocytopenic purpura following administration of mRNA-based SARS-CoV-2 and MMR vaccinations: a cautionary tale

Link: https://pubmed.ncbi.nlm.nih.gov/34635874/

Although our patient's clinical presentation and subsequent course are similar to those of other cases of ITP in association with SARS-CoV-2 vaccination, to our knowledge, this is the first reported case of ITP following MMR and mRNA SARS-CoV-2 vaccine coadministration. It would be impossible to conclusively prove that the patient's thrombocytopenia was secondary to the SARS-CoV-2 vaccine alone, the MMR vaccine, or an additive effect of both vaccines. However, with the CDC guidelines recommending the coadministration of the mRNA SARS-CoV-2 vaccine without regards to timing with other vaccines, we urge further caution as there is limited evidence to inform practice. This case highlights the need for further safety data regarding the coadministration and timing of the mRNA SARS-CoV-2 vaccine with other vaccines.”

139: Vaccine-induced massive pulmonary embolism and thrombocytopenia following a single dose of Janssen Ad26.COV2.S vaccination

Link: https://pubmed.ncbi.nlm.nih.gov/34986404/

Treatment with intravenous immunoglobulin, however, could mask the ability of anti-platelet factor 4-heparin antibodies to bind and activate platelets in the presence of heparin, leading to false-negative results on the immunoassay functional test. Therefore, if VITT is suspected, blood samples for diagnostic confirmation should be collected prior to any treatment to improve diagnostic performance.

107: An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine-a case report - PubMed

Link: https://pubmed.ncbi.nlm.nih.gov/34790811/

Considering our case did not have any evidence of thrombocytopenia, we discuss the possible pathophysiology of acute DVT following Moderna COVID-19 vaccine in contrast to adenoviral vector COVID-19 vaccines (ChAdOx1 nCoV-19 and Ad26.COV2.S), including mRNA COVID-19 vaccine binding to pattern recognition receptors (PRR) in the endosomes and cytosol leading to a pro inflammatory cascade and coagulopathy.

Extra Credit:

J&J Trial Investigator Blew Off VITT:

15: Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination

Link: https://pubmed.ncbi.nlm.nih.gov/33852795/

We note with interest that during the clinical evaluation of the Ad26.COV2.S vaccine, a 25-year-old man was found to have symptomatic transverse sinus thrombosis beginning 19 days after vaccination. Although the case investigation and expert opinion deemed this event to be unrelated to the vaccine,5 this finding may require reevaluation in light of our patient’s clinical course. Unlike the Pfizer–BioNTech and Moderna vaccines, which are messenger RNA–based, the ChAdOx1 nCov-19 and Ad26.COV2.S vaccines are nonreplicating adenovirus vector–based DNA vaccines. Our case suggests that the rare occurrence of vaccine-induced immune thrombotic thrombocytopenia could be related to adenoviral vector vaccines.

***********************************************************************************

Sheer Quantity

69: Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series - PubMed

Link: https://pubmed.ncbi.nlm.nih.gov/34393988/

During a 2-week period, we have encountered five cases presenting with the combination of cerebral venous thrombosis (CVT), intracerebral hemorrhage and thrombocytopenia. A clinical hallmark was the rapid and severe progression of disease in spite of maximum treatment efforts, resulting in fatal outcome in for 4 out of 5 patients. All cases had received ChAdOx1 nCov-19 vaccine 1-2 weeks earlier and developed a characteristic syndrome thereafter.

***********************************************************************************

Long Term

128: Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report - PubMed

Link: https://pubmed.ncbi.nlm.nih.gov/34835275/

The patient presented with extended superior sagittal sinus thrombosis with accompanying bifrontal intracerebral hemorrhage. Repeated treatment with intravenous immune globuline (IVIG) resolved recurrent episodes of thrombocytopenia. Moreover, the patient's serum remained strongly positive for platelet-activating anti-PF4-IgG over three months. After a period of clinical stabilization, the patient suffered a recurrent and fatal intracranial hemorrhage.

144: Combined Central Retinal Artery and Vein Occlusion with Ischemic Optic Neuropathy After COVID-19 Vaccination

Link: https://pubmed.ncbi.nlm.nih.gov/35079224/

“While the patient recovered 20/30 vision, he continued to note light and color desaturation and exhibited a 2+ relative afferent pupillary defect in the left eye. The most recent RNFL study demonstrated nerve fiber layer loss in the superior pole of the nerve consistent with the diagnosis of NAION. There was also a residual inferior altitudinal visual field defect (Figure 4).”

135: First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report

Link: https://pubmed.ncbi.nlm.nih.gov/34895163/

One month after the initial presentation, the patient is in good overall condition, but still receives daily caplacizumab due to ADAMTS-13 activity of < 1%.

82: A rare case of vaccine-induced immune thrombosis and thrombocytopenia and approach to management

Link: https://pubmed.ncbi.nlm.nih.gov/34513173/

Although she was left with long-term neurological deficits, an early presentation and a multidisciplinary approach to management contributed toward a relatively short stay in hospital and avoided mortality.

***********************************************************************************

Consequences of Denialism

31: Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience - ScienceDirect

Link: https://www.sciencedirect.com/science/article/pii/S235255682100093X

We were aware of the possibility of cerebral venous thrombosis after COVID-19 vaccination, and the declaration to our regional pharmacovigilance centre was made on the 23rd of March 2021. We would like, however, to share the difficulties we had to find reliable clinical information in this context.

Our knowledge of the pathophysiology and therapeutic possibilities was very limited.

This was the only reliable information we had at this time. Without information and feedback from similar cases, we felt like engaging in shady dealings without really understanding the pathophysiological processes of the disease and the risks/benefits balance of therapeutic options.

We believe that an early exchange between clinicians who reported similar events would have been very useful. Organising such a rapid online feedback, focusing on bedside experiences of clinicians facing similar critical situations would have probably avoided the pitfalls of a new and poorly known disease.

Professional networks, sometimes linked to scientific societies, can probably contribute a lot by allowing contact between physicians, quickly drafting guidelines and disseminating them through their usual network. They are however highly dependent on effective early warning systems.

We propose that, in the case of serious and life-threatening conditions, pharmacovigilance agencies, in addition to collecting and analysing serious events, should propose the possibility of a rapid contact between clinicians who have reported similar events via an exchange of e-mail addresses or the creation of discussion forums, on a global and international scale. As publication process for original articles and guidelines requires several weeks, this rapid feedback and sharing of information seem essential in such situations with new, serious, life-threatening and potentially frequent adverse events, for which the scientific knowledge and clinical experience are very limited.

***********************************************************************************

☠☠☠☠☠☠☠☠☠☠☠☠☠☠

This is not an exaggeration. It is one thing for doctors to get brainwashed to believe that the newly minted miracle covid ‘vaccines’ were, well, miraculous; the whole “safe and effective” canard. It is another matter entirely for doctors to conduct what amounts to ad hoc human experimentation by giving a second (or third) dose of a novel therapeutic to a patient who suffered an obvious clinical event following the preceding dose. There was no clinical data of any sort available regarding the safety profile of giving this product to someone who had just suffered a severe clinical event, whether or not it was caused by the administration of the first dose. And the data on the real-world benefit of getting a second dose over sticking with just the first dose was sparse, to say the least.

Yet as we shall see, numerous clinicians went ahead and decided to recommend to patients who suffered an adverse clinical episode following dose #1 that they should proceed with dose #2.

In other words, doctors were giving a drug to patients where there was:

• no safety data whatsoever at the time concerning someone with that medical profile

• little if any efficacy data on the absolute benefit of dose 2 vs remaining only single-dosed

• no way of knowing that the drug was NOT responsible for the adverse event that coincidentally occurred following the administration of dose #1

Siri, what word is defined as “an operation or procedure carried out under controlled conditions in order to discover an unknown effect or law”?

Below (and in subsequent installments in this series) are some of the case reports that I have come across where the patient was given dose #2 after suffering a Severe Adverse Event (SAE) following dose #1.

Quick primer on the formatting:

• I divided case reports into “Winners” & “Losers” based on whether dose #2 caused new or worsening of the SAE’s following dose #1.

  Yes, sometimes the patient gets dose #2 without suffering any SAE, at least in the short term, hence the title “Vaccine Roulette”.

  Obviously, surviving dose #2 without further injury does not suggest that it was a good idea to get dose #2 - this would be akin to claiming that playing real Russian Roulette is harmless because you survived.

• Each report has the case report title, link, timeline of events, and some ‘commentary’; I also am including the excerpts from the case report describing the basic narrative of the case in a footnote placed at the end of the link

• I have identified a few dozen of these case reports so far from the case reports that I have cataloged in detail, However, I have only cataloged about 350-400 or so out of the 2,360+ (and growing) that I have compiled to date.

Losers

Repeated Cardioembolic Stroke after COVID-19 mRNA Vaccination: A Case Report

https://www.sciencedirect.com/science/article/pii/S10523057210063881

TIMELINE

At least the physicians entertained that maybe - just maybe - the vaccine might have had something to do with the synchronous strokes occurring precisely 3 days after both doses.

*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*

Development of Venous Thromboembolism After COVID-19 mRNA-1273 Vaccine Inoculation

https://pubmed.ncbi.nlm.nih.gov/35308698/2

TIMELINE

79yo M:
D1: M dose 1
D4: Pain/swelling right leg, doc orders ultrasound 😫
D5-D28: US scheduling delay 😫
D29: M dose 2 😱
D29: Symptoms worsen 😨🙄
D30: Ultrasound finds "extensive DVT" 😱💣

So yeah, patient developed pain 3 days after Moderna Dose #1 that was bad enough to warrant an ultrasound. But scheduling is just sooo hard, especially amidst lockdown restrictions. Until after dose #2 that is, when it became so intolerable that the docs had a newfound sense of urgency to figure out what was going on.

*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*

Guillain‐Barré syndrome after mRNA‐1273 (Moderna) COVID‐19 vaccination: A case report

https://pubmed.ncbi.nlm.nih.gov/35441015/3

TIMELINE

80yo Male:
D1: M dose 1
D2-D28 (approx): numerous neurological symptoms 😨😫
D29 (approx): M dose 2 😱😓
D30 (approx): "unable to get out of his bed" 😱💣😱💣😱💣

This patient had clear and obvious neurological problems immediately following dose 1. His symptoms got progressively worse leading up to dose 2 (“progressive bilateral lower limb distal weakness, beginning at his feet and then ascending to involve his legs, knees, and hips”).

So of course, the doctors figured that yeah, totally he needs dose #2.

Dose 2 immediately relieved the poor patient of what little motor function he had left in his legs altogether.

The lesson?

“Physicians should remain vigilant for GBS following COVID‐19 vaccination”.

You don’t say? Does vigilant mean like how you were so super duper vigilant after the initial GBS symptoms manifestation after Dose #1? Did the clinical team hold off from doing proper neurological tests until after Dose #2 because they didn’t want to “risk” having to forgo Dose #2? Good questions. That we may never get a clear answer for.

*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*

Post coronavirus disease-2019 vaccination Guillain-Barré syndrome

 https://pubmed.ncbi.nlm.nih.gov/34975092/4

TIMELINE

49yo Male:
D1: AZ dose 1 
D8: GBS symtpom onset 😮😨
D12 (approx): Hospitalized 😣
D25 (approx): Discharged after some improvement 😕😥
D50: AZ dose 2 😱😱
D51+: ????🤔🤔🤔

No, you’re not missing anything, they don’t tell us if there was any clinical impact on symptoms from Dose #2. I can’t help but wonder if Dose #2 might be hampering recovery?

But seriously, how deranged is it to give the patient Dose #2 WHILE HE STILL HAD NOT YET RECOVERED FROM THE DOSE #1 GBS????

*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*

Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses

 https://pubmed.ncbi.nlm.nih.gov/34281950/5

TIMELINE

61yo Male:
D1: Pf dose 1
D1 + 5hr: Bell's Palsy #1 😮😱
D30 (approx): 'complete' resolution of palsy #1 😅😍
D43 (approx): Pf dose 2 😱😨😱
D45: Bell's Palsy #2 'new & improved' (ie worse)💣💣💣💣💣💣💣

“The patient has been advised to discuss future mRNA vaccines with the GP on a case-by-case basis, taking into account risk versus benefit of having each vaccine.”

Well at least ‘discuss’ is a step in the right direction 😂🤔🤔.

Did the patient really have to get dose #2? Just because you cured the Bell’s Palsy the 1st time means that you can cure every subsequent occurrence?

Bizarrely, the authors wrote this up almost as though it was an accomplishment:

“We describe the first case of Bell’s palsy occurring after each dose of any UK-approved COVID-19 vaccine”

“Single episodes of unilateral facial nerve palsies have been reported in clinical trials and in subsequent case reports. There has been no evidence, however, of an episode after each dose.”

This deficiency in the data is now deficient no longer. Points for SCIENCE!!

The title says it all on this one…..

*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*

Winners

Vestibular neuronitis after COVID-19 vaccination

https://pubmed.ncbi.nlm.nih.gov/35667696/6

TIMELINE

50's Female
D1: Pf dose 1
D3: symptom onset including vomiting, vertigo, unsteady gait, light-headedness, drowsiness 🤢🤮
D57: Fully recovered 😅😍
D>58: Pf dose 2 😨😱
D>58+: No complications 😍🥳🥳🥳🥳

It only took 6 weeks to recover from the probable Dose #1 SAE. So she can really savor the sweet, sweet taste of vaccine protection she acquired through lots of blood, sweat & tears. Probably copious amounts of the latter two.

The protection lasts about as long as her recover from Dose #1 did too!

Kudos to her doctors though, they actually waited for her to have a complete recovery, which is no small act of defiance against the vaccine cult.

*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*☠*

Special thanks to the DailyClout team for hosting it.

It seems prudent to provide an introduction to the compilation of case reports in order to keep things in context and maintain better clarity and precision discussing them. While the widespread avalanche of vaccine carnage is undeniable on a macro level, it is easy to make mistakes or formulate imprecise arguments when dealing with granular details.

I asked one of the most prolific authors involved in case report literature a number of questions about the nature of these case reports, whose answers are the foundation for the rest of this article.

Basically, this a limited FAQ sheet about vaccine injury case reports (even if they are not exactly “frequently asked”).

Are case reports reliable evidence?

One of the advantages of case reports is that they are probably the most reliable type of evidence pound for pound that an individual report of a medical condition following vaccination represents a genuine vaccine injury. A case report is typically written by the doctor/s or even sometimes a multidisciplinary team of specialists who treated and/or consulted on the case of the patient/s whose medical conditions are being documented. This means that the details are generally speaking more likely than any other scenario to be accurately and comprehensively documented. It also means that the judgement of the expert & experienced doctors - typically doctors who treat patients with the types of conditions the patient had - is that the vaccine is at least the likely if not plainly obvious cause of the patient’s condition/s.

Is every case report definitely a condition or injury caused by the vaccine?

No. While there are some that provide definitive evidence that the injury was caused by the vaccine - such as histopathological testing that reveals the presence of spike proteins or immunological infiltrates generated in response to the vaccine in damaged tissues - many case reports for various reasons were unable to affirmatively show a clear pathological chain-of-events from vaccination to injury, instead relying on factors like the timing, the nature of clinical presentation, or the lack of plausible alternate causes for the condition, in addition to the judgement of the medical professionals involved with the patient.

Can authors of case reports make mistakes or fail to consider every option?

Yes. But it is generally uncommon for there to be clear errors significant enough to suggest that the vaccine cannot be the likely cause of the injury or conditions contained in the case report. Remember that medicine is as much an art as it is a science.

Are all case reports more or less the same quality?

No.

• Some contain more details than others for various reasons often based on real-world practicalities (for instance, it is not necessarily feasible to run every available type of background test on a patient who needs treatment now).

• Some case reports are written retrospectively, for example the doctors at a hospital or medical center can go through their records and write up the cases of the patients they treated for a specific condition that started close to vaccination based on the data they recorded after a substantial amount of time has passed.

• Some case reports are written about conditions that were more amenable to being described clinically while others can document conditions or constellations of symptoms that resist an easy or conventional diagnosis.

• Some doctors are simply better at writing than other doctors, something that is more noticeable comparing case reports written by native English speakers to those written by medical professionals for whom English is not their native language.

When someone is reported to be “recovered” from their injury or condition, does that mean they are fully recovered?

Not necessarily, and it’s impossible to really know which ones are without seeing the patient for yourself.

For starters, outcomes are often insufficiently reported. Doctors do not necessarily follow up for enough time to know that the patient truly recovered without any relapses. Patients are also often transferred away from the treating or reporting physician for a variety of reasons such as a hospital policy or the patient requiring more specialized facilities for further treatment.

Additionally, “clinical recovery” often does not account for lingering effects that are not captured by formal diagnostic or laboratory criteria, but can affect quality of life, and can even be permanent. It is also possible for doctors to miss subtle signs or blips that are a manifestation of an underlying ongoing pathology but that are not big enough for them to notice or if they do notice they might not think they indicate anything out of the ordinary.

Do the case reports as a whole mirror the balance of nature, type and severity of the vaccine injuries being reported and experienced worldwide?

No. Overall, the case reports tend to be more predisposed to positive outcomes, and rarely document deaths compared to what is widely reported and indicated in the all-cause type/population level datasets.

Certain vaccine injuries also are more easily documented in case reports than others, for a variety of reasons. Typically the condition will have to be something that is difficult to explain without the vaccine, begins in close proximity to a vaccination event, and is something that a doctor could conceivably associate with the vaccines. Rapid onset or metastasis of cancer for instance is not something that doctors would typically even think to make the connection, and even if they do, it would be very difficult to write a case report about simply because they would be going out on a limb conjecturing without a solid clinical foundation in terms of quantifiable diagnostic markers that are traceable directly to the vaccines.

What is responsible for this disparity?

While it is impossible to definitively answer this question with 100% confidence, here are a few basic points to keep in mind (this list is not exhaustive):

• There is tremendous pressure not to say or do anything that portrays the vaccines in a negative light or can be used to promote “vaccine hesitancy”. Thus doctors will feel more comfortable writing about a case with a positive outcome, so those are more likely to get written up than cases with worse outcomes or prognoses.

• Case reports with worse outcomes will be censored from journals/pre-print servers more often than case reports with better outcomes.

• Doctors are more likely to resist attributing an injury to the vaccine when it’s more severe, because of the cognitive dissonance and because more severe injuries are more forcefully denied to exist generally by the medical community/literature.

• It is psychologically easier to ask a patient for permission to write up their personal medical condition in public literature when the patient recovers than when the patient does not.

• A doctor is more likely to be willing to write up a case report about his success than his failure to diagnose and/or treat a patient. Admitting - publicly - that you might have made a mistake, especially a consequential one, is emotionally difficult to say the least. Furthermore, sometimes a case report would reflect a profound lack of clinical judgement “after the fact” potentially even bordering on malpractice (such as counseling a patient who had a clear reaction from Dose 1 to get Dose 2 after which the patient suffers a severe injury).

Are case report authors always honest when expressing their judgement whether the vaccine caused the injury?

No.

As previously mentioned, and as anyone reading this is well aware, most of the doctors who can see the vaccine carnage are also afraid to say anything or speak up because they are afraid of losing their jobs and social lives or even their license/credentials. So authors are definitely being extra cautious with the language they use.

The culture of censorship has run so amok that in many instances, case reports include soliloquies or editorial opinion commentaries about the virtues and safety of the vaccines, which while often straying so radically that they are quite humorous nevertheless have no place in this type of scientific literature. (I wrote an article highlighting a few comical examples of this.)

The upshot is that case reports often include language that does not represent the genuine views of the authors but rather is intended to appease the censors and maintain their standing among their colleagues and profession.

Therefore, such language, or even claims that “this is unlikely to be related to the vaccine” are far more likely than not insincere representations than reflecting the considered judgement of the authors. And even when the authors do think that the vaccine is not necessarily or even unlikely to be the cause, it is important to remember the overwhelming propaganda campaign unleashed on healthcare professionals that these vaccines cannot possibly cause almost all of the side effects documented in the real world rollouts.

Overall, what % of case reports represent genuine vaccine injuries?

It’s hard to say precisely, but considering the totality of evidence from around the world, it is probably safe to assume that at least 90-95% of the published case reports represent injuries where the vaccine was a causal factor.

Other posts about case reports

#1 Title:             Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients - PubMed

#1 Author:        Abbate et al

#1 Link:              https://pubmed.ncbi.nlm.nih.gov/34416319/

******** ********    ******** ********

#2 Title:             Torsades de Pointes Following Vaccination for COVID-19

#2 Author:        Abrich & Olshansky

#2 Link:              https://pubmed.ncbi.nlm.nih.gov/35433264/

******** ********    ******** ********

#3 Title:             Myocarditis following COVID-19 mRNA vaccination

#3 Author:        Abu Mouch et al

#3 Link:              https://pubmed.ncbi.nlm.nih.gov/34092429/

******** ********    ******** ********

#4 Title:             Fulminant myocarditis following coronavirus disease 2019 vaccination: a case report

#4 Author:        Agdamag et al

#4 Link:              https://pubmed.ncbi.nlm.nih.gov/35088026/

******** ********    ******** ********

#5 Title:             Myocarditis after BNT162b2 and mRNA-1273 COVID-19 vaccination: A report of 7 cases

#5 Author:        Ahmed

#5 Link:              https://pubmed.ncbi.nlm.nih.gov/35479661/

******** ********    ******** ********

#6 Title:             Frequent Premature Ventricular Contraction and Non-Sustained Ventricular Tachycardia After the SARS-CoV-2 Vaccination in Patient With Implantable Cardioverter Defibrillator Due to Acquired Long-QT Syndrome

#6 Author:        Aiba et al

#6 Link:              https://pubmed.ncbi.nlm.nih.gov/34275963/

******** ********    ******** ********

#7 Title:             Pericarditis with Increased Vascular Permeability after COVID-19 Vaccination

#7 Author:        Aikawa et al

#7 Link:              https://pubmed.ncbi.nlm.nih.gov/35314555/

******** ********    ******** ********

#8 Title:             Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy

#8 Author:        Alania-Torres et al

#8 Link:              https://pubmed.ncbi.nlm.nih.gov/34712717/

******** ********    ******** ********

#9 Title:             Myocarditis following COVID-19 vaccination

#9 Author:        Albert et al

#9 Link:              https://www.sciencedirect.com/science/article/pii/S1930043321003289

******** ********    ******** ********

#10 Title:          A case of myocarditis after COVID-19 vaccination: incidental or consequential?

#10 Author:     Alizadeh et al

#10 Link:           https://pubmed.ncbi.nlm.nih.gov/35655920/

******** ********    ******** ********

#11 Title:          Kounis syndrome following COVID-19 vaccination

#11 Author:     Allam et al

#11 Link:           https://pubmed.ncbi.nlm.nih.gov/35518825/

******** ********    ******** ********

#12 Title:          American Journal of Case Reports | Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine: A Case Report - Article abstract #934399

#12 Author:     Al-Rasbi et al

#12 Link:           https://www.amjcaserep.com/abstract/full/idArt/934399

******** ********    ******** ********

#13 Title:          Acute Myopericarditis after COVID-19 Vaccine in Teenagers - PubMed

#13 Author:     Ambati et al

#13 Link:           https://pubmed.ncbi.nlm.nih.gov/34589238/

******** ********    ******** ********

#14 Title:          Myocarditis after COVID-19 mRNA vaccination in three young adult males: Significance of biopsy in vaccine-associated myocarditis

#14 Author:     Amemiya et al

#14 Link:           https://pubmed.ncbi.nlm.nih.gov/35583173/

******** ********    ******** ********

#15 Title:          First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction

#15 Author:     Ameratunga et al

#15 Link:           https://pubmed.ncbi.nlm.nih.gov/34978002/

******** ********    ******** ********

#16 Title:          Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection

#16 Author:     Ammirati et al

#16 Link:           https://www.sciencedirect.com/science/article/pii/S2352906721000622?via%3Dihub

******** ********    ******** ********

#17 Title:          Case Report: Transient Increase of CMR T1 Mapping Indices in a Patient With COVID-19 mRNA Vaccine Induced Acute Myocarditis

#17 Author:     Ansari et al

#17 Link:           https://pubmed.ncbi.nlm.nih.gov/35571183/

******** ********    ******** ********

#18 Title:          A Case of Systemic Capillary Leak Syndrome with Severe Cardiac Dysfunction after mRNA Vaccination for COVID-19

#18 Author:     Araki et al

#18 Link:           https://pubmed.ncbi.nlm.nih.gov/35345835/

******** ********    ******** ********

#19 Title:          COVID-19 mRNA vaccine-associated encephalopathy, myocarditis, and thrombocytopenia with excellent response to methylprednisolone: A case report

#19 Author:     Asaduzzaman et al

#19 Link:           https://pubmed.ncbi.nlm.nih.gov/35561428/

******** ********    ******** ********

#20 Title:          A case report: symptomatic pericarditis post-COVID-19 vaccination - PubMed

#20 Author:     Ashaari et al

#20 Link:           https://pubmed.ncbi.nlm.nih.gov/34693198/

******** ********    ******** ********

#21 Title:          Myocarditis Associated With COVID-19 Booster Vaccination

#21 Author:     Aviram et al

#21 Link:           https://pubmed.ncbi.nlm.nih.gov/35100809/

******** ********    ******** ********

#22 Title:          Acute Myocardial Infarction and Myocarditis following COVID-19 Vaccination - PubMed

#22 Author:     Aye et al

#22 Link:           https://pubmed.ncbi.nlm.nih.gov/34586408/

******** ********    ******** ********

#23 Title:          Long QT interval and syncope after a single dose of COVID-19 vaccination: a case report

#23 Author:     Azdaki & Farzad

#23 Link:           https://pubmed.ncbi.nlm.nih.gov/34804335/

******** ********    ******** ********

#24 Title:          STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine

#24 Author:     Azir et al

#24 Link:           https://pubmed.ncbi.nlm.nih.gov/34756746/

******** ********    ******** ********

#25 Title:          MODERNA mRNA-1273 vaccine-associated myopericarditis in a patient with a subclinical autoimmune predisposition

#25 Author:     Badshah et al

#25 Link:           https://pubmed.ncbi.nlm.nih.gov/34868402/

******** ********    ******** ********

#26 Title:          Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination: a single UK centre experience

#26 Author:     Bano et al

#26 Link:           https://pubmed.ncbi.nlm.nih.gov/34257129/

******** ********    ******** ********

#27 Title:          Myopericarditis with Significant Left Ventricular Dysfunction Following COVID-19 Vaccination: A Case Report

#27 Author:     Bartlett et al

#27 Link:           https://pubmed.ncbi.nlm.nih.gov/34795198/

******** ********    ******** ********

#28 Title:          Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report

#28 Author:     Basnet et al

#28 Link:           https://pubmed.ncbi.nlm.nih.gov/34508485/

******** ********    ******** ********

#29 Title:          Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series

#29 Author:     Baumeier et al

#29 Link:           https://pubmed.ncbi.nlm.nih.gov/35805941/

******** ********    ******** ********

#30 Title:          [Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19]

#30 Author:     Bautista García et al

#30 Link:           https://pubmed.ncbi.nlm.nih.gov/33776190/

******** ********    ******** ********

#31 Title:          A report of two cases of myocarditis following mRNA coronavirus disease 2019 vaccination

#31 Author:     Bengel & Kacapor

#31 Link:           https://pubmed.ncbi.nlm.nih.gov/35169677/

******** ********    ******** ********

#32 Title:          Takotsubo Cardiomyopathy After mRNA COVID-19 Vaccination

#32 Author:     Berto et al

#32 Link:           https://pubmed.ncbi.nlm.nih.gov/34330629/

******** ********    ******** ********

#33 Title:          COVID-19 Vaccination-Induced Myopericarditis: An Imager's Perspective

#33 Author:     Bews et al

#33 Link:           https://pubmed.ncbi.nlm.nih.gov/35128370/

******** ********    ******** ********

#34 Title:          [Translated article] Pleuropericardial Effusion and Systemic Inflammatory Syndrome Secondary to the Administration of the mRNA-1273 Vaccine for SARS-CoV-2

#34 Author:     Boira et al

#34 Link:           https://pubmed.ncbi.nlm.nih.gov/35428521/

******** ********    ******** ********

#35 Title:          Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia

#35 Author:     Bonato et al

#35 Link:           https://pubmed.ncbi.nlm.nih.gov/34261296/

******** ********    ******** ********

#36 Title:          68Ga-DOTATOC digital-PET imaging of inflammatory cell infiltrates in myocarditis following COVID-19 vaccination - PMC

#36 Author:     Boursier et al

#36 Link:           https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8572651/

******** ********    ******** ********

#37 Title:          Recurrent MRI-Documented Myocarditis Following Pfizer-BioNTech SARS-CoV-2 Vaccination

#37 Author:     Bucur et al

#37 Link:           https://pubmed.ncbi.nlm.nih.gov/35798058/

******** ********    ******** ********

#38 Title:          Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship?

#38 Author:     Cereda et al

#38 Link:           https://pubmed.ncbi.nlm.nih.gov/34236331/

******** ********    ******** ********

#39 Title:          A case of myocarditis and isolated hypopotassemia after Biontech-Pfizer vaccine for Covid-19

#39 Author:     Ceylan et al

#39 Link:           https://pubmed.ncbi.nlm.nih.gov/35430104/

******** ********    ******** ********

#40 Title:          First Report of Acute Myocarditis Post-Pfizer-BioNTech COVID-19 Vaccination in the Kingdom of Bahrain

#40 Author:     Chachar et al

#40 Link:           https://pubmed.ncbi.nlm.nih.gov/35028213/

******** ********    ******** ********

#41 Title:          Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?

#41 Author:     Chamling et al

#41 Link:           https://pubmed.ncbi.nlm.nih.gov/34333695/

******** ********    ******** ********

#42 Title:          Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents

#42 Author:     Chelala et al

#42 Link:           https://pubmed.ncbi.nlm.nih.gov/34704459/

******** ********    ******** ********

#43 Title:          Myocarditis following COVID-19 mRNA (mRNA-1273) vaccination

#43 Author:     Chellapandian et al

#43 Link:           https://pubmed.ncbi.nlm.nih.gov/35449778/

******** ********    ******** ********

#44 Title:          Acute myocarditis after mRNA vaccination against COVID-19

#44 Author:     Chodyla et al

#44 Link:           https://pubmed.ncbi.nlm.nih.gov/34794189/

******** ********    ******** ********

#45 Title:          Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings - PMC

#45 Author:     Choi et al

#45 Link:           https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8524235/

******** ********    ******** ********

#46 Title:          Postvaccination Multisystem Inflammatory Syndrome in Adult with No Evidence of Prior SARS-CoV-2 Infection

#46 Author:     Choi YK et al

#46 Link:           https://pubmed.ncbi.nlm.nih.gov/34852213/

******** ********    ******** ********

#47 Title:          Lymphohistiocytic Myocarditis Possibly Due to Moderna mRNA-1273 Vaccine

#47 Author:     Chow & Lai

#47 Link:           https://pubmed.ncbi.nlm.nih.gov/35285858/

******** ********    ******** ********

#48 Title:          Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man - ScienceDirect

#48 Author:     Cimaglia et al

#48 Link:           https://www.sciencedirect.com/science/article/pii/S0870255121003243?via%3Dihub

******** ********    ******** ********

#49 Title:          Lessons of the month 3: Haemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19)

#49 Author:     Cory et al

#49 Link:           https://pubmed.ncbi.nlm.nih.gov/34862234/

******** ********    ******** ********

#50 Title:          Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination

#50 Author:     Crane et al

#50 Link:           https://pubmed.ncbi.nlm.nih.gov/34625447/

******** ********    ******** ********

#51 Title:          Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis

#51 Author:     Cui et al

#51 Link:           https://pubmed.ncbi.nlm.nih.gov/35141289/

******** ********    ******** ********

#52 Title:          Myocarditis After SARS-CoV-2 Vaccination: A Vaccine-Induced Reaction?

#52 Author:     D'Angelo et al

#52 Link:           https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187737/

******** ********    ******** ********

#53 Title:          Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age

#53 Author:     Das BB et al

#53 Link:           https://pubmed.ncbi.nlm.nih.gov/34339728/

******** ********    ******** ********

#54 Title:          Post-RNA (mRNA) Vaccination Myocarditis: CMR Features

#54 Author:     Das KM et al

#54 Link:           https://pubmed.ncbi.nlm.nih.gov/35626190/

******** ********    ******** ********

#55 Title:          Cardiac Adverse Reactions With COVID-19 Vaccinations

#55 Author:     De Jesus et al

#55 Link:           https://pubmed.ncbi.nlm.nih.gov/35198284/

******** ********    ******** ********

#56 Title:          Acute Myocardial Injury Following COVID-19 Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events Reporting System Database.

#56 Author:     Deb et al

#56 Link:           https://pubmed.ncbi.nlm.nih.gov/34219532/

******** ********    ******** ********

#57 Title:          Cardiac magnetic resonance imaging of myocarditis and pericarditis following COVID-19 vaccination: a multicenter collection of 27 cases

#57 Author:     Di Dedda et al

#57 Link:           https://pubmed.ncbi.nlm.nih.gov/35230520/

******** ********    ******** ********

#58 Title:          Pericarditis after administration mRNA COVID-19 vaccine

#58 Author:     Díaz et al

#58 Link:           https://pubmed.ncbi.nlm.nih.gov/35506812/

******** ********    ******** ********

#59 Title:          A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2 - ScienceDirect

#59 Author:     Dickey et al

#59 Link:           https://www.sciencedirect.com/science/article/pii/S1936878X21004861?via%3Dihub

******** ********    ******** ********

#60 Title:          Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children | Cardiology | JAMA Cardiology | JAMA Network

#60 Author:     Dionne et al

#60 Link:           https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052

******** ********    ******** ********

#61 Title:          COVID-19 mRNA Vaccine-Associated Myocarditis Presenting as STEMI in a 48-Year-Old Male

#61 Author:     Dlewati et al

#61 Link:           https://pubmed.ncbi.nlm.nih.gov/35465413/

******** ********    ******** ********

#62 Title:          Post Covıd-19 Vaccınatıon Inflammatory Syndrome: A Case Report

#62 Author:     Durucan et l

#62 Link:           https://pubmed.ncbi.nlm.nih.gov/35556127/

******** ********    ******** ********

#63 Title:          Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report - PMC

#63 Author:     Ehrlich et al

#63 Link:           https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8419377/

******** ********    ******** ********

#64 Title:          From Muscles to Wires: Report of Two Cases and Literature Review on COVID-19 Vaccination and Cardiac Conduction Disturbance

#64 Author:     Elhassan et al

#64 Link:           https://pubmed.ncbi.nlm.nih.gov/34796078/

******** ********    ******** ********

#65 Title:          Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19

#65 Author:     Elhouderi et al

#65 Link:           https://pubmed.ncbi.nlm.nih.gov/35755512/

******** ********    ******** ********

#66 Title:          [Acute myocarditis in a young adult two days after Pfizer vaccination]

#66 Author:     Facetti et al

#66 Link:           https://pubmed.ncbi.nlm.nih.gov/34709227/

******** ********    ******** ********

#67 Title:          Acute Myopericarditis After First Dose of mRNA-1273 SARS-CoV-2 Vaccine in a Young Adult

#67 Author:     Fadah et al

#67 Link:           https://pubmed.ncbi.nlm.nih.gov/35308760/

******** ********    ******** ********

#68 Title:          COVID-19 Vaccine-Induced Pneumonitis, Myositis and Myopericarditis

#68 Author:     Farooq et al

#68 Link:           https://pubmed.ncbi.nlm.nih.gov/35004093/

******** ********    ******** ********

#69 Title:          Takotsubo syndrome after receiving the COVID-19 vaccine

#69 Author:     Fearon et al

#69 Link:           https://pubmed.ncbi.nlm.nih.gov/34539938/

******** ********    ******** ********

#70 Title:          Acute myocarditis after a third dose of the BNT162b2 COVID-19 vaccine

#70 Author:     Fosch et al

#70 Link:           https://pubmed.ncbi.nlm.nih.gov/35277352/

******** ********    ******** ********

#71 Title:          Acute cardiac side effects after COVID-19 mRNA vaccination: a case series

#71 Author:     Freise et al

#71 Link:           https://pubmed.ncbi.nlm.nih.gov/35655235/

******** ********    ******** ********

#72 Title:          Severe myopericarditis following the third dose of an mRNA COVID-19 vaccine: utility of a multimodal treatment approach

#72 Author:     Fritz et al

#72 Link:           https://pubmed.ncbi.nlm.nih.gov/35768161/

******** ********    ******** ********

#73 Title:          Cardiac MRI and Clinical Follow-up in COVID-19 Vaccine-associated Myocarditis

#73 Author:     Fronza et al

#73 Link:           https://pubmed.ncbi.nlm.nih.gov/35503017/

******** ********    ******** ********

#74 Title:          Hypersensitivity Myocarditis after COVID-19 mRNA Vaccination

#74 Author:     Frustaci et al

#74 Link:           https://pubmed.ncbi.nlm.nih.gov/35329986/

******** ********    ******** ********

#75 Title:          Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19

#75 Author:     Garcia et al

#75 Link:           https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075838/

******** ********    ******** ********

#76 Title:          A Late Presentation of COVID-19 Vaccine-Induced Myocarditis

#76 Author:     Gautam et al

#76 Link:           https://pubmed.ncbi.nlm.nih.gov/34660088/

******** ********    ******** ********

#77 Title:          Myocarditis after vaccination against covid-19

#77 Author:     Gellad

#77 Link:           https://pubmed.ncbi.nlm.nih.gov/34916217/

******** ********    ******** ********

#78 Title:          Myopericarditis with hemorrhagic pericardial effusion following BNT162b2 mRNA COVID-19 vaccine

#78 Author:     Generette et al

#78 Link:           https://pubmed.ncbi.nlm.nih.gov/35646594/

******** ********    ******** ********

#79 Title:          Autopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 Vaccine Dose | Archives of Pathology & Laboratory Medicine

#79 Author:     Gill et al

#79 Link:           https://meridian.allenpress.com/aplm/article/doi/10.5858/arpa.2021-0435-SA/477788/Autopsy-Histopathologic-Cardiac-Findings-in-Two

******** ********    ******** ********

#80 Title:          Transient Myopericarditis Following Vaccination for COVID-19

#80 Author:     Gill J et al

#80 Link:           https://pubmed.ncbi.nlm.nih.gov/35317093/

******** ********    ******** ********

#81 Title:          Acute myocarditis following COVID-19 mRNA vaccination: a paediatric case

#81 Author:     Giray & Epçaçan

#81 Link:           https://pubmed.ncbi.nlm.nih.gov/35105392/

******** ********    ******** ********

#82 Title:          Acute Myocarditis Following mRNA COVID-19 Vaccine

#82 Author:     Gomes et al

#82 Link:           https://pubmed.ncbi.nlm.nih.gov/35508057/

******** ********    ******** ********

#83 Title:          More than myocarditis, a rare adverse effect after the ChAdOx1 vaccine

#83 Author:     Gómez-Monterrosas et al

#83 Link:           https://pubmed.ncbi.nlm.nih.gov/35654764/

******** ********    ******** ********

#84 Title:          Cardiogenic shock complicating multisystem inflammatory syndrome following COVID-19 infection: a case report

#84 Author:     Gurin et al

#84 Link:           https://pubmed.ncbi.nlm.nih.gov/34715788/

******** ********    ******** ********

#85 Title:          A case of myocarditis in a 60-year-old man 48 h after mRNA vaccination against SARS-CoV2

#85 Author:     Habedank et al

#85 Link:           https://pubmed.ncbi.nlm.nih.gov/34731321/

******** ********    ******** ********

#86 Title:          Acute myocarditis following administration of BNT162b2 vaccine

#86 Author:     Habib et al

#86 Link:           https://pubmed.ncbi.nlm.nih.gov/34189042/

******** ********    ******** ********

#87 Title:          Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report

#87 Author:     Hasnie et al

#87 Link:           https://pubmed.ncbi.nlm.nih.gov/34348657/

******** ********    ******** ********

#88 Title:          Myocarditis following AstraZeneca (an adenovirus vector vaccine) COVID-19 vaccination: A case report

#88 Author:     Hassanzadeh et al

#88 Link:           https://pubmed.ncbi.nlm.nih.gov/35441011/

******** ********    ******** ********

#89 Title:          Giant cell myocarditis after first dose of BNT162b2 - a case report

#89 Author:     Hirsch VG et al

#89 Link:           https://pubmed.ncbi.nlm.nih.gov/35733299/

******** ********    ******** ********

#90 Title:          An autopsy case report of fulminant myocarditis: Following mRNA COVID-19 vaccination

#90 Author:     Hoshino et al

#90 Link:           https://pubmed.ncbi.nlm.nih.gov/35812802/

******** ********    ******** ********

#91 Title:          Cardiac Tamponade After COVID-19 Vaccination

#91 Author:     Hryniewicki et al

#91 Link:           https://pubmed.ncbi.nlm.nih.gov/34996671/

******** ********    ******** ********

#92 Title:          Myocarditis and pericarditis after vaccination for COVID-19

#92 Author:     Hudson et al

#92 Link:           https://pubmed.ncbi.nlm.nih.gov/34337595/

******** ********    ******** ********

#93 Title:          A case of myopericarditis with pleuritis following AstraZeneca Covid-19 vaccination

#93 Author:     Hung & Sun

#93 Link:           https://pubmed.ncbi.nlm.nih.gov/34741522/

******** ********    ******** ********

#94 Title:          Systemic capillary leak syndrome (SCLS) after receiving BNT162b2 mRNA COVID-19 (Pfizer-BioNTech) vaccine

#94 Author:     Inoue et al

#94 Link:           https://pubmed.ncbi.nlm.nih.gov/35292552/

******** ********    ******** ********

#95 Title:          Myocarditis Following COVID-19 Vaccination

#95 Author:     Isaak et al

#95 Link:           https://pubmed.ncbi.nlm.nih.gov/34342500/

******** ********    ******** ********

#96 Title:          A 17-year-old male with acute myocarditis following mRNA-1273 vaccination in Japan

#96 Author:     Iwamuro et al

#96 Link:           https://pubmed.ncbi.nlm.nih.gov/35495897/

******** ********    ******** ********

#97 Title:          COVID-19 Vaccine-Associated Takotsubo Cardiomyopathy

#97 Author:     Jani et al

#97 Link:           https://pubmed.ncbi.nlm.nih.gov/34375049/

******** ********    ******** ********

#98 Title:          An Unusual Case of Hemorrhagic Pleuropericarditis After COVID-19 Vaccination

#98 Author:     Javed et al

#98 Link:           https://pubmed.ncbi.nlm.nih.gov/35693361/

******** ********    ******** ********

#99 Title:          Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after mRNA-1273 vaccination - PubMed

#99 Author:     Kadwalwala et al

#99 Link:           https://pubmed.ncbi.nlm.nih.gov/34848416/

******** ********    ******** ********

#100 Title:        Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19)

#100 Author:   Kaneta et al

#100 Link:         https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-21-0818/_article

******** ********    ******** ********

#101 Title:        Fulminant Giant Cell Myocarditis following Heterologous Vaccination of ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19

#101 Author:   Kang et al

#101 Link:         https://pubmed.ncbi.nlm.nih.gov/35334625/

******** ********    ******** ********

#102 Title:        Myocarditis following COVID-19 vaccination

#102 Author:   Kaul et al

#102 Link:         https://pubmed.ncbi.nlm.nih.gov/34568540/

******** ********    ******** ********

#103 Title:        Acute Myocarditis in a Patient Following mRNA-1273 SARS-CoV-2 Vaccination

#103 Author:   Kawakami et al

#103 Link:         https://pubmed.ncbi.nlm.nih.gov/35249920/

******** ********    ******** ********

#104 Title:        Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following COVID-19 mRNA Vaccination

#104 Author:   Kazama et al

#104 Link:         https://pubmed.ncbi.nlm.nih.gov/35187464/

******** ********    ******** ********

#105 Title:        A case of myocarditis following ChAdOx1 nCov-19 vaccination

#105 Author:   Kerkhove et al

#105 Link:         https://pubmed.ncbi.nlm.nih.gov/35189775/

******** ********    ******** ********

#106 Title:        COVID-19 Vaccination-Induced Cardiomyopathy Requiring Permanent Left Ventricular Assist Device

#106 Author:   Khan MZ et al

#106 Link:         https://pubmed.ncbi.nlm.nih.gov/35651464/

******** ********    ******** ********

#107 Title:        Unusual Presentation of Acute Perimyocarditis Following SARS-COV-2 mRNA-1237 Moderna Vaccination

#107 Author:   Khogali & Abdelrahman

#107 Link:         https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381757/

******** ********    ******** ********

#108 Title:        Myocarditis following mRNA COVID-19 vaccination: call for endomyocardial biopsy

#108 Author:   Kiblboeck et al (Cases)

#108 Link:         https://pubmed.ncbi.nlm.nih.gov/35194974/

******** ********    ******** ********

#109 Title:        A Case Report for Myopericarditis after BNT162b2 COVID-19 mRNA Vaccination in a Korean Young Male - PubMed

#109 Author:   Kim et al

#109 Link:         https://pubmed.ncbi.nlm.nih.gov/34636504/

******** ********    ******** ********

#110 Title:        Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination

#110 Author:   Kim HW et al

#110 Link:         https://jamanetwork.com/journals/jamacardiology/article-abstract/2781602

******** ********    ******** ********

#111 Title:        Cardiac Imaging of Acute Myocarditis Following COVID-19 mRNA Vaccination - PubMed

#111 Author:   Kim IC et al

#111 Link:         https://pubmed.ncbi.nlm.nih.gov/34402228/

******** ********    ******** ********

#112 Title:        A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination

#112 Author:   Kim SH et al

#112 Link:         https://pubmed.ncbi.nlm.nih.gov/35380028/

******** ********    ******** ********

#113 Title:        Intermittent complete heart block with ventricular standstill after Pfizer COVID-19 booster vaccination: A case report

#113 Author:   Kimball et al

#113 Link:         https://pubmed.ncbi.nlm.nih.gov/35475120/

******** ********    ******** ********

#114 Title:        Myocarditis following mRNA vaccination against SARS-CoV-2, a case series - PubMed

#114 Author:   King et al

#114 Link:         https://pubmed.ncbi.nlm.nih.gov/34396358/

******** ********    ******** ********

#115 Title:        Serial histopathologic assessment of fulminant myocarditis after the first mRNA COVID-19 vaccine dose

#115 Author:   Koiwaya et al

#115 Link:         https://pubmed.ncbi.nlm.nih.gov/35178573/

******** ********    ******** ********

#116 Title:        Myocarditis after COVID-19 mRNA vaccines

#116 Author:   Koizumi et l

#116 Link:         https://pubmed.ncbi.nlm.nih.gov/34546329/

******** ********    ******** ********

#117 Title:        Case Report: Myocarditis Associated With COVID-19 mRNA Vaccination Following Myocarditis Associated With Campylobacter Jejuni

#117 Author:   Kojima et al

#117 Link:         https://pubmed.ncbi.nlm.nih.gov/35369323/

******** ********    ******** ********

#118 Title:        Fever-Related Ventricular Fibrillation - Potential Adverse Effect of SARS-CoV-2 Vaccination in Patients With Brugada Syndrome

#118 Author:   Kokawa et al

#118 Link:         https://pubmed.ncbi.nlm.nih.gov/34615807/

******** ********    ******** ********

#119 Title:        Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination

#119 Author:   Kornowski & Witberg

#119 Link:         https://pubmed.ncbi.nlm.nih.gov/35264415/

******** ********    ******** ********

#120 Title:        Case Report: Disappearance of Late Gadolinium Enhancement and Full Functional Recovery in a Young Patient With SARS-CoV-2 Vaccine-Related Myocarditis

#120 Author:   Korosoglou et al

#120 Link:         https://pubmed.ncbi.nlm.nih.gov/35345490/

******** ********    ******** ********

#121 Title:        Cardiac MRI in Suspected Acute Myocarditis After COVID-19 mRNA Vaccination

#121 Author:   Kravchenko et al

#121 Link:         https://pubmed.ncbi.nlm.nih.gov/35272355/

******** ********    ******** ********

#122 Title:        COVID-19 mRNA Vaccine-Associated Myocarditis

#122 Author:   Kyaw et al

#122 Link:         https://pubmed.ncbi.nlm.nih.gov/35154981/

******** ********    ******** ********

#123 Title:        Myocarditis After BNT162b2 and mRNA-1273 Vaccination - PMC

#123 Author:   Larson et al

#123 Link:         https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340725/

******** ********    ******** ********

#124 Title:        A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States - PMC

#124 Author:   Lazaros et al

#124 Link:         https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8491922/

******** ********    ******** ********

#125 Title:        Myocarditis associated with COVID‑19 vaccination in three male teenagers - Polish Archives of Internal Medicine

#125 Author:   Łaźniak-Pfajfer et al

#125 Link:         https://pubmed.ncbi.nlm.nih.gov/34851078/

******** ********    ******** ********

#126 Title:        FDG PET/MRI of Acute Myocarditis After mRNA COVID-19 Vaccination

#126 Author:   Lee & Kong

#126 Link:         https://pubmed.ncbi.nlm.nih.gov/35234199/

******** ********    ******** ********

#127 Title:        A spectrum of cardiac manifestations post Pfizer-BioNTech COVID-19 vaccination 

#127 Author:   Lee E et al

#127 Link:         https://academic.oup.com/qjmed/article/114/9/661/6311674

******** ********    ******** ********

#128 Title:        Complete AV Block in Vaccinated COVID-19 Patient

#128 Author:   Lee K et al

#128 Link:         https://pubmed.ncbi.nlm.nih.gov/35371571/

******** ********    ******** ********

#129 Title:        COVID-19 Vaccine-Induced Multisystem Inflammatory Syndrome With Polyserositis Detected by FDG PET/CT

#129 Author:   Lee SJ et al

#129 Link:         https://pubmed.ncbi.nlm.nih.gov/35175945/

******** ********    ******** ********

#130 Title:        Myocarditis following COVID-19 vaccination - A case series

#130 Author:   Levin et al

#130 Link:         https://pubmed.ncbi.nlm.nih.gov/34535317/

******** ********    ******** ********

#131 Title:        Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation - PubMed

#131 Author:   Lim et al

#131 Link:         https://pubmed.ncbi.nlm.nih.gov/34778411/

******** ********    ******** ********

#132 Title:        Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech)

#132 Author:   Lin et al

#132 Link:         https://pubmed.ncbi.nlm.nih.gov/35306680/

******** ********    ******** ********

#133 Title:        Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination

#133 Author:   Maeda et al

#133 Link:         https://pubmed.ncbi.nlm.nih.gov/34866122/

******** ********    ******** ********

#134 Title:        Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination

#134 Author:   Maki et al

#134 Link:         https://pubmed.ncbi.nlm.nih.gov/34601566/

******** ********    ******** ********

#135 Title:        [A rare case of myocarditis and pulmonary embolism after BNT162b2 mRNA vaccine]

#135 Author:   Mancini et al

#135 Link:         https://pubmed.ncbi.nlm.nih.gov/35343473/

******** ********    ******** ********

#136 Title:        Clinical Profiles and CMR Findings of Young Adults and Pediatrics with Acute Myocarditis Following mRNA COVID-19 Vaccination: A Case Series

#136 Author:   Manfredi et al

#136 Link:         https://pubmed.ncbi.nlm.nih.gov/35214629/

******** ********    ******** ********

#137 Title:        Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases

#137 Author:   Mansour et al

#137 Link:         https://pubmed.ncbi.nlm.nih.gov/34166884/

******** ********    ******** ********

#138 Title:        A case of myopericarditis recurrence after third dose of BNT162b2 vaccine against SARS-CoV-2 in a young subject: link or causality?

#138 Author:   Mapelli et al

#138 Link:         https://pubmed.ncbi.nlm.nih.gov/35602257/

******** ********    ******** ********

#139 Title:        [21/m-Chest pain after vaccination with mRNA vaccine : Preparation for the medical specialist examination: part 147]

#139 Author:   Maráz

#139 Link:         https://pubmed.ncbi.nlm.nih.gov/35362732/

******** ********    ******** ********

#140 Title:        Tachycardia as an undescribed adverse effect to the Comirnaty© vaccine (BNT162b2 Pfizer-BioNTech Covid-19 vaccine): Description of 3 cases with a history of SARS-CoV-2 disease

#140 Author:   Marco García et al

#140 Link:         https://pubmed.ncbi.nlm.nih.gov/35484063/

******** ********    ******** ********

#141 Title:        Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination - PubMed

#141 Author:   Marshall et al

#141 Link:         https://pubmed.ncbi.nlm.nih.gov/34088762/

******** ********    ******** ********

#142 Title:        Concomitant myocarditis and painless thyroiditis after AstraZeneca coronavirus disease 2019 vaccination: a case report

#142 Author:   Marsukjai et al

#142 Link:         https://pubmed.ncbi.nlm.nih.gov/35581666/

******** ********    ******** ********

#143 Title:        Post-mRNA COVID-19 Vaccination Myocarditis

#143 Author:   Matta et al

#143 Link:         https://pubmed.ncbi.nlm.nih.gov/34527626/

******** ********    ******** ********

#144 Title:        Myocarditis Post Moderna Vaccination: Review of Criteria for Diagnosis

#144 Author:   McCullough et al

#144 Link:         https://pubmed.ncbi.nlm.nih.gov/34956759/

******** ********    ******** ********

#145 Title:        Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report

#145 Author:   Mclean & Johnson

#145 Link:         https://pubmed.ncbi.nlm.nih.gov/34133825/

******** ********    ******** ********

#146 Title:        Cardiac magnetic resonance characteristics of acute myocarditis occurring after mRNA-based COVID-19 vaccines immunization

#146 Author:   Meyer-Szary et al

#146 Link:         https://pubmed.ncbi.nlm.nih.gov/34787887/

******** ********    ******** ********

#147 Title:        Cardiogenic shock revealing myocarditis after mRNA vaccination against covid-19: Case report and brief review for the first case in Morocco - ScienceDirect

#147 Author:   Mimouni et al

#147 Link:         https://www.sciencedirect.com/science/article/pii/S2049080121011602

******** ********    ******** ********

#148 Title:        Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent

#148 Author:   Minocha et al

#148 Link:         https://pubmed.ncbi.nlm.nih.gov/34166671/

******** ********    ******** ********

#149 Title:        Acute Myocarditis Following the Administration of the Second BNT162b2 COVID-19 Vaccine Dose

#149 Author:   Miqdad et al

#149 Link:         https://pubmed.ncbi.nlm.nih.gov/34804729/

******** ********    ******** ********

#150 Title:        Acute Myocardial Infarction After COVID-19 Vaccination: A Case Report

#150 Author:   Mishra et al

#150 Link:         https://pubmed.ncbi.nlm.nih.gov/35800833/

******** ********    ******** ********

#151 Title:        Constrictive pericarditis following mRNA COVID-19 vaccination in a patient with systemic sclerosis

#151 Author:   Misumi et al

#151 Link:         https://pubmed.ncbi.nlm.nih.gov/35401886/

******** ********    ******** ********

#152 Title:        A case of an elderly female who developed subacute pleuropericarditis following BNT162b2 mRNA COVID-19 vaccination

#152 Author:   Mizoguchi et al

#152 Link:         https://pubmed.ncbi.nlm.nih.gov/35600413/

******** ********    ******** ********

#153 Title:        Myocarditis Secondary to COVID-19 mRNA Vaccine: A Case Report

#153 Author:   Mohammed et al

#153 Link:         https://pubmed.ncbi.nlm.nih.gov/35371688/

******** ********    ******** ********

#154 Title:        Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military - PubMed

#154 Author:   Montgomery et al

#154 Link:         https://pubmed.ncbi.nlm.nih.gov/34185045/

******** ********    ******** ********

#155 Title:        COVID Vaccine-Associated Myocarditis in Adolescent Siblings: Does It Run in the Family?

#155 Author:   Moosman et al

#155 Link:         https://pubmed.ncbi.nlm.nih.gov/35455360/

******** ********    ******** ********

#156 Title:        A case of myopericarditis following administration of the Pfizer COVID-19 vaccine

#156 Author:   Morton et al

#156 Link:         https://pubmed.ncbi.nlm.nih.gov/35529098/

******** ********    ******** ********

#157 Title:        Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series - PubMed

#157 Author:   Murakami et al

#157 Link:         https://pubmed.ncbi.nlm.nih.gov/34840235/

******** ********    ******** ********

#158 Title:        In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine

#158 Author:   Muthukumar et al

#158 Link:         https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340727/

******** ********    ******** ********

#159 Title:        Acute myocarditis associated with COVID-19 vaccination: A case report - PMC

#159 Author:   Nagasaka et al

#159 Link:         https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/

******** ********    ******** ********

#160 Title:        Constrictive pericarditis after SARS-CoV-2 vaccination: A case report

#160 Author:   Nakanishi et al

#160 Link:         https://pubmed.ncbi.nlm.nih.gov/35063679/

******** ********    ******** ********

#161 Title:        COVID-19 vaccine-induced myocarditis: Case report with literature review

#161 Author:   Nassar et al

#161 Link:         https://pubmed.ncbi.nlm.nih.gov/34293552/

******** ********    ******** ********

#162 Title:        Acute myocarditis associated with anti-COVID-19 vaccination

#162 Author:   Nevet

#162 Link:         https://pubmed.ncbi.nlm.nih.gov/34222133/

******** ********    ******** ********

#163 Title:        Acute myocarditis after COVID-19 vaccination with mRNA-1273 in a patient with former SARS-CoV-2 infection

#163 Author:   Nguyen et al

#163 Link:         https://pubmed.ncbi.nlm.nih.gov/34536056/

******** ********    ******** ********

#164 Title:        Case Report: Myocarditis After COVID-19 Vaccination - Case Series and Literature Review

#164 Author:   Nunn et al

#164 Link:         https://pubmed.ncbi.nlm.nih.gov/35237634/

******** ********    ******** ********

#165 Title:        Case report of acute myocarditis after administration of coronavirus disease 2019 vaccine in Japan

#165 Author:   Ohnishi et al

#165 Link:         https://pubmed.ncbi.nlm.nih.gov/35075442/

******** ********    ******** ********

#166 Title:        Acute necrotizing eosinophilic myocarditis after COVID-19 vaccination

#166 Author:   Ohtani et al

#166 Link:         https://pubmed.ncbi.nlm.nih.gov/35551373/

******** ********    ******** ********

#167 Title:        Fulminant myocarditis after the second dose of COVID-19 mRNA vaccination

#167 Author:   Oka et al

#167 Link:         https://pubmed.ncbi.nlm.nih.gov/35154722/

******** ********    ******** ********

#168 Title:        Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine

#168 Author:   Olagunju et al

#168 Link:         https://pubmed.ncbi.nlm.nih.gov/35466745/

******** ********    ******** ********

#169 Title:        Severe myocarditis after SARS-CoV-2 vaccination in a 49-year-old woman

#169 Author:   Olmos et al

#169 Link:         https://pubmed.ncbi.nlm.nih.gov/35470205/

******** ********    ******** ********

#170 Title:        Myocarditis in the Setting of Recent COVID-19 Vaccination - PubMed

#170 Author:   Onderko et al

#170 Link:         https://pubmed.ncbi.nlm.nih.gov/34712497/

******** ********    ******** ********

#171 Title:        A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine

#171 Author:   Park & You

#171 Link:         https://pubmed.ncbi.nlm.nih.gov/35470603/

******** ********    ******** ********

#172 Title:        Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine

#172 Author:   Park et al

#172 Link:         https://pubmed.ncbi.nlm.nih.gov/34180390/

******** ********    ******** ********

#173 Title:        Myocarditis following COVID-19 mRNA vaccination

#173 Author:   Parmar et al

#173 Link:         https://pubmed.ncbi.nlm.nih.gov/35256821/

******** ********    ******** ********

#174 Title:        Recurrent Myocarditis Following COVID-19 Infection and the mRNA Vaccine

#174 Author:   Pasha et al

#174 Link:         https://pubmed.ncbi.nlm.nih.gov/35815297/

******** ********    ******** ********

#175 Title:        COVID-19 mRNA Vaccine Induced Pericarditis With Large Pericardial Effusion Followed by New-Onset Arrhythmia

#175 Author:   Patel K et al

#175 Link:         https://pubmed.ncbi.nlm.nih.gov/35663660/

******** ********    ******** ********

#176 Title:        Symptomatic Myocarditis Post COVID-19 Vaccination

#176 Author:   Patel P et al

#176 Link:         https://www.cureus.com/articles/86711-symptomatic-myocarditis-post-covid-19-vaccination

******** ********    ******** ********

#177 Title:        Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series - PMC

#177 Author:   Patel Y et al

#177 Link:         https://pubmed.ncbi.nlm.nih.gov/34496880/

******** ********    ******** ********

#178 Title:        Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection - PubMed

#178 Author:   Patrignani et al

#178 Link:         https://pubmed.ncbi.nlm.nih.gov/34367386/

******** ********    ******** ********

#179 Title:        Myocarditis Following Coronavirus Disease 2019 mRNA Vaccine: A Case Series and Incidence Rate Determination | Clinical Infectious Diseases | Oxford Academic

#179 Author:   Perez et al

#179 Link:         https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408?login=false

******** ********    ******** ********

#180 Title:        Rapid resolution of severe pericardial effusion using anakinra in a patient with COVID-19 vaccine-related acute pericarditis relapse: a case report

#180 Author:   Perna et al

#180 Link:         https://pubmed.ncbi.nlm.nih.gov/35445166/

******** ********    ******** ********

#181 Title:        Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2

#181 Author:   Plüß et al

#181 Link:         https://pubmed.ncbi.nlm.nih.gov/35116025/

******** ********    ******** ********

#182 Title:        COVID-19-Vaccination-Induced Myocarditis in Teenagers: Case Series with Further Follow-Up

#182 Author:   Puchalski et al

#182 Link:         https://pubmed.ncbi.nlm.nih.gov/35329143/

******** ********    ******** ********

#183 Title:        Pericarditis after administration of the BNT162b2 mRNA vaccine against COVID-19 - PMC

#183 Author:   Ramírez-García et al

#183 Link:         https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8196309/

******** ********    ******** ********

#184 Title:        A Case of Postural Orthostatic Tachycardia Syndrome Secondary to the Messenger RNA COVID-19 Vaccine

#184 Author:   Reddy et al

#184 Link:         https://pubmed.ncbi.nlm.nih.gov/33968543/

******** ********    ******** ********

#185 Title:        Chest Pain and Suspected Myocarditis Related to COVID-19 Vaccination in Adolescents-A Case Series

#185 Author:   Roh et al

#185 Link:         https://pubmed.ncbi.nlm.nih.gov/35626870/

******** ********    ******** ********

#186 Title:        Myocarditis Temporally Associated With COVID-19 Vaccination

#186 Author:   Rosner et al

#186 Link:         https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340723/

******** ********    ******** ********

#187 Title:        Cardiopulmonary Arrest After COVID-19 Vaccination: A Case Report

#187 Author:   Sadiq et al

#187 Link:         https://pubmed.ncbi.nlm.nih.gov/35165592/

******** ********    ******** ********

#188 Title:        Myopericarditis After COVID-19 mRNA Vaccination

#188 Author:   Sakaguchi et al

#188 Link:         https://pubmed.ncbi.nlm.nih.gov/34588400/

******** ********    ******** ********

#189 Title:        Kounis syndrome associated with BNT162b2 mRNA COVID-19 vaccine presenting as ST-elevation acute myocardial infarction

#189 Author:   Şancı et al

#189 Link:         https://pubmed.ncbi.nlm.nih.gov/35191390/

******** ********    ******** ********

#190 Title:        Cardiac magnetic resonance findings in acute myocarditis after mRNA COVID-19 vaccination

#190 Author:   Sano et al

#190 Link:         https://pubmed.ncbi.nlm.nih.gov/35169401/

******** ********    ******** ********

#191 Title:        Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents - PMC

#191 Author:   Schauer et al

#191 Link:         https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8253718/

******** ********    ******** ********

#192 Title:        HeartWare Thrombosis After mRNA COVID-19 Vaccination

#192 Author:   Schettle et al

#192 Link:         https://pubmed.ncbi.nlm.nih.gov/35787869/

******** ********    ******** ********

#193 Title:        Atrial fibrillation as a precursor of mRNA-1273 SARS-CoV-2 vaccine-induced pericarditis

#193 Author:   Scheuermeyer et al

#193 Link:         https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761835/

******** ********    ******** ********

#194 Title:        Acute Myocarditis after COVID-19 vaccination: A case report - ScienceDirect

#194 Author:   Schmitt et al

#194 Link:         https://pubmed.ncbi.nlm.nih.gov/34740463/

******** ********    ******** ********

#195 Title:        Case Report: Two Case Reports of Acute Myopericarditis After mRNA COVID-19 Vaccine

#195 Author:   Sciaccaluga et al

#195 Link:         https://pubmed.ncbi.nlm.nih.gov/35321100/

******** ********    ******** ********

#196 Title:        A rare case of COVID-19 vaccine-induced myopericarditis in a young adult

#196 Author:   Sharbatdaran et al

#196 Link:         https://pubmed.ncbi.nlm.nih.gov/35401904/

******** ********    ******** ********

#197 Title:        Myopericarditis After COVID-19 Booster Dose Vaccination

#197 Author:   Sharff et al

#197 Link:         https://pubmed.ncbi.nlm.nih.gov/35351285/

******** ********    ******** ********

#198 Title:        Possible Association Between COVID-19 Vaccine and Myocarditis

#198 Author:   Shaw et al

#198 Link:         https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245050/

******** ********    ******** ********

#199 Title:        A Case Series of Myocarditis Following Third (Booster) Dose of COVID-19 Vaccination: Magnetic Resonance Imaging Study

#199 Author:   Shiyovich et al

#199 Link:         https://pubmed.ncbi.nlm.nih.gov/35310989/

******** ********    ******** ********

#200 Title:        Acute myocarditis associated with the Pfizer/BioNTech vaccine

#200 Author:   Shumkova et al

#200 Link:         https://journals.viamedica.pl/kardiologia_polska/article/view/85495

******** ********    ******** ********

#201 Title:        Acute Pericarditis Post mRNA-1273 COVID Vaccine Booster

#201 Author:   Singh A et al

#201 Link:         https://pubmed.ncbi.nlm.nih.gov/35308666/

******** ********    ******** ********

#202 Title:        COVID-19 mRNA Vaccine and Myocarditis

#202 Author:   Singh B et al

#202 Link:         https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276934/

******** ********    ******** ********

#203 Title:        Pneumonitis and Myopericarditis After Booster COVID-19 mRNA Vaccination

#203 Author:   Singh R et al

#203 Link:         https://pubmed.ncbi.nlm.nih.gov/35383584/

******** ********    ******** ********

#204 Title:        Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine - PubMed

#204 Author:   Snapiri et al

#204 Link:         https://pubmed.ncbi.nlm.nih.gov/34077949/

******** ********    ******** ********

#205 Title:        Every rose has its thorns - acute myocarditis following COVID-19 vaccination

#205 Author:   Sokolska et al

#205 Link:         https://pubmed.ncbi.nlm.nih.gov/34331307/

******** ********    ******** ********

#206 Title:        A Case of Acute Pericarditis After COVID-19 Vaccination

#206 Author:   Sonaglioni et al

#206 Link:         https://pubmed.ncbi.nlm.nih.gov/35387019/

******** ********    ******** ********

#207 Title:        Severe Aplastic Anemia After Receiving SARS-CoV-2 Moderna mRNA Vaccination

#207 Author:   Sridhara et al

#207 Link:         https://pubmed.ncbi.nlm.nih.gov/35356634/

******** ********    ******** ********

#208 Title:        Myocarditis Associated with mRNA COVID-19 Vaccination | Radiology

#208 Author:   Starekova et al

#208 Link:         https://pubmed.ncbi.nlm.nih.gov/34282971/

******** ********    ******** ********

#209 Title:        Novel case of takotsubo cardiomyopathy following COVID-19 vaccination

#209 Author:   Stewart et al

#209 Link:         https://pubmed.ncbi.nlm.nih.gov/35042734/

******** ********    ******** ********

#210 Title:        Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: A case report and literature review - ScienceDirect

#210 Author:   Sulemankhil et al

#210 Link:         https://www.sciencedirect.com/science/article/pii/S1553838921005789

******** ********    ******** ********

#211 Title:        Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination

#211 Author:   Sung JG et al

#211 Link:         https://pubmed.ncbi.nlm.nih.gov/34364657/

******** ********    ******** ********

#212 Title:        Biopsy-Proven Giant Cell Myocarditis Following the COVID-19 Vaccine

#212 Author:   Sung K et al

#212 Link:         https://pubmed.ncbi.nlm.nih.gov/35439027/

******** ********    ******** ********

#213 Title:        Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine - PubMed

#213 Author:   Tailor et al

#213 Link:         https://pubmed.ncbi.nlm.nih.gov/34514306/

******** ********    ******** ********

#214 Title:        Chest Pain with New Abnormal Electrocardiogram Development after Injection of COVID-19 Vaccine Manufactured by Moderna

#214 Author:   Takase et al

#214 Link:         https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_8711-21/_article

******** ********    ******** ********

#215 Title:        Reverse Takotsubo Cardiomyopathy as a Cause of Acute Chest Pain in a Young Woman Following COVID-19 Vaccination

#215 Author:   Tamaura et al

#215 Link:         https://pubmed.ncbi.nlm.nih.gov/34961327/

******** ********    ******** ********

#216 Title:        Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine | Journal of the Pediatric Infectious Diseases Society | Oxford Academic

#216 Author:   Tano et al

#216 Link:         https://academic.oup.com/jpids/article/10/10/962/6329543?login=false

******** ********    ******** ********

#217 Title:        Isolated Tachycardia Presenting After Pfizer-BioNTech COVID-19 Vaccination

#217 Author:   Tate et al

#217 Link:         https://pubmed.ncbi.nlm.nih.gov/34466331/

******** ********    ******** ********

#218 Title:        Takotsubo syndrome after BNT162b2 mRNA Covid-19 vaccine: Emotional or causative relationship with vaccination?

#218 Author:   Tedeschi et al

#218 Link:         https://pubmed.ncbi.nlm.nih.gov/35340274/

******** ********    ******** ********

#219 Title:        Fulminant myocarditis in a patient with a lung adenocarcinoma after the third dose of modern COVID-19 vaccine. A case report and literature review

#219 Author:   Terán Brage et al

#219 Link:         https://pubmed.ncbi.nlm.nih.gov/35378738/

******** ********    ******** ********

#220 Title:        Imaging of Myocarditis Following mRNA COVID-19 Booster Vaccination

#220 Author:   Tijmes et al

#220 Link:         https://pubmed.ncbi.nlm.nih.gov/35506135/

******** ********    ******** ********

#221 Title:        Perimyocarditis Following COVID-19 Vaccination - PubMed

#221 Author:   Tinoco et al

#221 Link:         https://pubmed.ncbi.nlm.nih.gov/34866957/

******** ********    ******** ********

#222 Title:        Takotsubo cardiomyopathy after vaccination for coronavirus disease 2019 in a patient on maintenance hemodialysis

#222 Author:   Toida et al

#222 Link:         https://pubmed.ncbi.nlm.nih.gov/34731486/

******** ********    ******** ********

#223 Title:        Prominent J Waves and Ventricular Fibrillation Caused by Myocarditis and Pericarditis After BNT162b2 mRNA COVID-19 Vaccination

#223 Author:   Uesako et al

#223 Link:         https://pubmed.ncbi.nlm.nih.gov/35151782/

******** ********    ******** ********

#224 Title:        Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination

#224 Author:   Ujueta et al

#224 Link:         https://pubmed.ncbi.nlm.nih.gov/34514078/

******** ********    ******** ********

#225 Title:        Myocarditis after Covid-19 mRNA Vaccination | NEJM

#225 Author:   Verma et al

#225 Link:         https://pubmed.ncbi.nlm.nih.gov/34407340/

******** ********    ******** ********

#226 Title:        Effusive-constrictive pericarditis after the second dose of BNT162b2 vaccine (Comirnaty): a case report

#226 Author:   Viani et al

#226 Link:         https://pubmed.ncbi.nlm.nih.gov/35233481/

******** ********    ******** ********

#227 Title:        Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines - PubMed

#227 Author:   Vidula et al

#227 Link:         https://pubmed.ncbi.nlm.nih.gov/34277198/

******** ********    ******** ********

#228 Title:        Myocarditis Following mRNA COVID-19 Vaccine - PubMed

#228 Author:   Visclosky et al

#228 Link:         https://pubmed.ncbi.nlm.nih.gov/34731877/

******** ********    ******** ********

#229 Title:        Myocarditis Associated With COVID-19 Vaccination | Circulation: Cardiovascular Imaging

#229 Author:   Viskin et al

#229 Link:         https://pubmed.ncbi.nlm.nih.gov/34428917/

******** ********    ******** ********

#230 Title:        Acute Perimyocarditis Following First Dose of mRNA Vaccine Against COVID-19 - PMC

#230 Author:   Vollman et al

#230 Link:         https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8422910/

******** ********    ******** ********

#231 Title:        Case Report: Importance of MRI Examination in the Diagnosis and Evaluation of COVID-19 mRNA Vaccination Induced Myocarditis: Our Experience and Literature Review

#231 Author:   Watanabe et al

#231 Link:         https://pubmed.ncbi.nlm.nih.gov/35571222/

******** ********    ******** ********

#232 Title:        Myocarditis after BNT162b2 vaccination in a healthy male - PubMed

#232 Author:   Watkins et al

#232 Link:         https://pubmed.ncbi.nlm.nih.gov/34229940/

******** ********    ******** ********

#233 Title:        Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination

#233 Author:   Williams et al

#233 Link:         https://pubmed.ncbi.nlm.nih.gov/34308326/

******** ********    ******** ********

#234 Title:        Increased Interleukin 18-Dependent Immune Responses Are Associated With Myopericarditis After COVID-19 mRNA Vaccination

#234 Author:   Won et al

#234 Link:         https://pubmed.ncbi.nlm.nih.gov/35251049/

******** ********    ******** ********

#235 Title:        COVID-19 mRNA vaccine (Comirnaty)-induced myocarditis

#235 Author:   Wong J et al

#235 Link:         https://pubmed.ncbi.nlm.nih.gov/35075640/

******** ********    ******** ********

#236 Title:        Acute Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccine: A Case Report and Literature Review

#236 Author:   Wu CT et al

#236 Link:         https://pubmed.ncbi.nlm.nih.gov/35528839/

******** ********    ******** ********

#237 Title:        Acute myocarditis after receiving first dose of BNT162b2 mRNA vaccine

#237 Author:   Wu et al

#237 Link:         https://pubmed.ncbi.nlm.nih.gov/35018202/

******** ********    ******** ********

#238 Title:        COVID-19 mRNA Vaccination Mimicking Heart Attack in a Healthy 56-Year-Old Physician

#238 Author:   Xinias et al

#238 Link:         https://pubmed.ncbi.nlm.nih.gov/35200439/

******** ********    ******** ********

#239 Title:        Pathological findings of clinically suspected myocarditis temporally associated with COVID-19 vaccination

#239 Author:   Yamamoto M et al

#239 Link:         https://pubmed.ncbi.nlm.nih.gov/35488842/

******** ********    ******** ********

#240 Title:        Myocarditis Following the Second Dose of COVID-19 Vaccination in a Japanese Adolescent

#240 Author:   Yamamoto S et al

#240 Link:         https://pubmed.ncbi.nlm.nih.gov/35475062/

******** ********    ******** ********

#241 Title:        Self-Limited Myocarditis after the First Dose of Coronavirus Disease 2019 Messenger RNA-1273 Vaccine in a Healthy Male

#241 Author:   Yen KC et al

#241 Link:         https://pubmed.ncbi.nlm.nih.gov/35273443/

******** ********    ******** ********

#242 Title:        A Case of Acute Viral Pericarditis Complicated With Pericardial Effusion Induced by Third Dose of COVID Vaccination

#242 Author:   Zaki et al

#242 Link:         https://pubmed.ncbi.nlm.nih.gov/35165640/

******** ********    ******** ********

Resisting the Intellectual Illiteratti

LET THERE BE CARNAGE: Preliminary List of 1,759 Case Reports of Vaccine Injuries Part 1

To receive new posts and support my work, consider becoming a subscriber. This is a preliminary list of the case reports/series of vaccine associated injuries that I have collected so far. Enjoy the carnage!! …

Read more

4 years ago · 31 likes · 16 comments · Ashmedai

This is a preliminary list of the case reports/series of vaccine associated injuries that I have collected so far. Enjoy the carnage!!

****************************************************************************

Study #879 Title:           Reactive arthritis following COVID-19 vaccination with BNT162b2

Study #879 Author:      Lebowitz et al

Study #879 Link:            https://pubmed.ncbi.nlm.nih.gov/35571454/

Study #880 Title:           COVID-19: Post-vaccine Smell and Taste Disorders: Report of 6 Cases

Study #880 Author:      Lechien et al

Study #880 Link:            https://pubmed.ncbi.nlm.nih.gov/34467793/

Study #881 Title:           Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report - PubMed

Study #881 Author:      Leclerc et al

Study #881 Link:            https://pubmed.ncbi.nlm.nih.gov/34242687/

Study #882 Title:           FDG PET/MRI of Acute Myocarditis After mRNA COVID-19 Vaccination

Study #882 Author:      Lee & Kong

Study #882 Link:            https://pubmed.ncbi.nlm.nih.gov/35234199/

Study #883 Title:           Development of anti-NXP2 dermatomyositis following Comirnaty COVID-19 vaccination

Study #883 Author:      Lee AYS et al

Study #883 Link:            https://pubmed.ncbi.nlm.nih.gov/35131890/

Study #884 Title:           20 Post-COVID-19 vaccine-related shingles cases seen at the Las Vegas Dermatology clinic and sent to us via social media

Study #884 Author:      Lee C et al

Study #884 Link:            https://pubmed.ncbi.nlm.nih.gov/33991162/

Study #885 Title:           Neuroretinitis after the second injection of a SARS-CoV-2-vaccine: A case report

Study #885 Author:      Lee C et al

Study #885 Link:            https://pubmed.ncbi.nlm.nih.gov/35642221/

Study #886 Title:           Disc edema in one eye and central serous chorioretinopathy in the other eye shortly after AstraZeneca COVID-19 vaccination

Study #886 Author:      Lee DY et al

Study #886 Link:            https://pubmed.ncbi.nlm.nih.gov/34783448/

Study #887 Title:           A spectrum of cardiac manifestations post Pfizer-BioNTech COVID-19 vaccination 

Study #887 Author:      Lee E et al

Study #887 Link:            https://academic.oup.com/qjmed/article/114/9/661/6311674

Study #888 Title:           Combined Central Retinal Artery and Vein Occlusion with Ischemic Optic Neuropathy After COVID-19 Vaccination

Study #888 Author:      Lee et al

Study #888 Link:            https://pubmed.ncbi.nlm.nih.gov/35079224/

Study #889 Title:           Hyperglycemic Emergencies Associated With COVID-19 Vaccination: A Case Series and Discussion

Study #889 Author:      Lee HJ et al

Study #889 Link:            https://pubmed.ncbi.nlm.nih.gov/34604689/

Study #890 Title:           Aseptic Meningitis Following the Second Dose of Comirnaty Vaccination in an Adolescent Patient: A Case Report

Study #890 Author:      Lee JK

Study #890 Link:            https://pubmed.ncbi.nlm.nih.gov/34711784/

Study #891 Title:           Complete AV Block in Vaccinated COVID-19 Patient

Study #891 Author:      Lee K et al

Study #891 Link:            https://pubmed.ncbi.nlm.nih.gov/35371571/

Study #892 Title:           Early-Onset Myasthenia Gravis Following COVID-19 Vaccination

Study #892 Author:      Lee MA et al

Study #892 Link:            https://pubmed.ncbi.nlm.nih.gov/35289135/

Study #893 Title:           Alopecia areata following COVID-19 vaccination: vaccine-induced autoimmunity?

Study #893 Author:      Lee MM et al

Study #893 Link:            https://pubmed.ncbi.nlm.nih.gov/35107173/

Study #894 Title:           Multisystem Inflammatory Syndrome in Children After Breakthrough Infection in a COVID-19-vaccinated Child

Study #894 Author:      Lee S et al

Study #894 Link:            https://pubmed.ncbi.nlm.nih.gov/34974479/

Study #895 Title:           Central Nervous System Demyelination Following COVID-19 mRNA-Based Vaccination: Two Case Reports and Literature Review

Study #895 Author:      Lee S et al

Study #895 Link:            https://pubmed.ncbi.nlm.nih.gov/35633834/

Study #896 Title:           COVID-19 Vaccine-Induced Multisystem Inflammatory Syndrome With Polyserositis Detected by FDG PET/CT

Study #896 Author:      Lee SJ et al

Study #896 Link:            https://pubmed.ncbi.nlm.nih.gov/35175945/

Study #897 Title:           Acute gastric and Non-Mesenteric colonic infarction following mRNA COVID-19 vaccination

Study #897 Author:      Lee TG et al

Study #897 Link:            https://pubmed.ncbi.nlm.nih.gov/35618584/

Study #898 Title:           Herpes zoster reactivation after mRNA-1273 vaccination in patients with rheumatic diseases

Study #898 Author:      Lee TJ

Study #898 Link:            https://pubmed.ncbi.nlm.nih.gov/34876461/

Study #899 Title:           Neuromuscular complications after COVID-19 vaccination: a series of eight patients

Study #899 Author:      Leemans et al

Study #899 Link:            https://pubmed.ncbi.nlm.nih.gov/35499704/

Study #900 Title:           Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination - PubMed

Study #900 Author:      Leerunyakul et al

Study #900 Link:            https://pubmed.ncbi.nlm.nih.gov/34557507/

Study #901 Title:           Multisystem inflammatory syndrome with erythema multiforme-like rash in an adult after mRNA COVID-19 vaccination

Study #901 Author:      Lefeuvre et al

Study #901 Link:            https://pubmed.ncbi.nlm.nih.gov/35248401/

Study #902 Title:           New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report

Study #902 Author:      Lehmann et al

Study #902 Link:            https://pubmed.ncbi.nlm.nih.gov/34309932/

Study #903 Title:           Vocal fold palsy after vaccination against SARS-CoV-2

Study #903 Author:      Lehrer et al

Study #903 Link:            https://pubmed.ncbi.nlm.nih.gov/35190198/

Study #904 Title:           Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report

Study #904 Author:      Lellig et al

Study #904 Link:            https://pubmed.ncbi.nlm.nih.gov/35470099/

Study #905 Title:           Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report

Study #905 Author:      Lemoine et al

Study #905 Link:            https://pubmed.ncbi.nlm.nih.gov/35294664/

Study #906 Title:           Hepatitis C Virus Reactivation Following COVID-19 Vaccination – A Case Report - PMC

Study #906 Author:      Lensen et al

Study #906 Link:            https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8412816/

Study #907 Title:           Four cases of acquired hemophilia A following immunization with mRNA BNT162b2 SARS-CoV-2 vaccine

Study #907 Author:      Leone et al

Study #907 Link:            https://pubmed.ncbi.nlm.nih.gov/35081484/

Study #908 Title:           Reactivation of minimal change disease and IgA nephropathy after COVID-19 vaccination

Study #908 Author:      Leong et al

Study #908 Link:            https://pubmed.ncbi.nlm.nih.gov/35198161/

Study #909 Title:           Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2

Study #909 Author:      Lesort et al

Study #909 Link:            https://pubmed.ncbi.nlm.nih.gov/34131969/

Study #910 Title:           Myocarditis following COVID-19 vaccination - A case series

Study #910 Author:      Levin et al

Study #910 Link:            https://pubmed.ncbi.nlm.nih.gov/34535317/

Study #911 Title:           Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination

Study #911 Author:      Liang et al

Study #911 Link:            https://pubmed.ncbi.nlm.nih.gov/34599716/

Study #912 Title:           Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection

Study #912 Author:      Liao et al

Study #912 Link:            https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707922/

Study #913 Title:           A case of adenoviral covid-19 vector vaccine possibly linked to severe but reversible interstitial lung injury post-vaccination

Study #913 Author:      Liatsos et al

Study #913 Link:            https://pubmed.ncbi.nlm.nih.gov/35546097/

Study #914 Title:           A case of multisystem inflammatory syndrome in adults following natural infection and subsequent immunization

Study #914 Author:      Lieu et al

Study #914 Link:            https://pubmed.ncbi.nlm.nih.gov/34954311/

Study #915 Title:           Acute interstitial nephritis following SARS-CoV-2 virus vaccination

Study #915 Author:      Liew et al

Study #915 Link:            https://pubmed.ncbi.nlm.nih.gov/35113012/

Study #916 Title:           Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination

Study #916 Author:      Lim & Wylie

Study #916 Link:            https://pubmed.ncbi.nlm.nih.gov/34399001/

Study #917 Title:           Focal segmental glomerulosclerosis following the Pfizer-BioNTech COVID-19 vaccine

Study #917 Author:      Lim CA et al

Study #917 Link:            https://pubmed.ncbi.nlm.nih.gov/35286791/

Study #918 Title:           Bacillus Calmette-Guérin scar flare after an mRNA SARS-CoV-2 vaccine

Study #918 Author:      Lim D WT et al

Study #918 Link:            https://pubmed.ncbi.nlm.nih.gov/34344774/

Study #919 Title:           Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation - PubMed

Study #919 Author:      Lim et al

Study #919 Link:            https://pubmed.ncbi.nlm.nih.gov/34778411/

Study #920 Title:           Response to "Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases"

Study #920 Author:      Lim et al

Study #920 Link:            https://pubmed.ncbi.nlm.nih.gov/35071714/

Study #921 Title:           New-Onset Kidney Diseases after COVID-19 Vaccination: A Case Series

Study #921 Author:      Lim JH et al (1)

Study #921 Link:            https://pubmed.ncbi.nlm.nih.gov/35214760/

Study #922 Title:           New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review

Study #922 Author:      Lim JH et al (2)

Study #922 Link:            https://pubmed.ncbi.nlm.nih.gov/34342187/

Study #923 Title:           Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination - PubMed

Study #923 Author:      Lim XR et al

Study #923 Link:            https://pubmed.ncbi.nlm.nih.gov/34579211/

Study #924 Title:           Unusual Fever, Headache, and Abdominal Pain in a Healthy Woman

Study #924 Author:      Lin CY et al

Study #924 Link:            https://pubmed.ncbi.nlm.nih.gov/34339677/

Study #925 Title:           Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech)

Study #925 Author:      Lin et al

Study #925 Link:            https://pubmed.ncbi.nlm.nih.gov/35306680/

Study #926 Title:           Hemophagocytic Lymphohistiocytosis Following BNT162b2 mRNA COVID-19 Vaccination

Study #926 Author:      Lin TY et al

Study #926 Link:            https://pubmed.ncbi.nlm.nih.gov/35455321/

Study #927 Title:           Moyamoya disease with Sjogren disease and autoimmune thyroiditis presenting with left intracranial hemorrhage after messenger RNA-1273 vaccination: A case report

Study #927 Author:      Lin YH et al

Study #927 Link:            https://pubmed.ncbi.nlm.nih.gov/35147099/

Study #928 Title:           COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis

Study #928 Author:      Lindgren et al

Study #928 Link:            https://pubmed.ncbi.nlm.nih.gov/34120504/

Study #929 Title:           Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2

Study #929 Author:      Lindhoff-Last et al

Study #929 Link:            https://pubmed.ncbi.nlm.nih.gov/34794199/

Study #930 Title:           The syndrome of inappropriate antidiuresis after vaccination against COVID-19: case report

Study #930 Author:      Lindner & Ryser

Study #930 Link:            https://pubmed.ncbi.nlm.nih.gov/34560836/

Study #931 Title:           Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome

Study #931 Author:      Ling et al

Study #931 Link:            https://pubmed.ncbi.nlm.nih.gov/34810163/

Study #932 Title:           New-onset cutaneous lupus erythematosus after the COVID-19 vaccine

Study #932 Author:      Liu & Messenger

Study #932 Link:            https://pubmed.ncbi.nlm.nih.gov/35130405/

Study #933 Title:           Two Cases of Post-Moderna COVID-19 Vaccine Encephalopathy Associated With Nonconvulsive Status Epilepticus

Study #933 Author:      Liu et al

Study #933 Link:            https://pubmed.ncbi.nlm.nih.gov/34367780/

Study #934 Title:           New-onset and relapsing glomerular diseases related to COVID-19 vaccination

Study #934 Author:      Liu F et al

Study #934 Link:            https://pubmed.ncbi.nlm.nih.gov/34704408/

Study #935 Title:           Gross haematuria after mRNA COVID-19 vaccination in two patients with histological and clinical diagnosis of IgA nephropathy

Study #935 Author:      Lo & Chan

Study #935 Link:            https://pubmed.ncbi.nlm.nih.gov/34766415/

Study #936 Title:           Letter in Reply: Alopecia areata after SARS-CoV-2 vaccination

Study #936 Author:      Lo et al

Study #936 Link:            https://pubmed.ncbi.nlm.nih.gov/35571458/

Study #937 Title:           Varicella Zoster Reactivation Causing Acute Retinal Necrosis following mRNA COVID-19 Vaccination in a Young Immunocompetent Man

Study #937 Author:      Lo T et al

Study #937 Link:            https://pubmed.ncbi.nlm.nih.gov/35133925/

Study #938 Title:           Mammographic and sonographic findings in the breast and axillary tail following a COVID-19 vaccine

Study #938 Author:      Locklin & Woodward

Study #938 Link:            https://pubmed.ncbi.nlm.nih.gov/34340203/

Study #939 Title:           An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: Coincidence, autoimmunity or drug-related liver injury

Study #939 Author:      Lodato et al

Study #939 Link:            https://pubmed.ncbi.nlm.nih.gov/34256064/

Study #940 Title:           Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report

Study #940 Author:      Lohmann et al

Study #940 Link:            https://pubmed.ncbi.nlm.nih.gov/35585528/

Study #941 Title:           Another case of autoimmune hepatitis after SARS-CoV-2 vaccination - still casualty?

Study #941 Author:      Londoño et al

Study #941 Link:            https://pubmed.ncbi.nlm.nih.gov/34129886/

Study #942 Title:           Acute-onset polyradiculoneuropathy after SARS-CoV2 vaccine in the West and North Midlands, United Kingdom

Study #942 Author:      Loo et al

Study #942 Link:            https://pubmed.ncbi.nlm.nih.gov/34786740/

Study #943 Title:           BCG Scar Local Skin Inflammation as a Novel Reaction Following mRNA COVID-19 Vaccines in Two International Healthcare Workers

Study #943 Author:      Lopatynsky-Reyes et al

Study #943 Link:            https://pubmed.ncbi.nlm.nih.gov/33996313/

Study #944 Title:           Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination

Study #944 Author:      Lopez ED et al

Study #944 Link:            https://pubmed.ncbi.nlm.nih.gov/35256820/

Study #945 Title:           SARS-CoV-2 vaccine, a new autoimmune hepatitis trigger?

Study #945 Author:      López Romero-Salazar et al

Study #945 Link:            https://pubmed.ncbi.nlm.nih.gov/35373571/

Study #946 Title:           Pernio after COVID-19 vaccination

Study #946 Author:      Lopez S et al

Study #946 Link:            https://pubmed.ncbi.nlm.nih.gov/33893637/

Study #947 Title:           Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine

Study #947 Author:      López-Valle et al

Study #947 Link:            https://pubmed.ncbi.nlm.nih.gov/33855706/

Study #948 Title:           Solid organ procurement and transplantation from deceased donors with vaccine-induced thrombosis and thrombocytopenia

Study #948 Author:      Loupy et al

Study #948 Link:            https://pubmed.ncbi.nlm.nih.gov/34233058/

Study #949 Title:           Pure sensitive chronic inflammatory axonal polyneuropathy following Pfizer COVID-19 vaccine

Study #949 Author:      Luca et al

Study #949 Link:            https://pubmed.ncbi.nlm.nih.gov/34734345/

Study #950 Title:           SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study

Study #950 Author:      Luchetti Gentiloni et al

Study #950 Link:            https://pubmed.ncbi.nlm.nih.gov/35386714/

Study #951 Title:           Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review

Study #951 Author:      Lui et al

Study #951 Link:            https://pubmed.ncbi.nlm.nih.gov/34888290/

Study #952 Title:           Guillain-Barré syndrome following coronavirus disease vaccine: First report from Nepal

Study #952 Author:      Luitel et al

Study #952 Link:            https://pubmed.ncbi.nlm.nih.gov/35646371/

Study #953 Title:           Myocardial infarction post COVID-19 vaccine - coincidence, Kounis syndrome or other explanation - time will tell

Study #953 Author:      Maadarani et al

Study #953 Link:            https://pubmed.ncbi.nlm.nih.gov/34394944/

Study #954 Title:           An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine

Study #954 Author:      Maas et al

Study #954 Link:            https://pubmed.ncbi.nlm.nih.gov/33992727/

Study #955 Title:           Acquired Thrombotic Thrombocytopenic Purpura: a rare disease associated Acquired with BNT162b2 vaccine - PMC

Study #955 Author:      Maayan et al

Study #955 Link:            https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8237075/

Study #956 Title:           Rhabdomyolysis Secondary to COVID-19 Vaccination

Study #956 Author:      Mack et al

Study #956 Link:            https://pubmed.ncbi.nlm.nih.gov/34150372/

Study #957 Title:           Rhabdomyolysis Secondary to COVID-19 Vaccination

Study #957 Author:      Mack et al

Study #957 Link:            https://pubmed.ncbi.nlm.nih.gov/34150372/

Study #958 Title:           Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination

Study #958 Author:      Maeda et al

Study #958 Link:            https://pubmed.ncbi.nlm.nih.gov/34866122/

Study #959 Title:           Ulcers on the bilateral palate mucosa following mRNA-based vaccination for coronavirus disease 2019 (COVID-19): A case report

Study #959 Author:      Maeda et al

Study #959 Link:            https://pubmed.ncbi.nlm.nih.gov/35114426/

Study #960 Title:           Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2

Study #960 Author:      Magen et al

Study #960 Link:            https://pubmed.ncbi.nlm.nih.gov/34983707/

Study #961 Title:           The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin

Study #961 Author:      Magro et al

Study #961 Link:            https://pubmed.ncbi.nlm.nih.gov/34920834/

Study #962 Title:           First report of post-transplant autoimmune hepatitis recurrence following SARS-CoV-2 mRNA vaccination

Study #962 Author:      Mahalingham et al

Study #962 Link:            https://pubmed.ncbi.nlm.nih.gov/35390478/

Study #963 Title:           Reactivation of juvenile idiopathic arthritis associated uveitis with posterior segment manifestations following anti-SARS-CoV-2 vaccination

Study #963 Author:      Mahendradas et al